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Abstract 
 
Proper microtubule stability is crucial to build normal bipolar spindles and align 
chromosomes correctly during mitosis. Clathrin heavy chain 17 (CHC) is required for 
microtubule stability during mitosis independent of its functions in interphase. CHC interacts 
with the protein TACC3, which permits the CHC-TACC3 complex to translocate onto mitotic 
spindles. A mutant on the CHC terminal domain (TD) affects neither the TACC3 interaction 
nor their spindle localization. However, this mutant further causes mitotic defects, suggesting 
that the CHC TD has unique functions during mitosis. Here, we found that GTSE1 binds 
directly to the CHC terminal domain (TD) via several LIDL-like motifs that resemble motifs 
in clathrin adaptor proteins for binding the CHC TD. A pair of different interactions with 
these motifs is required for stabilizing the CHC-GTSE1 complex. Using X-ray 
crystallography, we further gained insight into this interaction in a molecular resolution. 
Moreover, its direct interaction with CHC is required for GTSE1’s recruitment to and 
functions on spindles. GTSE1 mutated at these CHC-binding motifs delocalizes from spindles 
and leads to defects in the spindle architecture, chromosome alignment and timely mitosis. 
We previously identified GTSE1 as a novel microtubule-stabilizing protein that inhibits the 
activity of the microtubule depolymerase MCAK. In this study, we reconstituted a 
microtubule-stabilizing complex including CHC, TACC3, ch-TOG and GTSE1 in vitro, and 
this complex can further interact with MCAK. Thus, one mechanism of how the CHC TD 
stabilizes spindle microtubules is by bringing GTSE1 to inhibit MCAK. Furthermore, we 
found that GTSE1 could weakly interact with the KMNZ network of kinetochores, dependent 
on Aurora B phosphorylation, and that GTSE1 occasionally colocalizes with MCAK on 
kinetochores. This recruitment might imply how GTSE1 regulates MCAK activity on 
kinetochores to maintain the proper microtubule-kinetochore attachment. In summary, here 
we showed that GTSE1 localizes on spindles via the CHC-TACC3 complex and is recruited 
to the outer kinetochores through the KMNZ complex, which globally regulates MCAK 
activity in mitosis to achieve a normal bipolar spindle and proper microtubule-kinetochore 
attachment. 
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Zusammenfassung 
 
Die richtige Mikrotubilistabilität ist sowohl entscheidend für den Aufbau normaler bipolarer 
Spindeln als auch für die korrekte Ausrichtung der Chromosomen während der Mitose. 
Clathrin Heavy Chain 17 (CHC) wird,  unabhängig von seinen Funktionen während der 
Interphase, während der Mitose zur Stabilisierung der Mikrotubuli benötigt. CHC interagiert 
mit dem Protein TACC3, was es dem CHC-TACC3 Komplex dann ermöglicht, sich auf 
mitotische Spindeln zu verlagern. Eine Mutation in der CHC Terminal Domäne (TD) 
beeinflusst weder die Interaktion mit TACC3 noch die Spindellokalisierung. Jedoch 
verursacht diese Mutation Defekte in der Mitose, was darauf hindeutet, dass die CHC TD 
einzigartige Funktionen während der Mitose ausübt. Hier konnten wir zeigen, dass GTSE1 
durch mehrere LIDL Motive, die den Motiven von Clathrinadaptorproteinen ähneln, direkt 
die CHC TD bindet. Zur Stabilisierung dieses Komplexes werden dabei drei individuelle 
LIDL Motive benötigt. Mit Hilfe von Röntgenkristallographie konnten wir weitere Einblicke 
in diese Wechselwirkung in molekularer Auflösung gewinnen. Darüber hinaus ist die direkte 
Interaktion von CHC mit GTSE1 für die Rekrutierung von GTSE1 und die Lokalisierung an 
der mitotischen Spindel erforderlich. Mutationen von GTSE1 im Bereich dieser CHC 
Bindungsmotive führen zur Delokalisation von GTSE1 von der Spindel und Defekten in der 
Spindelarchitektur, Chromosomenausrichtung und verzögerter Mitose. 
Zuvor konnten wir GTSE1 als neuartiges Mikrotubuli stabilisierendes Protein identifizieren, 
das die Depolymeraseaktivität von MCAK inhibiert. In dieser Studie rekonstruierten wir in 
vitro einen Mikrotubuli stabilisierenden Komplex aus CHC, TACC3, ch-TOG und GTSE1 
und konnten zeigen, dass dieser des Weiteren mit MCAK interagieren kann. Demnach ist ein 
Mechanismus, durch den Spindelmikrotubuli stabilisiert werden, dass GTSE1 von CHC-TD 
rekrutiert wird und in Folge dessen MCAK inhibieren kann. Darüber hinaus fanden wir 
heraus, dass GTSE1 schwach mit dem KMNZ-Netzwerk von Kinetochoren in Abhängigkeit 
von Phosphorylierung durch Aurora B interagieren kann und dass GTSE1 sich vereinzelt mit 
MCAK an Kinetochoren kolokalisiert. Diese Rekrutierung könnte zeigen, wie GTSE1 die 
Aktivität von MCAK an Kinetochoren reguliert, um die korrekte Bindung zwischen 
Mikrotubuli und Kinetochoren aufrechtzuerhalten. 
Zusammenfassend haben wir hier gezeigt, dass sich GTSE1 mit Hilfe des CHC-TACC3-
Komplexes an Spindeln lokalisiert und durch den KMNZ-Komplex zu den äußeren 
Kinetochoren rekrutiert wird, wodurch die Aktivität von MCAK in der Mitose global reguliert 
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wird, um eine normale bipolare Spindel und korrekte Bindungen zwischen Mikrotubuli und 
Kinetochoren zu erreichen. 
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1. Introduction 
The precise regulation of microtubule dynamics and stability ensures accurate chromosome 
segregation during cell division. Clathrin has recently emerged as an unexpected player to 
control mitotic microtubule stability. Clathrin heavy chain 17 (CHC) interacts with TACC3 in 
mitosis to form a complex that binds to microtubules and localizes to spindles. The CHC-
TACC3 complex is important for microtubule stability and chromosome alignment, but the 
mechanisms by which this complex stabilizes microtubules are still being unraveled. This 
complex has been shown to recruit GTSE1 onto spindles, suggesting that GTSE1 could be 
functionally involved in the CHC-TACC3 complex. Our laboratory previously found GTSE1 
as a novel microtubule-stabilizing protein that is required for maintaining proper microtubule 
stability, correct chromosome alignment, and timely mitosis. Additionally, we identified that 
the mechanism by which GTSE1 stabilizes microtubules is through the inhibition of MCAK. 
In this study, we aimed to ask if the GTSE1-MCAK complex could be a directly downstream 
effector of the CHC-TACC3 complex and understand how these protein complexes function 
together in stabilizing microtubules.      
 
1.1 Tubulin dimer and microtubules  
Microtubule dynamics is very important to regulate several cellular events such as cell 
migration and spindle integrity. The basic subunit of microtubule is tubulin dimer of one α- 
and one β-subunit that are tightly bound together. Each subunit of tubulin dimer binds GTP. 
The GTP bound to the α-tubulin is not hydrolyzed because it is trapped in the αβ-tubulin 
heterodimer. However, the GTP exposed on the β-tubulin is unstable and is hydrolyzed 
following polymerization (Akhmanova and Steinmetz, 2008). A protofilament is a polar 
polymer of the tubulin dimers in which the coming α-tubulin mainly adds onto the existing β-
subunit of protofilament. The α-subunit-exposed end is designated as the minus end and the 
other β-subunit-exposed end is the plus end. In general, 13 protofilaments are laterally bound 
together and form a helically hollow cylinder called a microtubule that is approximately 25 
µm in diameter (Akhmanova and Steinmetz, 2008). Microtubules show dynamic phases of 
growth and shrinkage/catastrophe at their plus ends where tubulin dimers are added or 
removed. The cycle between these two phases is termed dynamic instability (Mitchison and 
Kirschner, 1984). The GTP-containing end of microtubule (GTP-cap) is important for 
maintaining microtubule stability. If the GTP-cap is hydrolyzed, microtubule stops growing 
and depolymerizes. Once the GTP bound β-tubulin is added, this GTP-cap switches the 
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microtubule back to growth (Brouhard and Sept, 2012). In cells the minus ends of 
microtubules are captured and stabilized by microtubule organizing centers (MTOCs) and the 
plus ends show the growth and shrinkage of dynamics instability. However, in mitosis if the 
microtubule plus end is captured by chromosome, it is stabilized and the dynamic instability 
is suppressed (Heald and Khodjakov, 2015). 
 
Figure 1-1. The cycle of tubulin assembly and disassembly 
The GTP-bound tubulin dimer (purple) incorporates into the growing end (+) of microtubule. This 
process is called polymerization. GTP-bound β-tubulins on the plus end are termed a GTP-cap, which 
stabilizes the microtubule. Once the GTPs bound to β-tubulins are hydrolyzed (lightly blue), the 
tubulin dimers are removed from the plus end and undergo depolymerization/catastrophe, resulting in 
rapid shrinkage of the microtubule. When a rescue factor (e.g. a protein) approaches or new GTP-
bound tubulin dimers are added on the plus end, the microtubule stops shrinking and repolymerizes 
again. The cycle between microtubule growth and catastrophe is termed “dynamic instability”. Figure 
is adapted from Akhmanova and Steinmetz, 2015.  
 
1.2 Microtubule associated proteins (MAPs) 
MAPs are a group of proteins which associate with the tubulin subunit, the microtubule lattice 
or microtubule ends (Olmsted, 1986). Since microtubules are highly dynamic, MAPs 
generally either stabilize or destabilize microtubules. Recently, some MAPs have been found 
to accumulate specifically at the plus-end of microtubules, termed “+TIPs”. EB (End binding) 
proteins are well known +TIPs. EB1 is an evolutionarily conserved protein that directly binds 
the microtubule plus end and controls microtubule dynamics (Vaughan, 2005). Proteins that 
contain SxIP motif (Ser-any amino acid-Ile-Pro) have been characterized as potential EB1 
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binding-proteins (Honnappa et al., 2009). Therefore, the tip tracking ability of some +TIPs is 
due to the interaction with EB proteins, but does not necessarily bind directly to the 
microtubule plus end. Other MAPs, motor proteins, utilize the energy from ATP and generate 
mechanical movement along microtubules. According to the movement on microtubules, 
motors are divided into kinesin or dynein. Kinesin usually moves toward the plus end and 
dynein moves toward the minus end. Due to the microtubule binding and the movement of 
motors, some motors generate a pull force to slide antiparallel microtubules apart and drive 
chromosome movement such as Kinesin-5 (Prosser and Pelletier, 2017). Additionally, some 
motor proteins form homodimer that bundle and stabilize microtubules, for example, kinesin-
14 (Braun et al., 2009). The kinesin-13 family does not walk on microtubules, but acts as 
depolymerase to destabilize microtubules (Prosser and Pelletier, 2017).   
 
1.3 Mitotic spindle microtubules 
The mitotic spindle contains hundreds of microtubules in mammalian cells. Depending on 
whether they connect to kinetochores or not, microtubules can be simply divided into 
kinetochore fibers (k-fibers) or non-kinetochore fibers. In comparison with K-fibers, non-k-
fibers are the major microtubules in mammalian spindles and are required for spindle shape 
and spindle stability (Mastronarde et al., 1993). Parallel microtubules originating from 
centrosomes, which form bundles that end at kinetochores, are known as K-fibers (discussed 
in detail in 1.4). Non-K-fiber microtubules, which do not interact with kinetochores, include 
astral microtubules, polar microtubules and bridging microtubules (Prosser and Pelletier, 
2017; Tolic, 2017). Microtubules that grow from centrosomes towards the cell cortex are 
defined as astral microtubules. Polar microtubules are spindle microtubules that come from 
poles and have free ends. Recently, bridging microtubules/ fibers have been observed. They 
contain 10-15 microtubules originating from poles and pass the sister chromosomes, which 
are important for maintaining spindle integrity (Kajtez et al., 2016).  
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Figure 1-2. The mitotic spindle microtubules 
The composition of microtubules in metaphase. K-fibers are indicated in purple lines. Non-
kinetochore microtubules including astral microtubules (MTs), polar microtubules and bridging 
microtubules are labeled in green lines. Figure is adapted from Tolic, 2017 
 
1.4 kinetochore fiber (K-fiber)   
A K-fiber is a bundle of 20-40 parallel microtubules in which one end is located at the 
centrosome and the other end attaches to the kinetochore. Due to the connection between 
chromosome and kinetochores, K-fibers are essential for chromosome movement and 
segregation. K-fibers are remarkably more stable than the other spindle microtubules (Rieder, 
1981). The higher stability of k-fibers is considered to mainly be due to the protection of the 
plus-ends from catastrophe when attached to kinetochores. Some proteins can bundle pairs of 
microtubules and thereby stabilize microtubules. For example, Eg5, PRC-1 and kinesin-14 are 
known to slide cross-linked anti-parallel microtubules, potentially contributing to k-fiber 
stability by coupling some degree of non K-fibers with K-fibers (Manning and Compton, 
2008; Peterman and Scholey, 2009). However, due to the fact that microtubules are parallel 
inside K-fibers, these motors/proteins might not prefer to bundle microtubules and stabilize 
K-fibers per se. Additionally, they are barely found to decorate the entire K-fiber in cells. 
More recently, a clathrin-TACC3-ch-TOG complex has been shown to be associated with K-
fibers and to control microtubule stability (Hood and Royle, 2009; Hood et al., 2013; Nixon et 
al., 2015). (discuss in detail in 1.12). Additionally, TPX2, which localizes to K-fibers, has 
been shown to bundle microtubules in vitro. However, it is not clear if TPX2 could cross-link 
inner-microtubules within K-fibers in cells (Alfaro-Aco et al., 2017; Bird and Hyman, 2008).       
 
1.	Introduction	 	 8		
1.5 Mitotic phase  
Mitotic phase is a stage of the cell cycle that consists of mitosis and cytokinesis. Replicated 
chromosomes are segregated and delivered into two new cells during mitosis. At cytokinesis 
the cytoplasm, organelles, nuclei and cell membranes are finally equally split into two 
daughter cells. The process of mitosis can be divided into five distinct phases: In Prophase, 
chromosomes start to condense and the nuclear envelope breaks down. Meanwhile, motor 
proteins walk along microtubules and generate pulling forces by which centrosomes are 
pushed away from each other and will eventually form two spindle poles. During 
Prometaphase, microtubules are mainly nucleated from centrosomes and chromatin, which 
generate a microtubule spindle apparatus. Microtubules asynchronously and stochastically 
capture kinetochores to align them. In metaphase, all chromosomes are aligned at the center 
of the bipolar spindle known as metaphase plate. Each kinetochore chromosome has to be 
attached by microtubules from opposite poles, forming a status defined as the bi-orientation, 
to initiate anaphase. During anaphase, the cyclin B1 and securin are degraded, leading to 
inactivation of Cdk1 and liberation of separase. Separase cleaves cohesins between sister 
chromosomes. A pulling force, which is generated by depolymerization of kinetochore fibers 
at the pole and the kinetochore, segregates chromosomes towards opposite poles. In 
telophase, a new nuclear envelope surrounding the chromosomes is formed that completes 
mitosis (Asbury, 2017; Cheeseman and Desai, 2008). 
 
 
 
Figure 1-3. The overview of mitosis 
Mitosis comprises five phases including prophase, prometaphase, metaphase, anaphase and telophase. 
Chromatids are condensed and nuclear envelope breaks down during prophase. The microtubule-
1.	Introduction	 	 9		
kinetochore interaction starts being built in the period of prometaphase. In metaphase, all 
chromosomes are aligned on the equator of the mitotic spindle, which achieve the biorientated 
kinetochore-microtubule attachments. Once the biorientation is generated, chromosomes are 
segregated towards two poles so called anaphase. Separated chromosomes are surrounded by the new-
formed nuclear envelope in telophase. Figure is adapted from Cheeseman and Desai, 2008.      
     
1.6 The overview of organizations and functions of kinetochore 
The kinetochore is the multisubunit complex that generates load-bearing attachments between 
sister chromatids and spindle microtubules in mitosis and meiosis (Musacchio and Desai, 
2017). The vertebrate kinetochores can be simply divided into different layers as seen in 
electron micrographs including the inner layer and the outer layer. The inner layer is known 
as the CCAN (constitutive centromere associated network), functioning in the connection 
between the centromere and the outer kinetochore (Cheeseman and Desai, 2008; McClelland 
et al., 2007; Musacchio and Desai, 2017; Pesenti et al., 2016). The outer kinetochore KMN 
network is composed of three different complexes assembling from the two-subunit Knl1 
complex, the four-subunit Mis12 complex and the four-subunit Ndc80 complex. This network 
is assembled in prophase and disassembled during late ana-/telophase (Cheeseman and Desai, 
2008). The functions of KMN network are to build the stable kinetochore-microtubule 
attachment and the recruitment of the spindle assembly checkpoint (SAC) complex, which is 
majorly regulated by Aurora B kinase (further discussed in 1.7).  
The Ndc80 complex is thought to be the major platform for microtubule-kinetochore 
attachment, consisting of Ndc80 (also known as Hec1), Nurf2, Spc24 and Spc25, forming a 
long coiled-coil with globular domains at both ends (Ciferri et al., 2005; Wei et al., 2005). 
Noteworthy, the RNAi depletion of Ndc80 complex results in a K-fiber-null-phenotype, 
indicating that the Ndc80 complex is the major component to build microtubule-kinetochore 
attachments. Additionally, a highly basic and disordered ~80-residues of the N-terminal 
Ndc80 have been implicated in microtubule binding (Alushin et al., 2010). Phosphorylations 
on this N-terminal peptide by Aurora B kinase affect Ndc80 to bind microtubules (discuss in 
detail in 1.7). Interestingly, the internal loop of Ndc80 has been shown to interact with Cis1 
(ch-TOG orthologous in fission yeast) that recruits Cis1 to kinetochores (Hsu and Toda, 
2011), and this interaction can be also found in human and budding yeast (Miller et al., 2016). 
The Ndc80 loop mutant, which retains forming the Ndc80 complex and localizes at 
kinetochores, fails to interact with Cis1, leading to the defective kinetochore-microtubule 
attachment. In addition to the microtubule binding by Ndc80 per se, this result suggests that 
1.	Introduction	 	 10		
Ndc80 cooperates with ch-TOG in regulating kinetochore-microtubule attachment as well 
(Hsu and Toda, 2011). Thus, Ndc80 complex comprises two microtubule-binding surfaces: 
the N-terminal region directly binds microtubule lattice and the internal loop indirectly 
interacts with plus end of microtubules through ch-TOG.     
 
 
Figure 1-4. The overview of human kinetochore 
Left; the electron micrographs of chromosomes and kinetochores. Centromere region in pink, inner 
kinetochore in red, outer kinetochore in yellow and microtubules in green. Figure is adapted from 
Cleveland et al., 2003. Right; the schematic cartoon of kinetochore-microtubule attachment based on 
the known structure and features of kinetochore proteins. The kinetochore comprises the inner 
kinetochore (constitutive centromere associated network, CCAN) and the outer kinetochore (KMN 
network). Figure is modified from Petrovic et al., 2016.  
1.7 The proper Kinetochore-Microtubule attachment 
To segregate chromosomes equally, cells must build the proper kinetochore-microtubule 
attachment by which accurate copies of genetic materials are delivered to two daughter cells. 
When improper chromosome segregation happens due to erroneous kinetochore-microtubule 
attachment, cells have a high risk to acquire the incorrect number of chromosomes (known as 
aneuploidy) that might lead to carcinogenesis in the end. Kinetochore-microtubule 
attachments can be simply divided into four different types as shown below. 
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Figure 1-5. Types of the kinetochore-microtubule attachment 
 (A) Monotelic attachment is a transient state in which only one kinetochore is bound to microtubules 
from one pole. There are two types of erroneous kinetochore attachments (B)(D). (B) Syntelic 
attachment is that both kinetochores connect with microtubules from the same pole. (C) Amphitelic 
attachment: sister kinetochores are attached to microtubules from opposite poles.  (D) Merotelic 
attachment is that a single kinetochore interacts with microtubules emanating from both poles. Figure 
is adapted from Tanaka et al., 2005 
 
The initial capture of microtubules by kinetochores is asynchronous and stochastic (Magidson 
et al., 2011; Rieder, 1981). Consequently, erroneous attachments including monotelic, 
syntelic and merotelic attachments are often observed in early mitosis. However, monotelic 
attachments and unattached kinetochores arrest cells before anaphase onset that prevent 
chromosome segregation due to the activation of SAC signaling. Once SAC is activated, 
Mps1, Mad1, Mad2, Bub1, BubR1 and Bub3 are recruited to the unattached kinetochores, 
leading to the formation of mitotic checkpoint complex (MCC) (Lara-Gonzalez et al., 2012.) 
The MCC, a complex including Cdc20, Mad2, Bub3 and BubR1, prevents premature 
chromosome segregation through inhibiting the anaphase promoting complex (APC/C). Once 
all sister chromosomes display amphitelic attachments, the SAC is satisfied and disassembles 
Cdc20 from MCC. Cdc20 as a co-activator then associates and activates APC/C that degrades 
both cyclin B1 and securin (Lara-Gonzalez et al., 2012; Musacchio and Desai, 2017). On one 
hand, the degradation of cyclin B1 inactivates Cdk1, allowing subsequent exit from mitosis; 
on the other hand, the degradation of securin liberates separase to cleave cohesin between two 
sister chromatids that separates sister chromatids and allows anaphase onset. Syntelic 
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attachments rarely persist in human cell because the error correction by Aurora B kinase can 
efficiently adjust this mal-attachment. However, merotelic attachments are more common and 
dangerous because both kinetochores are attached by microtubules and therefore cells evade 
the SAC (Cimini et al., 2004; Cimini et al., 2006). As a consequence, anaphase can continue 
prior correcting them in which chromosomes show a delayed movement. These chromosomes 
are defined as lagging chromosomes and perhaps cause aneuploidy. Thus, these mal-
attachments have to be corrected to amphitelic attachments by the error correction machinery. 
The error correction highly relies on the dynamic disassociation of microtubules from mal-
attachments. Thus a balance between stable kinetochore-microtubule attachments and the 
efficient error correction is required to form proper bi-oriented attachments.    
For correcting erroneous attachments, the detachment of microtubules from chromosomes 
seems to be the rate-limiting step (Li and Nicklas, 1995; Nicklas and Ward, 1994).  Aurora B 
kinase, which localizes on inner centromeres and is enriched at misaligned chromosome, is 
one of key players in destabilizing kinetochore-microtubule attachments during the error 
correction (Cimini et al., 2006). Ndc80 is thought to be the major component to mediate 
kinetochore-microtubule attachments, which can be phosphorylated up to 9 sites by Aurora B 
kinase. The Aurora B phosphorylation neutralizes the positive charge of Ndc80 that disrupts 
the electrostatic interaction between Ndc80 and microtubules (Cheeseman and Desai, 2008; 
Cheeseman et al., 2013; Ciferri et al., 2008; DeLuca et al., 2006; DeLuca et al., 2011). When 
bi-oriented attachments are achieved, sister chromosomes are being pulled away from 
centromeres and towards opposite spindle poles to generate tension. This tension enlarges a 
distance between centromeres and outer kinetochores where Aurora B activity gradually 
decreases from centromere towards the outer kinetochore (Lampson and Cheeseman, 2011; 
Liu et al., 2009; Wang et al., 2011). Thus, once bi-oriented attachments are achieved and 
tensions are higher, Ndc80 is away from centromere and escapes from Aurora B 
phosphorylation and is more dephosphorylated by phosphatases on kinetochores, leading to 
stabilization of kinetochore-microtubule attachment. Consistent with this idea of tension, 
syntelic attachments that the tensions are not generated can be efficiently corrected Aurora B 
kinase (Hauf et al., 2003). Conversely, active Aurora B kinase has been shown to enrich at 
merotelic attachment even though the tension is sufficient, and might perform the error 
correction (Knowlton et al., 2006). The model of how Aurora B repairs these mal-attachments 
is shown below.  
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Figure 1-6. Aurora B corrects the merotelic attachment  
Aurora B activity is higher in inner centromere. (A) In early prometaphase, there is no tension 
between unattached sister kinetochores. As a result, the turnover of kinetochore-microtubule 
attachment is fast. (B) Once amphitelic attachment is built, two sister kinetochores are pulled towards 
opposite poles and are away from the Aurora B enriched region. The kinetochore-microtubule 
attachments become more stable. (C) When merotelic attachment happens, the incorrect attachment 
sites are relatively close to the higher Aurora B gradient. Thus, Aurora B kinase destabilizes the error 
attachments and leaves empty sites on kinetochores shown in D (blue cross). As illustrated in E, the 
possibility of new microtubule reattachments (blue microtubule) is generated. The new and stochastic 
attachment (blue microtubule) can be formed in the correct way (E, left) or incorrect way (E, right). 
Figure is adapted from Cimini et al., 2006. 
 
MCAK is a potent microtubule depolymerase that accumulates at centrosomes and 
kinetochores (Knowlton et al., 2006; Lan et al., 2004; Parra et al., 2006). Loss of MCAK 
activity, for instance MCAK depletion or MCAK mutation, has been shown to cause 
persistently hyper-stable kinetochore-microtubule attachments (Bakhoum et al., 2009a; 
Bakhoum et al., 2009b; Maney et al., 1998). The persistent mal-attachments at kinetochores 
lead to lagging chromosomes, chromosome missegregation and chromosomal instability 
(CIN) (Bakhoum et al., 2009a; Bakhoum et al., 2009b; Ertych et al., 2014). Consistent with 
this idea, excess MCAK, which destabilizes microtubules, significantly reduces mal-
attachments and chromosome missegregation in high CIN cell lines (Bakhoum et al., 2009a; 
Bakhoum et al., 2009b). Thus, the regulation of MCAK in controlling microtubule stability 
might be an additional way to repair mal-attachments.  
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1.8 Clathrin heavy chain (CHC) 
The best-known role of clathrin is its functions in membrane trafficking. In fact, clathrin is 
unable to bind membranes by itself.  However, through the interaction with different adapter 
proteins on membranes, clathrin can be recruited at the cell membrane or the trans Golgi 
network to generate clathrin-coated vesicles (CCVs) that are involved in endocytosis or cargo 
transport (Brodsky, 2012). Two CHC isoforms, CHC17 and CHC22, have been identified in 
human and are named by their encoding chromosomes. CHC17 is expressed and functions in 
endocytosis and intracellular transport. Most vertebrates have the second isoform, CHC22, 
which shares 85% sequence identity with CHC17 and plays a very defined step in retrograde 
transport from endosome to the trans-Golgi network. Notably, CHC22 lacks the QLMLT 
motif for Hsc70 binding, therefore the CHC22 cage is not efficiently uncoated by the Hsc70-
auxilin complex (Dannhauser et al., 2017). In addition, CHC22 does not substitute for CHC17 
in endocytosis because CHC22 is not recruited to the plasma membrane by specific adaptor 
proteins such as AP2 (Dannhauser et al., 2017). In this study, we focused on CHC17, and 
abbreviated CHC17 as CHC. 
 
 
Figure 1-7. Roles of CHC17 and CHC22 in membrane trafficking 
(A) Schematic domain organization of clathrin heavy chain. The amino acid boundaries are indicated 
for functional domains in CHC17 and CHC22. Red boxes show the conserved differences between 
CHC17 and CHC22; however, two proteins have 85% identity in sequences. (B) Functions of CHCs 
(CHC 17 in blue and CHC22 in red) in membrane trafficking. In general, proteins are synthesized in 
the endoplasmic reticulum, and are passed through the Golgi network undergoing post-translational 
modifications. Afterwards, proteins leave from trans-Golgi network (TGN) and are packed as vesicles. 
These vesicles are further transported to the cell membranes or endosomes. In membrane traffic 
pathways, CHC17 is restricted in endocytosis, being involved in transporting from the TGN to 
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endosomes. CHC22 is involved in retrograde transport where it is in charge in transporting vesicles 
from the endosome back to the TGN, which retrieves the cargo or protein components. Figure is 
adapted from (Brodsky, 2012). 
          
1.9 The CHC structure and triskelion 
Three CHC form a trimer by its C-terminus known as a triskelion. The N-terminal region of 
CHC (1-330) folds into a β-propeller with seven-blades containing four well-defined binding 
sites, which interact with most clathrin adaptor proteins (Figure 1D) (ter Haar et al., 1998). 
The site 1 is located between blades 1 and 2 and binds a LϕXϕ[D/E] (“clathrin box”) motif 
(ter Haar et al., 2000). The site 2 accommodates a “W-box” motif (PWXXW), located in the 
center of the β-propeller (Miele et al., 2004). A groove between blades 4 and 5 constitutes the 
third site that binds a ϕϕGXL motif that is similar to the clathrin-box (Kang et al., 2009). 
Recently a fourth site has been proposed by mutational analysis and is probably located 
between blades 6 and 7. However, the corresponding motif that binds to the site 4 is still 
unclear (Willox and Royle, 2012). More recently, it has been proposed that these peptide-
motif interactions should not be considered exclusive. These short peptide sequences may 
retain some ability to interact with different CHC TD sites, as has been determined by 
crystallization analysis (Muenzner et al., 2017).  
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Figure 1-8. The structure of CHC 
(A) Domain organization of CHC. (B) The electron micrograph of the CHC triskelion. (C) Low 
resolution of the structure of the CHC triskelion. The terminal domain (1-330) in green, the ankle 
domain (542-838) in black and the trimerization domain (1576-1675) in red. The N-terminal domain is 
circled with purple line and enlarged in D. (D) The β-propeller of CHC N-terminus. Four distinct 
binding sites are indicated as site 1, site 2, site 3 and site 4, respectively. Figures are modified from 
Brodsky, 2012; Kirchhausen et al., 2014; Royle, 2012. 
  
1.10 Roles of clathrin heavy chain 17 (CHC) during mitosis 
1.10.1 CHC specifically localizes on K-fibers in metaphase 
The first evidence showing the spindle localization of CHC was in 1985 when Maro et al. 
used antibodies against CHC on mouse meiotic spindle (Maro et al., 1985). Much later, the 
spindle localization of CHC was further confirmed by immunofluorescence using several 
antibodies in various cell lines in metaphase (Okamoto et al., 2000). More recently, 
immunofluorescence indicated that CHC is localized at K-fibers and there is no detectable 
signal at astral, interpolar and midzone microtubules when cells go through mitosis (Royle et 
al., 2005). The specific K-fiber localization of CHC was further confirmed by immunogold 
and electron microscopy (Booth et al., 2011; Royle et al., 2005). These observations gave us a 
hint that CHC specifically localize at spindles/K-fibers and might play unique functions 
during mitosis.  
 
 
 
Figure 1-9. The cellular localization of CHC in interphase and metaphase 
U2OS expressing CHC-GFP was fixed and stained with indicating antibodies. Left; in interphase CHC 
showed the vesicle-like patterns and some vesicles located along microtubules. Right; large portions 
of CHC were recruited to mitotic spindles, which are distinct from the vesicle-like particles in 
interphase.    
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1.10.2 Mitotic functions of CHC are distinct from interphase 
The mitotic functions of CHC are apparently distinct from its roles in vesicle formation and 
membrane trafficking. CHC that localizes on spindle does not appear associated with 
membranes, and most CHC accessory proteins involved in CCVs formation have not been 
found to localize on spindles yet. Furthermore, the spaces within K-fibers are too narrow to 
accommodate clathrin-coated vesicles, suggesting that CHC may not tend to form cages, but 
possibly remain as individual triskelia on spindles. To support the idea that CHC stays as the 
triskelion instead of forming a cage on spindles in mitosis, GAK-depletion experiments were 
designed. The function of GAK is to disassemble CCVs that releases free CHC triskelia from 
vesicles. Therefore, the GAK depletion leads to the accumulation of clathrin cages in both 
interphase and mitosis, which reduces free CHC triskelia in cells. Interestingly, the spindle 
localization of CHC is significantly reduced following GAK depletion even though the total 
amount of CHC proteins in cells is unchanged, which arrests cells in prometaphase or leads to 
misaligned chromosomes (Shimizu et al., 2009; Tanenbaum et al., 2010). These data 
suggested that CHC prefers to stay as a triskelion rather than a cage to perform its mitotic 
functions, which is distinct from its cage formation for endocytosis during interphase. To 
further distinguish roles of CHC between interphase and mitosis in terms of its conformation 
and functions, several mutations were designed and examined. A truncated mutant CHC 
lacking the trimerization domain can not rescue the endocytosis defects in CHC depleted cells 
during interphase. Surprisingly, this mutant still localizes to mitotic spindles but is unable to 
restore the mitotic defects including mitotic index and misaligned chromosomes (Royle and 
Lagnado, 2006). Additionally, a small version of CHC triskelion, which can form a trimer but 
the CHC legs are much shorter, can fully rescue the mitotic defects but not endocytosis 
(Royle and Lagnado, 2006). These results suggested that the trimerization of CHC is required 
for both endocytosis and the mitotic functions but not its spindle localization. Additionally, 
even thought the trimer is formed, legs of the trimer have to be long enough to form the 
lattice/cage for endocytosis. Conversely, this length is not important for CHC in mitosis, 
suggesting that this small triskelion containing the TD, ankle and trimerization domain is 
enough for its mitotic functions (Royle and Lagnado, 2006). 
Clathrin has recently emerged as an unexpected player to control mitotic microtubule 
stability. Loss of microtubule-kinetochore attachment is often observed following CHC 
depletion. As a consequence, CHC knockdown results in chromosome misalignment in 
metaphase-like cells, and chromosomes that are aligned on the metaphase plate are much 
thicker than control cells. Furthermore, the interkinetochore distance of equatorial 
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chromosomes is significantly shorter at metaphase following CHC depletion, suggesting that 
CHC depletion leads to less microtubule stability during mitosis (Royle et al., 2005). 
However, the mechanisms of how CHC stabilizes microtubules remain unclear yet. It 
becomes clear that CHC indeed localizes to spindles and regulates spindle integrity during 
mitosis. During interphase, CHC does not seem to directly bind microtubules on its own but it 
can decorate microtubules by interacting with an adaptor protein in interphase (Cleghorn et 
al., 2015). However, most CHC-binding proteins that are required for recruiting CHC in 
interphase do not localize at spindle during mitosis. It suggests that there must be novel 
interacting proteins to recruit CHC to spindles. Surprisingly, a CHC22 variant that lacks 
residues 457-507 forms a trimer and shares high sequence identity with CHC17, but it is 
unable to localize at spindles during mitosis. Interestingly, a chimeric CHC22 construct, CHC 
17(1-728)-CHC22 (729-1640), replaced CHC22 (1-728) with CHC17 N-terminus is sufficient 
to confer spindle binding to CHC22. In contrast, the chimeric CHC22 variant only containing 
CHC17 TD (1-330) can not localize at spindles, suggesting that CHC17 331-728 has its 
unique interacting partner to bring CHC to spindles (Hood and Royle, 2009).  
 
1.10.3 The CHC-TACC3 complex  
CHC is recruited to spindles and maintains the spindle integrity during mitosis. In fact, CHC 
is not a microtubule binding protein, suggesting that CHC needs its interacting proteins for 
the spindle localization. To identify CHC’s interactors in mitosis, Hubner et al. used mass 
spectrometer and found that CHC forms a complex with TACC3 (Hubner et al., 2010). 
TACC3 has been shown to play crucial roles in maintaining proper K-fiber integrity. 
Additionally, it is a well-studied substrate of Aurora A (Kinoshita et al., 2005) (discuss 
Aurora A in 1.14). Using in vitro purified proteins Lin et al. further confirmed a direct 
interaction between CHC (331-542) and TACC3 (522-577), where the S558 phosphorylation 
on TACC3 by aurora A is crucial for the interaction (Lin et al., 2010). Furthermore, depletion 
of either CHC or TACC3 results in similar mitotic defects, suggesting that these two proteins 
might regulate the spindle integrity via a common pathway (Lin et al., 2010). Similar results 
were also seen in Xenopus where the interaction between xTACC3 (Xenopus TACC3) and 
CHC is also dependent on Aurora A phosphorylation (Fu et al., 2010). Moreover, xTACC3 
fails to localize at spindles in CHC depleted oocytes, suggesting that xTACC3 indeed needs 
to interact with CHC to localize on spindles (Fu et al., 2010). Similarly, like CHC, the 
purified D-TACC3 (Drosophila TACC) protein is unable to bind microtubules by itself in 
vitro; however, D-TACC significantly increases the microtubule binding while incubating 
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with Drosophila embryo extracts, suggesting that there must be some TACC3-interacting 
proteins for its microtubule binding (Gergely et al., 2000a; Gergely et al., 2000b). Altogether, 
the interaction between CHC and TACC3 is mediated by Aurora A, and the spindle 
localization of these proteins are to some extent dependent on each other. Consistent with this 
idea, when Aurora A activity is inhibited by MLN8054, non-phosphorylated TACC3 
disassociates with CHC and also delocalizes from spindles (Hubner et al., 2010). These 
results suggested that the CHC-TACC3 interaction is able to bind microtubules and thereby 
brings this complex to spindles. However, whether the CHC-pTACC3 (phospho-TACC3) 
complex directly binds microtubules is still debated. Purified proteins of CHC (1-574) and 
TACC3 (519-838) incubated with aurora A seem to have very low affinity to bind 
microtubules by in vitro flow cell assays (Hood et al., 2013). On the contrary, GST-CHC and 
MBP-phosphorylated TACC3 can not co-pellet with purified microtubules in vitro (Lin et al., 
2010). It remains unclear if the CHC-pTACC3 complex per se is sufficient to bind 
microtubules or whether the affinity between them is high enough to promote a stable 
microtubule interaction. Further experiments are needed to test whether the CHC-pTACC3 
complex directly binds microtubules.           
Immunofluorescence analysis indicated that CHC is specifically localized on K-fibers in 
mitosis (Royle et al., 2005). Furthermore, CHC-depleted cells lead to the mitotic delay as a 
result of defects in chromosome congression, less stable K-fibers and microtubule-
kinetochore attachments, suggesting that CHC has its unique functions in mitosis (Lin et al., 
2010; Royle et al., 2005). It is not clear if these defects in CHC depletion are because of the 
loss of the CHC-TACC3 complex per se, or an additional effect due to the loss of other CHC 
interacting proteins. Since CHC mediates vesicles trafficking together with its interacting 
proteins in interphase, it leads us to ask whether any of them are also involved in the CHC-
mediated mitotic functions. Importantly, it remains unknown how the CHC TD that is critical 
for interacting with its adaptor proteins may contribute to the CHC’s function in mitosis. One 
hint is that mutation on the site 1 of CHC TD results in a mitotic delay even though this 
mutant is able to interact with TACC3 and localize on spindle, suggesting that CHC might 
recruit downstream proteins for its mitotic functions (Hood et al., 2013). Furthermore, a small 
molecule inhibitor, Pitstop2, that was designed to target the CHC TD, also induces a mitotic 
delay and disrupts spindle formation in mitosis, without perturbing clathrin localization on 
spindles (Smith et al., 2013). These results strongly indicated that the CHC TD may recruit its 
downstream proteins that are required for the spindle integrity. However, most CHC adaptors 
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are membrane bound or membrane associated proteins. To date, proteins that are recruited to 
spindles by the CHC TD are not well characterized. 
 
1.11 TACC3 in mitosis 
The human TACC family is comprised of three members: TACC1, TACC2 and TACC3, all 
of which contain a conserved TACC coiled-coil domain. Even though they all associate with 
microtubules, each TACC protein has a distinct localization pattern in cells. In general, 
TACC2 primarily presents on centrosomes throughout the cell cycle whereas TACC1 and 
TACC3 only localize on centrosomes during mitosis (Gergely, 2002). Moreover, TACC3 is 
associated with mitotic spindles during mitosis and interacts directly with ch-TOG and forms 
a one-to-one complex (Kinoshita et al., 2005). This interaction does not depend on the Aurora 
A phosphorylation (Thakur et al., 2014). Interestingly, interacting with TACC3 is required for 
ch-TOG to localize to spindles but not kinetochores and centrosomes (Gergely et al., 2003; 
Gutierrez-Caballero et al., 2015). ch-TOG is a microtubule polymerase and acts as a +TIP, 
which adds tubulin dimer on the ends of microtubules and stimulates microtubule growth 
rates (Brouhard et al., 2008; Widlund et al., 2011). In cooperation with TACC3, the TACC3-
ch-TOG complex strongly antagonizes MCAK activity (Kinoshita et al., 2005). Interestingly, 
TACC3 depletion leads to shorter astral microtubules, suggesting that TACC3 is required for 
the microtubule nucleation on centrosomes (Singh et al., 2014). However, this could also be 
because ch-TOG can not sufficiently antagonize MCAK activity without TACC3 on 
centrosomes that leads to shorter astral microtubules. Interestingly, GTSE1 delocalizes from 
centrosomes following TACC3 depletion, suggesting that under these conditions GTSE1 is 
unable to inhibit MCAK activity, thus resulting in shorter astral microtubules (Bendre et al., 
2016; Hubner et al., 2010). In addition to the centrosomal localization of the TACC3-ch-TOG 
complex, TACC3 also shows the tip-tracking activity in cells due to the interaction with ch-
TOG, suggesting that this complex might have additional functions in regulating microtubule 
dynamics on the microtubule ends (Gutierrez-Caballero et al., 2015).     
Furthermore, TACC3 interacts with CHC that permits these two proteins to localize on the 
spindles. Interestingly, overexpression of TACC3 shows more electron-dense matrixes so 
called mesh or bridges that increases microtubule interconnectivity within K-fibers (discussed 
in next section) (Nixon et al., 2015). TACC3 overexpression also increases the amounts of 
microtubules that are associated with K-fibers, but it does not increase K-fiber microtubules 
per se. The extra microtubules that appear after TACC3 overexpression are gone after a cold 
treatment, suggesting that they are not K-fibers (Nixon et al., 2015). Additionally, TACC3 
1.	Introduction	 	 21		
overexpression indeed increases microtubule “bridge/mesh” interconnectivity within K-fibers, 
indicating that it recruits more CHC and ch-TOG onto the K-fibers and forms more 
bridges/mesh to stabilize microtubules (Nixon et al., 2015). Additionally, more TACC3-ch-
TOG complexes on spindles might also increase more microtubule nucleation by ch-TOG, 
which increase the amounts of microtubules on spindles. 
 
1.12 Inter-microtubule bridges/mesh 
Recently, the CHC-TACC3-ch-TOG complex has been proposed to form the bridges/mesh 
within K-fiber that cross-links microtubules and thereby stabilizes K-fibers (Booth et al., 
2011; Hood et al., 2013; Nixon et al., 2015). The first evidence to support this hypothesis was 
to label CHC using immunogold and to visualize the gold particles by the electron 
microscopy, showing that the majority of CHC localizes between paired-microtubules in 
metaphase. CHC also appears to often localize on a stick-like bridge that interconnects 
parallel microtubules within K-fibers (Booth et al., 2011; Royle et al., 2005). Evidence 
supporting the idea that CHC bridges microtubules to stabilize K-fibers is that following CHC 
depletion, that most of shorter bridges are disappear, and k-fibers are thinner due to the loss of 
microtubules (Booth et al., 2011). The simplest explanation of the bridge hypothesis is that 
CHC stabilizes K-fiber by using its triskelion together with TACC3 to physiologically 
crosslink microtubules. Therefore, removal of TACC3 from spindles has similar phenotype as 
compared with CHC depletion, showing that most shorter inner-microtubule bridges are gone 
(Booth et al., 2011; Cheeseman et al., 2013). These results suggest that the CHC-TACC3 
complex can physiologically crosslink and stabilize parallel microtubules by using CHC 
trimerization. Interestingly, the non-trimerized CHC is unable to rescue the mitotic delay 
following CHC depletion even though this mutant still localizes on spindles (Royle and 
Lagnado, 2006), which further support the bridge hypothesis of the CHC triskelion. To test if 
the CHC-TACC3 complex can physiologically crosslink microtubules in vitro, the purified 
proteins including CHC, TACC3, ch-TOG and GTSE1 were phosphorylated by Aurora A 
kinase and mix with microtubules. Bundles of microtubules could be formed in the presence 
of these proteins mixture. Additionally, pairs of microtubules are connected by “bridge-like” 
shorter electron dense connector (Nixon et al., 2015). However, a trimeric CHC plus three 
molecules of TACC3 would allow for bridging between three microtubules and could lead to 
less parallel movement of microtubules compared with that formed by biopolar linker. 
Therefore, whether each CHC arm in the triskelion is able to bind one microtubule needs 
further investigation. In addition, after mutation of the site 1/Clathrin Box motif in CHC, 
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nether its trimerization nor the spindle localization is perturbed. This mutant, in theory, 
should be able to form the inner-bridges within K-fibers; however, it still causes a mitotic 
delay (Hood et al., 2013). Therefore, CHC might have distinct functions independent of its 
bridge functions. One reasonable possibility is that CHC should recruit its downstream 
effectors in regulating spindle integrity. Using mass spectrometer analysis GTSE1 has been 
found as the novel CHC interactor in mitosis, and the spindle localization of GTSE1 depends 
on CHC (Hubner et al., 2010). It leads us to hypothesize if GTSE1 could act as the 
downstream effector in the CHC-mediated mitotic functions.   
  
Figure 1-10. The roles of CHC in bridging paired microtubules on mitotic spindles 
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(A) A cartoon illustrating that the mitotic spindle organization and different kinds microtubules on 
spindles. (B) Electron micrographs of intra-k-fiber bridges in the mitotic spindle. Left: an orthogonal 
section and microtubules appear as circles; right: a longitudinal section and microtubules are ling 
stripes. Bridges are the electron-dense connections between microtubules labeled by arrows. (C) left: 
A mitotic spindle purified from Hela cell visualizing by electron microscopy following immunogold 
labeling; Right: enlarged view form left boxes labeled with indicated antibodies. Arrows indicate the 
site of bridges. (D) The bridge hypothesis. Initially, Aurora A phosphorylates TACC3 which allows 
TACC3 to bind CHC. The CHC-TACC3-chTG complex interacts with microtubule and crosslinks 
microtubule through the triskelion of CHC. Figures are modified from Booth et al., 2011; Royle, 2012.  
 
1.13 G2 and S-phase expressed 1 (GTSE1) 
GTSE1 is predicted as an intrinsically disordered protein and only exists in vertebrates. It 
directly binds EB1 and shows the tip-tracking activity during interphase (Scolz et al., 2012). 
Schneider’s laboratory initially screened genes whose protein levels can be up-regulated by 
p53 in mouse, and they found B99 that mainly associates with microtubules in interphase  
(Utrera et al., 1998). However, the B99/GTSE1 protein level is only induced by p53 in mouse 
but not in human (Monte et al., 2003). Additionally, the same laboratory further characterized 
B99 and found that it decreases in G1, peaking in G2 /M-phase, and is highly phosphorylated 
during mitosis. Due to its expression profile in the cell cycle, they renamed B99 as G2 and S-
phase express 1 (GTSE1) (Collavin et al., 2000). In fact, GTSE1 has a KEN motif in its C-
terminus, which is identified as the substrate of APC/Cdh1; therefore its protein is degraded 
by APC/Cdh1 in late mitosis and is absent in G1 (Pfleger and Kirschner, 2000). Surprisingly, 
p53 binds not only GTSE1 promoter but also GTSE1 proteins. After DNA damage, GTSE1 is 
phosphorylated by PLK1 at residue 435, enhancing its translocation from the cytoplasm to the 
nucleus, shuttling out p53 to the nucleus, and mediates p53 degradation (Liu et al., 2010).  
 
1.13.1 GTSE1 in cancer 
GTSE1 has recently been associated with multiple potential roles in cancers. Interestingly, its 
expression level is positively correlated with tumor size, venous invasion, advanced tumor 
stage, and short overall survival in breast cancer (Scolz et al., 2012) and hepatocellular 
carcinoma (Guo et al., 2016), but probably not in lung cancer (Tian et al., 2011). Similarly, 
GTSE1’s mRNA and protein levels are relatively low in two low invasive MCF-7 and 
MCF10A lines in comparison with three highly invasive lines including MDA-MB-231, 
MDA-MB-468 and MDA-MB-157. Furthermore, modulating GTSE1 protein affects cell 
1.	Introduction	 	 24		
migration in both breast and hepatocyte cells (Guo et al., 2016; Scolz et al., 2012). For 
instance, ectopic overexpression of GTSE1 in MCF-7 cells enhances the cell mobility 
whereas GTSE1 depletion reduces the migratory ability in MDA-MB-231. Moreover, GTSE1 
is found to directly bind EB1 through its two SKIP (Ser-Lys-Iso-Pro)-like motifs. This 
interaction not only accumulates GTSE1 at microtubule plus-ends but also requires for 
GTSE1-induced cell migration. Mutating SKIP motifs on GTSE1 abolishes it interaction with 
EB1 in which GTSE1 is unable to enrich on the +TIP and also fails to induce focal adhesion 
disassembly (Scolz et al., 2012). More recently, GTSE1 has been reported to facilitate 
epithelial-to-mesenchymal transition (EMT) modulation in hepatocellular carcinoma (Wu et 
al., 2017). EMT mediates tumor cells to depart from the primary tumor due to the loss of the 
cell-cell adhesion, which gains the migratory and invasive properties of tumor cells. 
Interestingly, by analyzing the mRNA levels of 28 types of cancers from the TCGA database, 
GTSE1 is approximately 100 times higher in cancer tissues than non-tumor tissues (Wu et al., 
2017). Additionally, GTSE1 mRNA and protein levels are significantly up-regulated in 
hepatocellular carcinoma tissues compared with relative adjacent tissues (Guo et al., 2016). 
High expression of GTSE1 in hepatocellular carcinoma is correlated to the levels of Snail and 
N-cadherin that have been identified as the marker of EMT (Wu et al., 2017). Therefore, high 
level of GTSE1 might induce EMT that increases cell migration and invasion.  
 
1.13.2 Roles of GTSE1 in mitosis 
GTSE1 is identified as a MAP and enriches on microtubule growing ends by the interaction 
with EB1 throughout interphase. In fact, GTSE1 is highly phosphorylated during mitosis by 
which GTSE1 loses the microtubule binding and the microtubule plus end tracking until 
anaphase onset (Scolz et al., 2012). Thus, GTSE1 might have distinct functions during mitosis 
independent of its roles in interphase. By mass spectrometry analysis GTSE1 has been found 
to interact with CHC and TACC3 in mitosis (Hubner et al., 2010). Interestingly, GTSE1 
delocalizes from the mitotic spindles in either CHC depletion or TACC3 depletion, 
suggesting that the CHC-TACC3 complex is required for GTSE1 to localize at the spindles 
(Cheeseman et al., 2013; Hubner et al., 2010). Several LIDL (Leu-Ile-Asp-Leu) motifs, which 
are well-known motifs to bind to the CHC TD, are localized in GTSE1 C-terminus; therefore 
GTSE1 might potentially interact with CHC. Altogether, these findings strongly suggested 
that GTSE1 is involved in the CHC-TACC3-mediated mitotic functions. However, it is 
unclear whether GTSE1 interacts directly with CHC or TACC3 by which GTSE1 is recruited 
1.	Introduction	 	 25		
to the spindles, or how GTSE1 participates in the CHC-TACC3 complex to stabilize 
microtubules.  
Previously, our lab found that GTSE1 is a novel microtubule-stabilizing protein in mitosis to 
control chromosome alignment and segregation. GTSE1 mainly localizes to K-fibers and 
spindle poles, and loss of GTSE1 from cells leads to the global destabilization of 
microtubules. Additionally, we further found that the mechanism by which GTSE1 stabilizes 
microtubules is through the inhibition of MCAK-depolymerizing activity (Bendre et al., 
2016). MCAK mainly localizes to the centromeres, centrosomes, midbody and microtubule 
plus tips during mitosis, and plays a crucial role in assembling a bipolar spindle, correcting 
improper kinetochore-microtubule attachments, facilitating accurate chromosome segregation 
(Domnitz et al., 2012; Lan et al., 2004; Wordeman and Mitchison, 1995). Through an 
interaction with MCAK, GTSE1 inhibits MCAK activity, which is crucial for regulating 
MCAK-induced microtubule depolymerization. Consequently, GTSE1 depletion results in the 
excess MCAK depolymerization activity, which leads to short astral microtubules, less inner 
spindle microtubules, less K-fibers and improper kinetochore-microtubule attachments. 
Notably, these mitotic defects can be restored by co-depleting GTSE1 and MCAK, suggesting 
that GTSE1 indeed inhibits MCAK activity in vivo during mitosis (Bendre et al., 2016). 
Interestingly, GTSE1 seems to regulate the MCAK activity at kinetochores in order to 
achieve proper kinetochore-microtubule attachments. It raises questions whether the K-fiber 
localization of GTSE1 is sufficient to bring GTSE1 onto kinetochores or GTSE1 is able to 
localize at kinetochore per se through a direct interaction with kinetochore proteins. However, 
we could not detect GTSE1 at kinetochores yet by immunofluorescence. It might due to that 
the kinetochore localization of GTSE1 is very dynamic or there is very little portion of 
GTSE1 at kinetochores. To test if GTSE1 localizes at kinetochores, further experiments are 
needed. 
Hyper-stable kinetochore-microtubule attachments were found in several cancer cell lines and 
lead to chromosome instability (CIN) (Bakhoum et al., 2009a; Bakhoum et al., 2009b; Ertych 
et al., 2014). Interestingly, an increase of MCAK expression could restore hyper-stable 
kinetochore-microtubule attachments and decreases CIN (Bakhoum et al., 2009a; Bakhoum et 
al., 2009b). Notably, GTSE1 levels are relatively higher in CIN cell lines, suggesting that 
high GTSE1 expression leads to MCAK inactivation and causes chromosome missegregation. 
Additionally, the defect in chromosome missegregation can be reduced following GTSE1 
depletion in CIN cell lines. Similarly, up-regulation of GTSE1 in HCT116, a chromosomally 
stable line, for many generations induces CIN (Bendre et al., 2016). In summary, GTSE1 
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plays several roles in carcinogenesis. First, up-regulated GTSE1 results in hyper-stable KT-
MT attachments due to the inhibition of MCAK in mitosis, which frequently leads to CIN. 
Additionally, higher GTSE1 level also induces EMT, which increases higher cell migration 
and invasion during interphase for the following tumor progression. Therefore, GTSE1 
expression should be precisely controlled in cells. Due to the fact that GTSE1 is highly 
expressed in several cancers, it might have high potential as a marker for cancer diagnosed 
and a target for cancer therapy.    
 
 
Figure 1-11. The functional domains and phosphorylation sites on GTSE1 
(A) Schematic domains based on the validated interaction. The N-terminal region of GTSE1 interacts 
with p21, MCAK and microtubules. Two SXLP motifs in the middle are required for the EB1-binding. 
The C-terminal terminus of GTSE1 interacts with p53 and cdh1 as well through the KEN box. There 
are several LIDL motifs on the very C-terminal tail, which are putative CHC-binding motifs. BD: 
binding-domain. (B) All phosphorylated sites with more than five references are listed on GTSE1, 
which are validated by mass spectrometry (https://www.phosphosite.org/).     
 
1.14 Aurora A kinase in cancers 
Aurora kinases belong to serine/threonine kinases that consist of three members in 
mammalian cells termed as Aurora A, B and C. Both Aurora A and B are cell cycle regulated 
proteins and are detectable in somatic cells during mitosis. Aurora A and B share 70% 
homology in their catalytic domains (D'Assoro et al., 2015). However, their cellular 
localizations are distinct during mitosis. Aurora A mainly localizes on centrosomes, spindle 
poles and transiently along spindle microtubules, which is important in centrosome 
maturation, mitotic entry and spindle assembly (Barr and Gergely, 2007; Bird and Hyman, 
2008; Dutertre et al., 2002; Marumoto et al., 2005). In contrast, Aurora B that interacts with 
chromosomal passenger complex is primarily presented to the inner centromere from 
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prophase until metaphase, and moves to the spindle midzone and midbody during late mitosis 
and cytokinesis. Aurora B is mainly involved in chromatin modification, microtubule-
kinetochore attachment, spindle checkpoint and cytokinesis (Ruchaud et al., 2007; Vader et 
al., 2006). In fact, both kinases can share the same substrates such as CENP-A, Survivin and 
p53 (Carmena et al., 2009). Recently, a single amino acid change on Aurora A has been 
shown to convert into Aurora B-like kinase in terms of the cellular localization and interacting 
partners, suggesting that the different functions between them could be due to the localization 
(Fu et al., 2009; Hans et al., 2009). Interestingly, Aurora A kinase is highly expressed in 
aneuploid tumors. The effects of Aurora A in tumorigenesis have been applied in centrosome 
duplication and mitosis. Accurate centrosome numbers are important to maintain the normal 
bipolar spindle responsible for the accurate chromosome segregation. Therefore, centrosome 
amplification is thought to form multipolar spindles and causes aneuploidy and cancer (Raff 
and Basto, 2017). Aurora A is known to phosphorylate several proteins on centrosomes that 
are required for centrosome maturation (Barr and Gergely, 2007; Wang et al., 2014). 
However, excess Aurora A in cultured cells causes cytokinesis failure that accumulates 
centrosomes and leads to centrosome amplification (Meraldi et al., 2002). PLK1 activity is 
known to regulate centrosome duplication and mitotic entry (Liu and Erikson, 2002; Macurek 
et al., 2008). Additionally, Aurora A can also phosphorylate and activate PLK1, which 
increases PLK1-induced centrosome amplification. Recently, higher Aurora A level has been 
reported to increase the plus end assembly rate of microtubules that causes hyper-stable 
microtubule-kinetochore attachments and CIN (Ertych et al., 2014). Even through the TACC3 
phosphorylation level is higher in their system, the mechanisms by which Aurora A induces  
microtubule stability remain unclear.
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CHC has emerged as an unexpected player to localize to mitotic spindles that controls spindle 
integrity and chromosome segregation. Thus, CHC depletion leads to mitotic defects 
including fewer microtubules within k-fibers and misaligned chromosomes (Booth et al., 
2011; Hood et al., 2013; Royle et al., 2005). Importantly, these mitotic roles of CHC have 
been established to be independent of its role in endocytosis and membrane trafficking 
(Royle, 2012; Royle, 2013; Royle et al., 2005; Royle and Lagnado, 2006). Recently, the 
CHC-TACC3-ch-TOG complex has been proposed to stabilize K-fibers by forming bridges 
between microtubules within K-fibers (Cheeseman et al., 2013; Nixon et al., 2015). A mutant 
of the CHC TD, which loses its interacting proteins, localizes on spindles and presumably 
forms triskelion; however, this mutant still causes some mitotic defects. It strongly suggests 
that CHC might have distinct roles independent of its bridging functions (Hood et al., 2013). 
Interestingly, GTSE1 was previously identified as a novel CHC-interacting protein from 
mitotic cell lysates by mass spectrometric analysis (Hubner et al., 2010). Noteworthy, GTSE1 
contains several Lue-Ile-Asp (LID) motifs that are implicated in interacting with the CHC 
TD. Additionally, depleting CHC in cells delocalizes GTSE1 from mitotic spindles, 
suggesting that GTSE1 is recruited by CHC and acts downstream of CHC. Furthermore, 
GTSE1 depletion phenocopies CHC depletion in cells, showing loss of microtubule stability 
and misaligned chromosome, implying that these two proteins might function together in the 
same pathway. Previously, our laboratory identified GTSE1 as a new microtubule-stabilizing 
protein by inhibiting MCAK activity (Bendre et al., 2016). MCAK is a potent microtubule-
depolymerase and also localizes at kinetochores to regulate kinetochore-microtubule 
attachments. GTSE1 depletion results in more active MCAK that induces the detachment of 
microtubules from kinetochores. It raises an interesting question whether GTSE1 
physiologically interacts with kinetochore under certain conditions in order to regulate 
MCAK activity. Altogether, the main goal is to understand mechanisms of how CHC 
functions in maintaining spindle integrity. One hypothesis is that CHC stabilizes microtubules 
by directly recruiting GTSE1 to inhibit MCAK. However, the recruitment of GTSE1 on 
kinetochores seems to be independent of CHC. Another question is to check if GTSE1 
directly interacts with kinetochore, presumably outer kinetochore. During my PhD, I aimed to 
address following questions. 
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Questions: 
(1) Does CHC directly interact with GTSE1? 
-Where is/are the interacting surface(s) on CHC and GTSE1?  
-How does CHC structurally interact with GTSE by using X-ray crystallography? 
-How does CHC interaction with GTSE1 determine GTSE1 subcellular localization? 
-Does the CHC-GTSE1 complex specifically localize at K-fibers? 
(2) What does GTSE1 interaction with, and recruitment by, CHC on the spindle 
contribute to microtubule stability? 
(3) How does the interaction between CHC and GTSE1 impact chromosome alignment 
and segregation? 
(4) Whether GTSE1 forms an interacting network together with CHC-TACC3-ch-TOG-
MCAK, which supports the hypothesis that CHC stabilizes K-fiber by directly 
recruiting GTSE1 to inhibit MCAK? 
(5) Does the GTSE1 colocalize with MCAK on kinetochores to inhibit MCAK activity? 
-How is GTSE1 recruited to kinetochores? What is/are the binding partner(s) of 
GTSE1 on kinetochore? Does this interaction depend on phosphorylations?  
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CHC has been reported to maintain spindle integrity by intra-microtubule bridging within K-
fiber. A mutation of the CHC TD, which loses its adaptor-like interacting proteins, localizes 
on spindles and affects neither its trimerization nor the TACC3 binding. However, it still 
causes some mitotic defects, suggesting that this N-terminal domain of CHC has its distinct 
functions independent of the triskelion that bridges microtubules (Hood et al., 2013). 
Furthermore, Pitstop2, an inhibitor that competes with other proteins to bind the CHC TD, 
does not affect CHC localization to spindles, but it induces misaligned chromosomes and a 
mitotic delay (Smith et al., 2013). These results highly suggested that the N-terminal domain 
of CHC has its unique functions in mitosis. Since this domain has been shown to interact with 
many adaptor proteins and most of them are not found on spindles yet, we reason that CHC 
TD might recruit a novel player to regulate spindle integrity. GTSE1 was found to interact 
with CHC by mass spectrometry and delocalized from spindles following CHC depletion, 
suggesting that CHC recruits GTSE1 to spindles (Hubner et al., 2010). Our lab previously 
identified that GTSE1 is a novel microtubule-stabilizing protein by inhibiting MCAK activity 
in mitosis. Additionally, GTSE1 depletion leads to less inner spindle intensity and misaligned 
chromosomes. These mitotic defects are very similar in CHC depletion, indicating that 
GTSE1 and CHC should function in the same pathway. Thus, one mechanism of how the 
CHC TD stabilizes microtubules is by recruiting GTSE1 to inhibiting MCAK. However, it 
remains unclear if the CHC-GTSE1 interaction is through a direct binding or an indirect 
effect. Thus, we first aimed to address the interaction between GTSE1 and CHC.   
 
3.1 GTSE1 specifically interacts with two sites on the CHC TD.   
To confirm the interaction results from mass spectrometry, we first performed 
immunoprecipitation (IP). The mitotic cell lysate was prepared by nocodazole 
synchronization after 14 hour, and IPs were conducted using either anti-GTSE1, anti-CHC or 
anti-myc antibodies. As expected, GTSE1 can be detected in complexes precipitated by CHC 
antibodies and vice versa, indicating that GTSE1 indeed formed a complex with CHC (Figure 
3-1A). To further address if this is a direct interaction, an in vitro pull-down assay was 
performed. Both full-length GTSE1 and full-length CHC proteins were expressed and 
purified from insect cells. As shown in Figure 3-1B, GST-CHC can pull down GTSE1 
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detected by western blot. Because there are only CHC and GTSE1 proteins in the reaction, 
this result revealed that CHC directly interacts with GTSE1. 
 
Figure 3-1. GTSE1 interacts directly with CHC 
(A) IPs indicating that CHC and GTSE1 form a stable complex during mitosis. IPs were performed 
using either anti-CHC, anti-GTSE1 or anti-myc (IgG) antibodies. (B) In vitro pulldown showing that 
GTSE1 interacts directly with CHC. GTSE1 proteins were incubated with GST or GST-CHC full-
length proteins to perform the pulldown assay.   
 
We next examined if GTSE1 can bind the CHC TD, supporting the idea that GTSE1 is 
recruited by the CHC TD to regulate the spindle integrity. To test that, serial GST-tagged 
CHC proteins purified from bacteria were incubated with GTSE1-EGFP FL proteins. 
Interestingly, only the N-terminal domain of CHC (1-330) can sufficiently pull down GTSE1, 
indicating that GTSE1 indeed binds to the β-propeller where CHC accommodates most of its 
adaptor proteins in interphase (Figure 3-2A). To date, four distinct binding sites on the CHC 
β-propeller have been identified that mediate the interaction with their corresponding motifs 
in clathrin adaptor proteins (Willox and Royle, 2012). Pitstop 2, a small molecule inhibitor, 
mainly binds the site 1 of the CHC β-propeller by which Pitstop 2 prevents proteins 
containing clathrin box motifs (LΦXΦD/E) to bind (von Kleist et al., 2011). Because GTSE1 
contains several LIDL motifs (Figure 3-4), it could potentially bind to the CHC TD site 1. To 
test this hypothesis, we pre-incubated GST-CHC (1-330) with 30 µM Pitstop 2 or DMSO for 
half hour and examined the interaction by pulldown assays. Interestingly, Pitstop 2 
significantly reduced the interaction between CHC and GTSE1, indicating that the site 1 of 
the CHC β-propeller is important for the binding (Figure 3-2B). To further confirm this result, 
we individually mutated each of three established adaptor-binding sites on CHC. The detail of 
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mutations is listed in Figure 3-2C. We next examined the interaction between GTSE1 and 
CHC mutants (Figure 3-2D and E). As expected, the site 1 mutant (S1M) strongly impaired 
the interaction, which is consistent with Pitstop 2 that prevents the GTSE1 binding. 
Surprisingly, the site 3 mutant (S3M) also significantly reduced the interaction, indicating that 
GTSE1 also binds to the CHC TD site 3. However, mutation of the site 2 (S2M) has no effect 
or very little effect. In fact, we could not find any PWXXW motifs, a well-known site 2-
binding motif on GTSE1 (Miele et al., 2004). 
    
 
Figure 3-2. The site 1 and 3 of CHC TD interact with GTSE1 
(A) Western blot indicating that GTSE1 directly interacts with the CHC TD. GTSE1-EGFP proteins 
were incubated with GST or various GST-tagged CHC proteins to perform pulldowns and analyzed by 
western blot. (B) Pitstop 2 competes the interaction between GTSE1 and CHC. Western blot to detect 
GTSE1 after the pulldown using GST-tagged CHC (1-330) proteins in the presence or the absence of 
Pitstop 2. (C) Structural model of CHC (1-330) with the seven-bladed β-propeller. Three interaction 
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sites on CHC TD are indicated by arrowheads. Mutations that abolish each binding site on CHC were 
shown on the list. The figure is adapted from Royle, 2012. (D) GTSE1 binds both the site 1 and the 
site 3 on the CHC TD. GTSE1 proteins were incubated with GST-CHC (1-330) WT or mutants and 
performed pulldowns. (E) Quantification of three independent pulldown assays from D. All 
interactions were normalized to the WT.     
 
3-2 GTSE1 utilizes its LID motifs to bind the CHC TD. 
Next, we aimed to identify the CHC-binding region on GTSE1. Different truncated fragments 
of GTSE1 proteins with 6xHis tag were purified from bacteria. To test the interaction, we 
used GST pulldown assays. GST-CHC (1-364) proteins are immobilized on GSH beads and 
incubated with various GTSE1 proteins. As shown in Figure 3-3A, GST-CHC (1-364) can 
pull down two C-terminal fragments of GTSE1 including GTSE1 (463-739) and GTSE1-C 
(639-739) but not the N-terminus (1-460), indicating that a fragment containing last hundred 
residues (GTSE1-C, 639-739) is sufficient to bind CHC. Because we found two sites on the 
CHC TD that interact with GTSE1, we hypothesized that GTSE1-C (639-739) should contain 
two distinct binding-regions corresponding to these two binding sites on CHC. To further 
identify these CHC-binding regions, three smaller GTSE1 fragments with GST-tags (C1, C2 
and C3) were purified from bacteria and tested the interaction. As shown in Figure 3-3C, both 
two individual fragments, GST-C1 (651-687) and GST-C3 (693-739), can pull down CHC, 
indicating that these two distinct surfaces directly interact with CHC. Because GTSE1-C, a 
longer fragment, contains these two distinct binding regions, we reasoned that it should bind 
tighter than two short fragments. As expected, GTSE1-C showed a stronger interaction than 
either GTSE1-C1 or GTSE1-C3 (Figure 3-3C). Here, we found two distinct regions on 
GTSE1 that are required for the interaction with CHC. This finding is consistent with the 
results where two sites on the CHC TD are required for the interaction with GTSE1 (Figure 3-
2D). The overall interactions were summarized in Figure 3-3D.    
3.	Results	 	 34		
 
 
Figure 3-3. Two distinct fragments of GTSE1 interact with CHC 
(A) Various GTSE1 proteins were performed pulldown assays using GST or GST-CHC (1-364). (B) 
Equal amount of GST and GST-CHC (1-364) proteins was shown on a SDS-gel stained with 
coomassie blue. (C) CHC (1-642)-His proteins were incubated with various GTSE1 proteins tagged 
with GST and analyzed by western blot. (D) The summary of CHC-binding regions in GTSE1. 
Positive-interacting fragments were marked with the cross and labeled in red. 
 
To further identify motifs on GTSE1 C1 and C3 that bind the CHC TD, we next aligned 
GTSE1 proteins sequences among human (H. sapiens), mouse (M. musculus), cow (B. 
taurus), rat (H. Glaber) and frog (X. tropicalis). Notably, we found that five LID(Q)L motifs 
on the very C-terminal region are very conserved in all spices (639-739 in human). This 
LΦXΦ[D/E] (Leu-[Leu/Ile/Val]-any residue-[Leu/Ile /Val/Phe]-[Asp/Glu])-like motif is well-
known to bind the CHC TD, implying that these five LID(Q)L motifs might mediate the 
interaction between GTSE1 and CHC. Consistent with our pulldown results, we confirmed 
that a GTSE1 fragment containing all five LID(Q)L motifs interacts with the CHC TD 
(Figure 3-3C and D, GTSE1-C). Because GTSE1 has more than one LID(Q)L motif, it raises 
a question of how GTSE1 uses them to bind CHC. To distinguish each motif, we named these 
five LID(Q)L motifs as Box A to E (Figure 3-4).  
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Figure 3-4. Five putative CHC-binding motifs on GTSE1 
Five putative CHC-binding motifs, LID(Q)L, on GTSE1 are highly conserved among different spices. 
According to the order of these motifs, they are named as Box A to E.   
 
To further identify which LID(Q)L motif on GTSE1 contributes the interaction, we aimed to 
mutate this motif and examined its interaction with CHC. Thus, we decided to substitute the 
first three residues as triple alanine (AAA) on the LID(Q)L motif. These Mutants that we 
generated are illustrated in detail in Figure 3-5B. To examine the interaction, we first 
performed the yeast-two hybrid assays. The CHC TD (1-330) with a Gal4 activation domain 
(AD) was co-transformed with either GTSE1 (463-739) wild-type (WT) or different mutants 
into yeast. Cells were then serial diluted and grown on either a histidine positive (+His) or a 
selecting plate (histidine negative, -His) for 3 days shown in Figure 3-5A. Yeast were grown a 
similar amount on a +His plate, indicating the number of cells were very similar among 
different groups. However, as compared with wild type, yeast containing LID(Q) mutants 
showed quite different growth phenotypes on the selecting plate (–His), suggesting that some 
of these mutants impair the interaction with CHC. Neither the Box A mutant (A-m) nor the 
Box E mutant (E-m) had strong effects on the interaction. Notably, mutation of the Box B or 
D had very sick growth phenotypes, suggesting that these two motifs predominantly bind to 
CHC. Interestingly, the ACDE-m, multiple mutations on GTSE1 (all putative LID(Q) sites 
were mutated except the Box B), totally lost its interaction. This observation strongly suggests 
that GTSE1 uses more than one LID(Q)L motif to interact with CHC. Consistent with our 
previous pull-down experiments, two distinct fragments containing multiple LID(Q)L motifs 
are required for the binding (Figure 3-3D and E). Altogether, here we showed that each motif 
contributes to the binding even though some of them might have predominant interactions and 
mutations on the first three residues of LID(Q)L are sufficient to disrupt the binding. 
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Figure 3-5. Multiple LID motifs of GTSE1 contribute their interaction with CHC 
To identify which LID(Q)L motif is required for the CHC binding, several mutants were examined the 
interaction using the yeast two-hybrid assy. (A) The growth phenotypes of yeast was plated on a either 
growth plate (+His) or selecting plate (-His). (B) The detail of mutations on GTSE1 designed and used 
in the yeast two-hybrid assay from A. (WT: wild-type, A-m: Box A mutant, B-m: Box B mutant, C-m: 
Box C mutant, D-m: Box D mutant, E-m: Box E mutant and ACDE-m: Box ACDE mutant)  
 
To further identify which exact LID motifs interact with CHC, we next used shorter 
fragments of GTSE1 and performed pulldowns. Due to the fact that only GTSE1-C1 and 
GTSE1-C3 but not GTSE1-C2 bind to CHC, we then mutated LID Boxes on both GTSE1-C1 
(Box A and B) and GTSE1-C3 (Box D and E), and tested their interaction. Interestingly, 
triple alanine substitution of the Box A, B or AB on GTSE1-C1 strongly reduced the 
interaction, suggesting that these two LID motifs are required for the CHC-binding (Figure 3-
6A, B and C). Since the Box B is more conserved among different spices (Figure 3-4) and its 
mutation has a stronger reduction than the Box A mutant (Figure 3-6A and B), we postulated 
that the Box B might be the dominant binding-motif on GTSE1-C1. This result is in 
consistent with the yeast-two-hybrid where the Box B mutant has strongest influence for the 
binding (Figure 3-5A). Next, we examined which motifs on GTSE1-C3 are required for the 
interaction. To mutate the Box D, three different triple-alanine replacements were introduced 
(LIDL to AAAL, LIDL to LAAA or LIDL to AADA, Figure 3-6 D, E and F). All three 
mutations on the Box D significantly perturbed the CHC-binding. However, mutating the Box 
E had very minor effect. Taken together, substitutions of the first three residues to triple 
alanine on LIDL motif seem to disrupt its interaction with CHC as we showed in the yeast-
two-hybrid assay. Here we identified two distinct motifs of GTSE1 in which LIDLPLIDLF 
(the Box A and B) on GTSE1-C1 and LIDL  (the Box D) on GTSE1-C3 interact directly with 
the CHC TD.  
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Figure 3-6. Several LIDL Boxes on GTSE1 are required for the interaction with CHC 
(A) Both the Box A and the Box B are required for the interaction. Pull-down analysis of CHC (1-
642)-His using GTSE1-C1 WT and mutants. (B) Quantification of three independent experiments 
from A. Interactions were normalized to the WT. (C) Peptide sequences of GTSE1-C1 WT and 
mutants used in A. (D) The Box D is required for the interaction. The pulldown analysis of CHC (1-
642)-His using GTSE1-C3 WT and mutants. (E) Quantification of three independent experiments 
from D. Interactions were normalized to the WT. (F) Peptide sequences of GTSE1-C1 WT and 
mutants used in D. 
 
3.3 A proposed model of the CHC-GTSE1 interaction 
Here we revealed that GTSE1 uses several LIDL motifs (A, B and D) to bind two sites on the 
CHC TD (site 1 and site 3). Due to the fact that the shorter GTSE1 fragments (C1 and C3) 
reduced almost half the interaction in comparison to the longer one (Figure 3-3C), suggesting 
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that these short fragments selectively bound only one site on CHC and thereby reduce the 
interaction. However, the exact CHC-GTSE1 binding model is unrevealed. For instance, 
GTSE1-C1 fragment might bind to the either site 1 or the site 3, and it will be the same case 
for GTSE1-C3 fragment. To examine that, we used the site 1 mutant (S1M) or the site 3 
mutant (S3M) of CHC and performed the pulldown analysis in combination with GTSE1-C1 
and C3 fragments. The idea is that; for example, if GTSE1-C1 specifically binds the CHC site 
1, the S1M but not the S3M should abolish the interaction. Thus, using these mutants of CHC 
could inform the binding model of the CHC-GTSE1 complex. As shown in Figure 3-7, the 
input of GTSE1 and CHC were relatively similar in each condition, and GST alone did not 
interact with any CHC proteins. Notably, the S1M did not interact with GST-GTSE1-C1 but 
the S3M can. These results indicated that GTSE1-C1 (Box A and Box B) specifically 
interacts with the CHC site 1. Therefore, mutation of the CHC site 1 abolished the binding. 
Similarly, GTSE1-C3 specifically binds to the CHC sites 3, as only the S3M abolished the 
interaction with GST-GTSE1-C3.  
 
 
 
Figure 3-7. LIDL Boxes of GTSE1 specifically bind to different sites on the CHC TD 
GST, GST-GTSE1-C1 or GST-GTSE1-C1 proteins were incubated with CHC WT or mutants. 
Pulldown assays showing that the S1M (site 1 mutant) on CHC abolished the interaction with GST-
GTSE1-C1. Additionally, the S3M (site 3 mutant) can not bind to GST-GTSE1-C3. These results 
indicated that GTSE1-C1 selectively binds to the CHC site 1, and similarly GTSE1-C3 specifically 
interacts with the CHC site 3.       
 
Here we elucidated that GTSE1 uses its Boxes AB and D to bind the CHC TD site 1 and site 
3, respectively. Interestingly, the site 1 and 3 are on the opposite sides of the CHC TD which 
creates a certain distance between them. If one molecule of GTSE1 is able to interact with 
both sites at the same time, a loop between the Box A and D has to be long enough to fit this 
distance. In fact, there are 38 amino acids between these two boxes on GTSE1, which is 
theoretically long enough to bridge the two interactions together, based on modeling of 
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GTSE1 peptides on the CHC TD structure (Dr. Ingrid Vetter, personal communication). We 
postulated that once the loop is shortened, GTSE1 would only be able to bind one site on the 
CHC TD at a time. Therefore, the loop deletion mutant should have a weaker interaction than 
the full-length. To test this hypothesis in which the loop is important for the interaction 
between GTSE1 and CHC, we deleted the loop on GTSE1 (del(675-705)). Here we used 
GTSE-C containing all LID motifs as the template to generate different mutants and 
examined their interaction Figure 3-8A and B. Consistent with our previous results, mutations 
on either Boxes AB (AB-M) or Box D (D-M) significantly reduced its interaction with CHC. 
As expected, mutating all 5 LID motifs (5xLID) totally abolished the interaction. The loop 
deletion mutation, del(675-705), also significantly impaired the binding (Figure 3-8A). 
Although this loop does not interact with CHC pre se, it does provide a distance to bridge two 
interactions together and therefore stabilize the interaction. However, we can not distinguish 
the stoichiometry of the interaction by pulldowns. Since this loop is long enough to bridge 
two interactions, it remains a question if one molecule of GTSE1 can intramolecularly bind 
two sites on the CHC TD or it can bridge two molecules of CHC TDs together (Figure 3-8C).    
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Figure 3-8. A proposed model of the CHC-GTSE1 complex 
(A) Pulldown assays showing that several LIDL motifs and a “loop” are required their interaction with 
CHC. The WT and different mutants of GST-GTSE1 (639-739) were incubated with CHC (1-642)-His 
proteins. (B) A scheme illustrated mutants that were used in A. (C) Two proposed models illustrating 
how GTSE1 binds CHC. Left; GTSE1 might bind to two sites on one CHC TD or right; GTSE1 can 
bridge two molecules of CHC TDs.  The site 1 and 3 on CHC TD are labeled in red and green and the 
GTSE1 peptides is in purple. 
 
3.4 The CHC-GTSE1 interaction is independent of the phosphorylation. 
Here we showed that GTSE1 interacts with CHC. Due to the fact that GTSE1 is highly 
phosphorylated and shows a molecular weight shit during mitosis (Figure 3-9A), it leads us to 
ask if the phosphorylation of GTSE1 alters its interaction with CHC. Our lab has identified 
that Aurora A, B and Cdk1 kinases are able to phosphorylate GTSE1 in vitro (Divya Sighn, 
unpublish data). Therefore, we first used these kinases to phosphorylate GTSE1 and 
compared the interaction before and after the phosphorylation. GTSE1 was phosphorylated by 
kinases confirmed by ProQ Diamond staining (Figure 3-9C), and the equal loading was 
examined by CB staining (Figure 3-9B). To test the interaction, 1 µM GST-GTSE1 proteins 
were incubated with 1 µM CHC (1-642) for an hr at 4 degree and following added GSH beads 
for 1 more hr incubation. GSH beads were washed 3 times with GST-binding buffer and 
analyzed by a SDS-page. Here, we did not see any remarkable differences of the CHC-
GTSE1 interaction before or after phosphorylation (Figure 3-9D). Furthermore, we did detect 
the interaction from all pulldown assays where CHC and GTSE1 proteins were purified from 
bacteria and not phosphorylated. In addition, we can easily detect the interaction from 
asynchronized cell lysates by IP in which the majority of GTSE1 is non-phosphorylated or 
not full phosphorylated (Figure 3-9E). These results are consistent with the idea that the 
phosphorylation on GTSE1 might not change the binding intensity to CHC. However, we do 
not know yet if the phosphorylation of GTSE1 changes its stoichiometry of the interaction 
with CHC. Further experiments are needed to perform in order to test this idea. 
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Figure 3-9. Phosphorylation of GTSE1 does not alter its interaction with CHC 
(A) GTSE1 is highly phosphorylated in mitosis. U2OS cells were synchronized with nocodazole for 
18 hour and released from nocodazole in the culture medium. Cell lysates were prepared at the 
indicated time point and analyzed by western blot using indicated antibodies. asyn: asynchronized cell 
lysates (B) GST-GTSE1 proteins were in vitro phosphorylated by either Aurora A (Aur-A), Aurora B 
(Aur-B), Cdk 1 or Aurora A plus Aurora B plus Cdk1 kinases (ABC). Proteins were analyzed by a 
SDS-page and stained with coomassie blue. Non-phosphorylated GST-GTSE1 proteins is labeled as 
Non-P (C) ProQ staining showing that GTSE1 proteins were phosphorylated after incubating with 
kinases in vitro from B. (D) CHC (1-642) proteins were pulled down by non-phosphorylated or 
phosphorylated GST-GTSE1 proteins. (E) IPs indicating that GTSE1 interacts with CHC in cycling 
cells. IPs were performed using anti-CHC and anti-myc (IgG) antibodies.    
  
3.5 X-ray crystallography of the CHC-GTSE1 complex  
Although we have characterized the interaction between CHC and GTSE1 in detail, we could 
not provide the binding model of how these LIDL motifs of GTSE1 interact with their 
corresponding binding sites on CHC on the molecular level. In order to gain insight into this 
interaction at the atomic resolution by means of X-ray crystallography, we attempted to 
crystallize the complex using the vapor diffusion method with the sitting-drop 
implementation.   
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To prepare the CHC-GTSE1 complex for crystallization trials, we subcloned CHC (1-364) 
and GTSE1 peptide (662-726) containing all 5 LIDL motifs into pGEX-6p-1 vector shown in 
Figure 3-10. In this construct, the GTSE1 peptide was fused after a GST tag following a 
PreScission protease cleavage site, and CHC has no additional tag. Because the ribosome-
binding site (RBS) is located between GST-GTSE1 and CHC, this construct allows two 
individual proteins to be translated at the same time from the same mRNA transcript that 
facilitates equimolar expression of both proteins.  
 
 
 
Figure 3-10. The construct of GTSE-GTSE1-CHC complex 
Left; The pGEX-6p-1 vector containing GTSE1 and CHC was used for the protein expression in 
bacteria. GTSE1 (661-726) was first subcloned following the GST tag with a PreScission Protease 
cleavage site, and CHC (1-364) without any tag was then cloned into the vector after a ribosome-
binding site (2rbs). Right; the exact amino acids of each gene are shown in green letters. The five 
LIDL motifs on the GTSE1 peptide are labeled in red.     
 
This construct was transformed into E. coli BL21 (DE3) cells for protein expression. To get 
the stable CHC-GTSE1 complex, the idea is if the short GTSE1 peptide has high affinity to 
CHC we can efficiently co-purify CHC while purifying GST-GTSE. To check the stable 
CHC-GST-GTSE1 complex was formed, the bacteria lysate was first purified by GST affinity 
column, and proteins was following subject to size-exclusion chromatography using a 
Superdex 75(16/600) column.  As shown in Figure 3-11A and B, GST-GTSE1 and CHC were 
eluted at same fractionations, suggesting that two proteins have an affinity high enough to 
form a stable complex. To cleave GST tags form the complexes, protein fractionations from 1 
to 4 (Figure 3-11B) were pooled and incubated with GST-PreScission protease at 4°C 
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overnight. As the final purification step to remove GST and GST-PreScission protease, the 
cleaved GTSE1-CHC complex was again subject to the Superdex 75 (16/600) column 
attached a GST column and equilibrated in a buffer containing 20 mM Tris pH 7.0 and 50 
mM NaCl by which GST-tagged proteins were trapped in the GST column and CHC-GTSE1 
complexes without GST tags were presented in the flowthrough (Figure 3-11C). We collected 
the fractionations and analyzed by the SDS-page. Here, we can only detect CHC proteins 
from CHC-GTSE1 complexes after the gel filtration. Because the molecular weight of GTSE1 
peptide is very small (~12 Kd) and contains very less basic amino acids, this peptide is not 
detectable using the coomassie blue staining on a SDS-page (Figure 3-11D). At the first 
purification step, we showed that GST-GTSE1 forms a very stable complex with CHC 
following the gel filtration (Figure 3-11A and B), we assumed that GTSE1 without GST tag 
should also bind CHC. The CHC-GTSE1 complexes were concentrated to 30 mg/ml for the 
crystallization trail. 
 
 
Figure 3-11. Protein purification of the CHC-GTSE1 complex 
To check if the affinity of GST-GTSE1-CHC complex is high enough while purification, the proteins 
after the GST affinity purification were subject to a Superdex 75(16/600) column (A and B). The 
GST-GTSE1 and CHC proteins were eluted at same fractionations evidenced by the chromatography 
(A) and the SDS-pages (B), indicating that GST-GTSE1and CHC form a stable complex. To remove 
the GST tag from the GTSE1-CHC complex, the GST-GTSE1-CHC complex was treated with GST-
PreScission protease. To get rid of the GST and GST-tagged proteins including the PreScission 
protease, the protein mixtures were separated by the Superdex 75(16/600) column attached with an 
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additional GST affinity column. The chromatography was shown in C, and the GTSE1-CHC complex 
was analyzed by the SDS-page in D.     
         
To crystalize the complex, proteins were screened against a broad range of commercial 
crystallization conditions at 20°C in sitting drop 96-well plates. Box-shaped crystals grew in 
several conditions containing middle-chain to long-chain of PEGs (4000 and 8000). Crystals 
formation usually occurred within hour to few days. Due to the predicted flexibility of the 
GTSE1 peptide, crystallization trials were also set up in the presence of trypsin using in-situ 
proteolysis approach. Crystals were isolated in a very thin liquid film from the crystallization 
drop and flash-cooled without additional cryo-protection. The best crystals, GTSE1-CHC-2, 
diffracted better than 2.4 Å resolution on a rotating anode using an image plate detector in 
house. High resolution data were collected at X10SA beamline at Swiss Light Source of PSI 
(Villigen, Switzerland). Shapes of crystals were shown in the middle panel in Figure 3-12, 
and crystallization conditions were summarized in Table 3-1. All diffracted crystals are 
belonged to space group P43 and contain one molecule of the GTSE1 peptide and CHC in the 
asymmetric unit.  
 
 
Figure 3-12. Crystals of the CHC-GTSE1 complex 
The CHC-GTSE1 complex was crystalized in several different conditions. The left crystal was in the 
condition of 0.1 M Tris pH 8.5 and 8% PEG 8000 after 56 hour; the middle one is the same crystal as 
left one after 104 hour; the right condition was in 0.1 M Tris pH 8.5, 8% PEG 8000 and 75ng/ml 
trypsin after 36 hour. Figure is provided by Dr. Arthur Porfetye. 
 
Table 3-1. Crystallization conditions of the CHC-GTSE1 complex 
Cystal name Resolution Space group Salt  Buffer Precipitant Condition 
GTSE1/CHC -2 < 2.4Å P43 / 0.1 M Tris pH 8.5 8% PEG 8000 PEG2 H6 
GTSE1/CHC-3 < 2.4Å P43 / 0.1M Tris pH 8.5 
75 ng/ml Trypsin 
8% PEG 8000 PEG2 H6 
GTSE1/CHC-6 < 2.3Å P43 0.1 M NaAc 
0.05 M MgAc 
/ 10% PEG 8000 PEG2 H9 
GTSE1/CHC-11 2.5Å P43 0.1 M MgAc 0.1M Tris pH 7.5 12% PEG 8000 ProComplex E8 
GTSE1/CHC-9 no diffraction  / 0.1M imidazole pH 8.0 10% PEG 8000 Core4 C7 
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The diffraction data set of the GTSE1/CHC-2 crystal was indexed, integrated and processed 
using the XDS package. The structure of CHC 1-364 was solved by molecular replacement 
using PHASER of the CCP4i suite based on a model of CHC 1-357 (PDB 4G55). The 
structure was refined in iterative cycles using refmac5 and coot, the statistic are shown in 
Figure 3-13D. After a few cycles of refinement, strong consecutive electron density is 
unambiguously fitted to the GTSE1 peptide (Figure 3-13 A, B and C) in which the Box D 
(LIDL) binding to the site 3 (Figure 3-13C) and the Box E (LIQL) bound to the site 1 of the 
CHC symmetry neighbor (Figure 3-13B). Interestingly, a weaker peptide-like electron density 
potentially fitting a few amino acids is visible in this crystal, which was found above the CHC 
site 2 (data not shown). Even though the exact sequences of GTSE1 could not be assigned 
into the electron density above this site, it is much different from the published amphiphysin 
peptide (PWDLW) that binds to the site 2 (Miele et al., 2004). It suggested that GTSE1 could 
potentially bind to the site 2 of CHC; however, this weak electron density could also be an 
artifact on the crystallization. Additionally, the mutation on the site 2 of CHC (S2M) does not 
affect the GTSE1-binding (Figure 3-2D), indicating that GTSE1 might not interact with this 
site. In summary, in our crystal this GTSE1 peptide (Box D) can interact with the site 3 and it 
can extend and cross over the site 2 on the same CHC TD. Perhaps, the GTSE1 peptide could 
further extend in which GTSE1 binds the site 1 by the Box A and B. However, we can not 
observe the electron density from these Boxes in the crystal.  
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Figure 3-13. Electron density of GTSE1 peptide on the CHC TD 
(A) The overview of the unambiguous electron density of GTSE peptide bound to the CHC TD. (B) 
The electron density of GTSE1 on the site 1 of CHC TD. (C) The electron density of GTSE1 on the 
site 3 of CHC TD.  (D) Crystallographic data and refinement statistics. Figures are provided by Dr. 
Arthur Porfetye. 
 
Unambiguous electron density corresponding to the N-terminal part of GTSE1 peptide (662-
699) could not be observed in this crystal structure. Residues 700-725 of GTSE1 were fitted 
into the final crystal structure, in which one molecule of GTSE1 bridges two CHC TDs 
(Figure 3-14A). The GTSE1 Box D (694-697) interacts with the CHC site 3 in the crystal 
(Figure 3-14B) that is consistent with our pulldown results. The key residues contributing the 
interaction in the Box D (LIDL) are L694, I695 and L697, which insert into hydrophobic 
pockets made by residues of CHC R188, Q192, L183, F216, F218 and H229. Interestingly, 
Arrestin2L was first reported to bind the CHC TD site 3 using a LLGXL motif (Arrestin 
motif) in which three leucines are buried into these hydrophobic packets as GTSE1 does. 
However, the binding mode of Arrestin2L is different in which the directionality of 
Arrestin2L peptide is reverse compared to GTSE1. Even through the glycine of Arrestin motif 
has no direct interaction with CHC, it might make this peptide very flexible and tends to bend 
this peptide in order to fit three leucines spatially into these pockets; therefore, alanine 
replacement of this glycine totally abolished the interaction (Kang et al., 2009). To date, 
GTSE1 is the second protein that specifically binds the canonical site 3 on CHC solved by X-
ray crystallography. Remarkably, the sequence of the Box D on GTSE1 is distinct from the 
arrestin motif. Instead of bending the arrestin motif by glycine, GTSE1 used the side chain of 
Q712 to form the intra-hydrogen bond to I695. This intramolecular hydrogen bond might 
curves the peptide, which makes itself more feasible bind to the CHC site 3.   
Unexpectedly, we observed that the GTSE1 Box E (LIQL) bound the site 1 on the symmetric 
CHC neighbor (Figure 3-14C). This result controverts our findings from pulldowns (Figure 3-
6D) and yeast two-hybrid assays (Figure 3-5A) in which the Box E mutation did not 
significantly perturb the interaction with CHC, indicating that this motif should not interact 
with the CHC TD. Nevertheless, three hydrophobic amino acids (L, I and L) on the Box E 
inserted into hydrophobic pockets formed by blades 1 and 2, fitting into the known canonical 
model on the CHC TD site 1. Since all diffracted crystals that we have gotten are belonged to 
the same space group (P43), so far we can not check if this interaction is reproducible in a 
different crystal packing. In fact that there are only 3 residues between the Box D and E, it is 
hard to believe that GTSE1 is able to physiologically bridge two CHC TDs using these two 
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boxes. Based on to our pulldown assay and the crystal packing, we postulated that the Box E 
might be an artificial binding due to this specific crystal packing. As a consequence, the Box 
E unexpectedly occupied the site 1 on the symmetry neighbor CHC TD, and it might further 
block the Box A or B to interact with the site 1. Additionally, an explanation why the crystal 
structure differs from pulldown results in which we did not detect these Boxes to bind CHC is 
that the peptide for crystallization is too short. This peptide only contains two residues before 
the Box A that is ten residues shorter than GTSE1-C1 used for pulldowns. Thus, if these 
amino acids preceding Box A contribute to the binding and help discriminate between the 
different binding boxes, the affinity to the CHC TD of the shorter peptide might be reduced. 
 
Figure 3-14. Crystal structure of the CHC-GTSE1 complex 
(A) The overview of the crystal structure. GTSE1 peptide (residues 700-725, pink) binds to one CHC 
(green) and bridges to another neighbor molecule of CHC (cyan). (B) Detailed view of the interface 
between the CHC TD site 3 and GTSE1 Box D. GTSE1 L694, I695 and L697 interact with 
hydrophobic pockets made by residues of CHC R188, Q192, L183, F216, F218 and H229. (C) The 
interaction between the CHC site 1 and GTSE1 Box E in detail. GTSE1 L720 fits into a small 
hydrophobic pocket. GTSE1 I721 and L723 fit into a large second hydrophobic pocket of CHC I66, 
I80, L82, I93 and F91. Figures are provided by Dr. Arthur Porfetye.     
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3.6 Characterizing functions of the CHC-GTSE1 interaction in cells  
Here, we revealed that GTSE1 interacts with CHC using its LID motifs by different 
biochemical approaches, and further gained insight into this interaction by X-ray 
crystallography. Additionally, we also showed that different combinations of LID mutations 
gradually affected their binding to CHC. Next, we aimed to address if this interaction between 
GTSE1 and CHC has its biological relevant and functions in cells. Thus, we used a bacteria 
artificial chromosome (BAC) to express the transgene in cells. Because BACs contain 
regulatory elements from the genome, the gene expression is relatively equal to the 
endogenous level. To generate GTSE1 mutant in which we would assure abolishment of the 
interaction with CHC, we decided to substitute all 5 LID motifs to 5 times triple alanine and 
referred it as 5xLID mutant in our study. To examine functions of transgenes without a 
disturbance from the endogenous background, GTSE1-WT and GTSE1-5xLID were made 
resistant to GTSE1 siRNA and tagged with GFP. U2OS cells were transfected with these 
BACs, and clonal cells stably expressing GTSE1-WT or GTSE1-5xLID mutant were isolated. 
We first checked if the GTSE1-5xLID mutant also abolishes its interaction with CHC in cells. 
To test that, we prepared the unsynchronized cell lysates from both GTSE1-WT and GTSE1-
5xLID lines and used anti-CHC antibodies to perform IPs. As expected, CHC can efficiently 
pull down endogenous GTSE1 proteins in both WT and 5xLID lines. However, CHC can 
only interact with the WT transgene but not the 5xLID mutant, indicating that this mutant 
indeed abolishes the interaction with CHC in vivo (Figure 3-15A). Because these transgenes 
are siRNA resistant and unaffected following GTSE1 depletion, we next characterized the 
cellular localization of them after GTSE1 depletion. It is worth to mention that these 
transgenes’ levels are comparably equal to the endogenous GTSE1 in the control depletion, 
and the WT and the 5xLID mutant transgene also showed similar protein expression (Figure 
3-15B). Cells were fixed by 4% PFA/PIPES buffer and stained with anti-GFP antibodies to 
label the GTSE1 transgene. GTSE1 is higher expressed in G2 phase and mitosis we then 
selected the G2 phase to represent interphase. As is shown in Figure 3-15C, GTSE1-5xLID 
showed a similar cellular localization as GTSE1-WT during certain cell cycle phases. Both of 
them were accumulated on centrosomes/ poles in interphase and late mitosis. Remarkably, 
their localizations in metaphase are very different. GTSE1-WT can be easily observed on the 
mitotic spindle and poles in metaphase. However, GTSE1-5xLID was hard to detect or just 
very little on spindles and defused in the cytoplasm. Due to the high cytosolic background in 
GTSE1-5xLID, it is very difficult to distinguish whether this mutant is able to present on the 
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poles in metaphase. Altogether, here we showed that GTSE1 5xLID mutant abolishes the 
interaction with CHC in vitro (Figure 3-8A) and in vivo and thereby this mutant does not 
localize on mitotic spindles in metaphase, revealing that this interaction is required for 
GTSE1 to localize at spindles. Due to the fact that we only observed the different cellular 
localization of 5xLID mutant in metaphase in which it delocalizes from spindles, it highly 
suggested that this mutant might have some mitotic defects. We thereby investigated and 
characterized the phenotypes of GTSE1-5xLID mutant during mitosis.   
 
 
 
Figure 3-15. The GTSE1-5xLID does not bind CHC and delocalizes from spindles 
(A) IPs indicating that the 5xLID mutant does not bind CHC in vivo. IPs were performed using anti-
CHC antibodies. (B) Western blot showing that these transgenes are siRNA resistant following 
GTSE1 depletion. Figure is provided by Dr. Arnaud Rondelet. (C) The 5xLID mutant delocalized 
from spindles in metaphase. IFs showing that the localization of GTSE1-WT and 5xLID mutant in 
different cell cycle stages. Images were taken by DeltaVision with a Z-optical spacing of 0.2 µm, 
subsequently deconvolved and analyzed using the SoftWoRx 5.0. 
 
Here we showed that the CHC-GTSE1 interaction is required for GTSE1 to localize on 
spindles in metaphase; therefore the 5xLID mutant does not interact with CHC and 
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delocalizes from spindles. This result strongly suggested that CHC might recruit GTSE1 to 
the spindles. A direct experiment to test this hypothesis is to check the cellular localization 
following CHC depletion. To avoid the GTSE endogenous background, we visualized the 
localization of transgenes following GTSE1 siRNA in combination with CHC depletion. As 
expected, the WT GTSE1 transgene localized on spindle in the control condition (Figure 3-
16A (i)). Notably, it delocalized from mitotic spindles following CHC depletion, indicating 
that CHC indeed recruits GTSE1 to mitotic spindles (Figure 3-16A (ii)). In consistence with 
this idea, the 5xLID mutant does not present or only very little on spindles. Interestingly, 
abnormal shapes of spindles are often observed in this mutant (Figure 3-16A (iii)). These 
results revealed that the spindle recruitment of GTSE1 is dependent on CHC. Since the 5xLID 
mutant is unable to bind CHC, the CHC-GTSE1 interaction is specifically to recruit GTSE1 
to spindle microtubules. However, it is hard to detect if GTSE1 still localized on poles 
following CHC depletion due to the high cytosolic background by the IF. Next, we examined 
the dependency of CHC and TACC3 after GTSE1 siRNA. Both CHC and TACC3 were 
unaffected and remained to localize on spindles following GTSE1 depletion shown in Figure 
3-16B (ii), suggesting that GTSE1 functions downstream of the CHC-TACC3 complex which 
is consistent with previous findings (Bendre et al., 2016; Cheeseman et al., 2013; Hubner et 
al., 2010). Taken together, here we showed that GTSE1 directly interacts with CHC and 
GTSE1 is recruited by CHC as a downstream effector to regulate the spindle integrity.   
                              
 
 
Figure 3-16. CHC recruits GTSE1 to the mitotic spindle 
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(A) The interaction with CHC is required for GTSE1 to localized on spindles. U2OS cells expressing 
GTSE1-WT-GFP were depleted by GTSE1 siRNA (i) or GTSE1 plus CHC siRNA (ii). IF showing 
that GTSE1-WT transgene delocalized from spindles following CHC depletion (ii). U2OS cells 
expressing GTSE1-5xLID-GFP were treated with GTSE1 siRNA and this mutant was undetectable or 
hard to detect on spindles (iii). (B) The spindle localization of the CHC-TACC3 complex was not 
affected following GTSE1 depletion. U2OS cells expressing CHC-GFP were treated with GTSE1 
siRNA. IF showing that the localization of CHC and TACC3 has no visually changes following 
GTSE1 depletion (ii) in comparison to control siRNA (i). Images were taken by DeltaVision with a Z-
optical spacing of 0.2 µm, subsequently deconvolved and analyzed using the SoftWoRx 5.0. 
 
3.7 The CHC-GTSE1 complex specifically presents on K-fibers                 
Here we revealed that the CHC-GTSE1 complex presented on the mitotic spindle. CHC has 
been shown to specifically localize to K-fibers by IF staining and immunogold electron 
microscopy (Booth et al., 2011; Royle et al., 2005). Since the spindle localization of GTSE1 
is dependent on CHC, we reason that the majority of GTSE1 should localize to K-fibers 
because of their direct interaction. A good way to examine this idea is to deplete Hec1. Hec1 
is one subunit of Ndc80 complex, which is identified to mediate kinetochore-microtubule 
attachment. Thus, following Hec1 deletion the bipolar spindle can still be formed, but 
chromosomes are unable to congress due to loss of K-fibers. We first examined the cellular 
localization of CHC following Hec1 depletion in U2OS expressing CHC-GFP. In control-
depleted cells, CHC is easily seen on mitotic spindles in metaphase (Figure 3-17A (i)). After 
depleted Hec1, cells showed typical defects in which chromosomes can not congress on the 
metaphase plate (Figure 3-17A (ii-iv)). As expected, we could not observe the detectable 
signal of CHC on spindles. Due to the fact that Hec1 depletion leads to the K-fiber null 
phenotype and CHC is no longer on spindles, we thereby confirmed that CHC might 
specifically present on K-fibers. Next, we checked the GTSE1-GFP signal after Hec1 
depletion. In control-depleted cells, GTSE1 was localized on spindles and spindle poles 
(Figure 3-17B (i)). Interestingly, the majority of GTSE1 delocalized from spindles following 
Hec1 depletion, suggesting that a large portion of GTSE1 does bind K-fibers (Figure 3-17B 
(ii-iv)). Additionally, we very often observed that GTSE1 accumulated on poles (Figure 3-
17B (iii-v)) and few cells did show the weak spindle localization (Figure 3-17B (v)) following 
Hec1 depletion. Although GTSE1 is a microtubule-binding protein, it is highly 
phosphorylated during mitosis (Figure 3-9A) and the majority of GTSE1 does not tend to 
bind microtubules (Scolz et al., 2012). Thus, its K-fiber localization is highly dependent on 
CHC, which is also confirmed by the fact that the 5xLID mutant, loss of CHC-binding, does 
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not present on K-fibers (data not shown). Altogether, these results indicated that CHC recruits 
GTSE1 to K-fibers. However, we do see that GTSE1 localizes on poles following CHC 
depletion in live cells (Hubner et al., 2010) and Hec1 depletion. It strongly suggests that the 
pole localization of GTSE1 is independent of CHC. The pole/centrosomal localization of 
GTSE1 is presumably due to its intrinsic microtubule-binding ability under unphosphorylated 
status, or GTSE1 might potentially interact with centrosomal proteins. 
      
 
Figure 3-17. The CHC-GTSE1 complex specifically localizes on K-fibers 
(A) CHC presents on K-fibers and it loses the localization following Hec1 depletion. U2OS cells 
expressing CHC-GFP were treated with Control siRNA (i) or Hec1 siRNA (ii-iv). (B) The majority of 
GTSE1 is bound to K-fibers in metaphase. U2OS cells expressing GTSE1-GFP were treated with 
Control siRNA (i) or Hec1 siRNA (ii-v). The major phenotypes following Hec1 depletion were ii and 
iii where GTSE1 accumulates on two poles and defuses from poles. Little amount of GTSE1 can be 
found at spindles after Hec1 depletion in few cells (v). Images were taken by DeltaVision with a Z-
optical spacing of 0.2 µm, subsequently deconvolved and analyzed using the SoftWoRx 5.0. 
 
3.8 GTSE1 binds the outer kinetochore and colocalizes with MCAK on kinetochores. 
Here we showed that the CHC-GTSE1 complex localizes on K-fibers. We previously 
identified that GTSE1 is a novel microtubule-stabilizing protein by inhibiting MCAK. MCAK 
is recruited by Sgo2 to kinetochores where MCAK depolymerizes microtubules and regulates 
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microtubule-kinetochore attachment (Huang et al., 2007). Interestingly, GTSE1 depeltion also 
leads to slight defects in microtubule-kinetochore attachment even if chromosomes are fully 
congressed and correctly alignmed at the metaphase plate (Bendre et al., 2016). This result 
implied that GTSE1 might presumably localize on kinetochore to inhibit the MCAK-
depolymerizing activity. Although GTSE1 is presented on K-fibers, we do not know yet if the 
K-fiber localization is able to bring itself to kinetochores, or GTSE1 is able to localized on 
kinetochores independent of K-fibers. However, we could not clearly detect GTSE1 on 
kinetochores by IF so far. It may be because the portion of GTSE1 on kinetochore is very 
little and even very dynamic. Thus, to answer if GTSE1 localizes to kinetochores, the best 
way is to test whether GTSE1 is able to interact with kinetochore proteins. In fact, MCAK 
localizes on the outer kinetochore or corona. In order to inhibit MCAK activity, GTSE1 has to 
be physiologically close and interact with MCAK. We therefore hypothesized that GTSE1 
might localize at outer kinetochore through interacting with protein complexes on outer 
kinetochore. Additionally, GTSE1 is highly phosphorylated during mitosis. Thus, we 
reasoned that this interaction might depend on the phosphorylation. To examine the 
interaction, here we used the KMNZ complex containing 10 proteins, which almost cover all 
components on the outer kinetochore (Cheeseman and Desai, 2008; Musacchio and Desai, 
2017; Pesenti et al., 2016). We first phosphorylated GST-GTSE1 by different kinases, and 
checked the interaction with the KMNZ complex. Because the interaction is very weak we 
can not detect any kinetochore proteins that were pulled down by the coomassie staining (data 
not shown). We next used western blot to detect the interaction. Each subunit of the KMNZ 
complex forms a very stable network, meaning that if one protein from this complex is pulled 
down the whole KMNZ complex can be detected. Thus, we used anti-His or anti-Hec1 
antibodies to detect samples from pulldowns. As shown in Figure 3-18A, GTSE1 can pull 
down the outer kinechore once GTSE1 is phosphorylated by either Aurora A or Aurora B 
kinase. Interestingly, the non-phosphorylated GTSE1 or phosphorylated by cdk1 can not bind 
the outer kinetochore. Next, we exmained whether the 5xLID mutant is able to interact with 
the outer kinetochore. We then independently performed the second pull down assays and 
detected by anti-Hec1 antibodies. As indicated in Figure 3-18B, the non-phosphorylated 
GTSE1 can not bind the KMNZ complex as expected. Once GTSE1 got phosphorylated by 
Aurora B, both WT and 5xLID can interact with the outer kinetochore. Interestingly, we 
found the phosphorylation by Aurora A or B kinase is required for GTSE1 to interact with 
kinetochores. This is not surprising because these two kinases regonize similar motifs. In fact, 
lpl1, the only Aurora kinase in yearst, shares functions and substrates with Aurora A and 
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Aurora B. More recently, a single amino acid change coverts Aurora A into Aurora B-like 
kinase in terms of substrates and celluar localization (Fu et al., 2009; Hans et al., 2009). Thus, 
these phsophrylation events are more dependent on Aurora kinases’ subcellular localizations. 
Since Aurora B kinase physiologically localizes near kinetochores, we hypothsize that 
GTSE1 is phosphorylated by Aurora B which induces GTSE1 to bind kinetochores. The 
5xLID mutant, which does not bind CHC and delocalizes from spindles/k-fibers, also binds 
kinetochores. Thus, the kinetochore recruitment of GTSE1 is dependent on Aurora B kinase 
rather than its K-fiber localization. However, GTSE1 somehow only shows a weak affinity to 
outer kinetochores.     
 
 
 
Figure 3-18. GTSE1 interacts with kinetochores in an Aurora B phosphorylation-dependent 
manner 
(A) GTSE1 interacts with the KMNZ complex after Aurora A and Aurora B phosphorylation. 2µM of 
GST-GTSE1 proteins were phosphorylated by different kinases at 4°C overnight. Non-
phosphorylated- or phosphorylated-GST-GTSE1 were immobilized on GSH beads and washed with 
buffer to remove kinases. These beads were incubated with the KMNZ complex to perform the 
pulldown assays. A: Aurora kinase A. B: Aurora B kinase. C: cdk1 kinase. ABC: A plus B plus C. (B) 
Both GTSE1 WT and 5xLID mutant interact with the KMNZ complex after Aurora B 
phosphorylation. 
 
To further confirm if GTSE1 can interact with MCAK on kinetochore, we decided to use the 
proximity ligation assay (PLA) that allowed us to detect the interaction in situ. We treated 
cells with 3.3 µM nocodazole overnight and performed the PLA. As shown in Figure 3-19, 
the PLA signal can be detected in both GTSE1-WT and 5xLID mutant. Interestingly, we 
found that the PLA signal occasionally overlaps with CREST and is not detected on each 
kinetochore, suggesting that the GTSE1-MCAK complex is only formed under certain 
circumstances and could function together on kinetochores. Because we treated cells with 
nocodazole, the kinetochore localization of this complex is independent of microtubules. 
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Importantly, using PLA we first identify that GTSE1 can localize on kinetochores and 
interacts with MCAK. Moreover, the 5xLID mutant still colocalizes with MCAK on 
kinetochores. Even through the mutant could not bind K-fibers, it could still localize to 
kinetochores and perhaps controls the proper microtubule-kinetochore attachment by 
inhibiting MCAK.  
 
 
 
Figure 3-19. GTSE1 interacts with MCAK on kinetochores 
Cells were fixed with 4% PFA/PIPES following the nocodazole treatment. GFP and MCAK 
antibodies were diluted 200 times and performed PLA. The green color represents the GTSE1-MCAK 
interaction by the PLA signal. Kinetochores were labeled by CREST. Both GTSE1-WT and 5xLID 
can interact and colocalize with MCAK on kinetochores. Images were taken by DeltaVision with a Z-
optical spacing of 0.5 µm, subsequently deconvolved and analyzed using the SoftWoRx 5.0. 
 
3.9 In vitro reconstitution of the microtubule-stabilizing complex 
CHC has been shown to interact with TACC3 in an Aurora A kinase-dependent manner, 
which permits this complex to translocate onto mitotic spindles and regulates spindle integrity 
(Fu et al., 20110; Hubner et al., 20110; Lin et al., 20110). Additionally, the CHC-TACC3 
complex functions as a central hub to interact with different proteins. On one hand, TACC3 
recruits ch-TOG to spindles (Cheeseman et al., 2013; Gutierrez-Caballero et al., 2015; Thakur 
et al., 2014); on the other hand, CHC directly recruits GTSE1 onto spindles during mitosis, 
indicating that the CHC-TACC3 complex can bring another novel microtubule-stabilizing 
protein, GTSE1, to spindles. The cooperation of ch-TOG and TACC3 is proposed to 
antagonize MCAK activity in vitro although high concentration of ch-TOG alone slightly 
reduced MCAK activity (Kinoshita et al., 2005). However, this complex does not seem to 
bind MCAK directly. We previously showed that GTSE1 interacts with MCAK and inhibits 
MCAK-depolymerizing activity (Bendre et al., 2016). Thus, this large protein complex 
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containing CHC, TACC3, ch-TOG and GTSE1 can simply stabilize microtubules through 
regulating the activity of microtubule polymerase (ch-TOG) and deploymerase (MCAK) in 
addition to its function in bridging microtubules. Here, we defined this protein complex as the 
microtubule-stabilizing complex and schemed in Figure 3-20. 
 
 
Figure 3-20. A microtubule-stabilizing complex including CHC, TACC3, ch-TOG and GTSE1 
TACC3 interacts with CHC in an Aurora A phospho-dependent manner that translocates to spindles. 
Furthermore, the CHC-TACC3 complex acts as a central hub to recruit GTSE1 and ch-TOG onto 
spindles. ch-TOG could polymerize microtubules that maintains spindle integrity. Additionally, 
GTSE1 direct interacts with MCAK and inhibits MCAK-mediated microtubule depolymerization. 
Figure is provided by Dr. Arnaud Rondelet. 
 
Next, to test if this is a bona fide microtubule-stabilizing complex formed only in mitosis, we 
performed IPs. To get cell lysates from different stages of cell cycle. U2OS cells were 
arrested in mitosis with nocodazole or in S phase using a single thymidine block. IPs were 
performed using anti-CHC, anti-TACC3 or anti-GTSE1 in presence of phosphatase inhibitors. 
As shown in Figure 3-21B, we can detect CHC, TACC3 and GTSE1 in a complex pulled 
down by CHC, TACC3 or GTSE1 antibodies in mitosis. In contrast, neither the CHC-TACC3 
nor the TACC3-GTSE1 complex can be formed, and only the CHC-GTSE1 complex can be 
found in interphase (Figure 3-21A). TACC3 needs to be phosphorylated by Aurora A, which 
permits its interaction with CHC. Thus, it is unlikely to see the CHC-TACC3 complex in 
interphase as expected. Since we do see GTSE1 forming a complex with TACC3 only in 
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mitosis (Figure 3-21B), suggesting that the TACC3-GTSE1 interaction might depend on the 
phosphorylation, or it is an indirect interaction through CHC. Therefore, the interaction 
between GTSE1 and TACC3 needs to be further clarified.   
 
 
Figure 3-21. CHC, TACC3 and GTSE1 form a complex only in mitosis 
(A) IPs indicating that TACC3 does not interact with the CHC-GTSE1 complex in interphase. Cells 
were arrested in S phase by thymidine block for 30 hour. Cell lysates were prepared and performed 
IPs using indicated antibodies. (B) IPs showing that CHC, TACC3 and GTSE1 form a stable complex 
in mitosis. Cells were synchronized in mitosis by adding nocodazole for 18 hour. Cell lysates were 
prepared and performed IPs using indicated antibodies. 
 
Notably, GTSE1’s spindle localization depends on not only CHC but also TACC3. Removing 
TACC3 from spindles severely impairs GTSE1’s spindle localization (Hubner et al., 2010; 
Cheeseman et al., 2011).  Here, we elucidated that GTSE1 indeed forms a complex with 
TACC3 in mitosis. Delocalizing GTSE1 from spindles following TACC3 depletion raises a 
question if TACC3 directly recruits GTSE1 to spindles or it is simply due to loss of CHC on 
spindles. Therefore, we next examined the interaction between TACC3 and GTSE1 by using 
the recombinant proteins. Because GTSE1 is heavily phosphorylated during mitosis, and 
TACC3 is phosphorylated by Aurora A as well, it leads us to consider if the interaction is 
mediated by phosphorylation. To test that, we thereby phosphorylated GTSE1 using different 
kinases and phosphorylated TACC3 by Aurora A. The phosphorylation of GTSE1 was 
confirmed by pro-Q staining shown in Figure 3-22A (low panel). Phosphorylated TACC3 was 
analyzed using anti-pS558 TACC3 antibodies that specific detect against the phosphorylated 
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serine 558 on TACC3 (Figure 3-22B). However, we could not detect any interaction between 
TACC3 and GTSE1 in vitro after phosphorylation, suggesting that there is no direct 
interaction, or this interaction is mediated by other kinases (Figure 3-22C). To answer this 
question, the idea is to do IPs using the mitotic cell lysates of GTSE1-5xLID, because this 
mutant, in theory, should get fully phosphorylated in cells during mitosis. Since the 5xLID 
mutant does not bind CHC, we can check the TACC3-GTSE1 interaction independent of 
CHC. U2OS cells expressing GTSE1-WT or GTSE1-5xLID tagged with GFP were arrested 
using nocodazole. Mitotic cell lysates were then prepared to perform IPs. As shown in Figure 
3-22D, GTSE1-WT could pull down an interacting complex including CHC and TACC3 (line 
1). However, GTSE1-5xLID does not bind to CHC and failed to interact with TACC3 (line 
2), suggesting that there is no direct interaction between GTSE1 and TACC3. To further 
confirm this observation, we then added Aurora A kinase inhibitor (MLN8054) in our IPs, 
which prevented TACC3 phosphorylation by Aurora. The interaction between CHC and 
TACCs is Aurora A dependent. Thus, the MLN8054 treatment abolished their interaction as 
expected (line 3). Remarkably, it also eliminated the interaction between TACC3 and GTSE1. 
In summary, GTSE1 does not bind TACC3; however, through the direct interaction with 
CHC, GTSE1 can indirectly form a complex together with TACC3 during mitosis.  
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Figure 3-22. GTSE1 does not interact directly with TACC3 
(A) GST-GTSE1 proteins were phosphorylated by either Aurora A (Aur-A), Aurora B (Aur-B), Cdk 1 
or Aurora A plus Aurora B plus Cdk1 kinases (ABC) in vitro and stained with coomassie blue. Non-P: 
non-phosphorylated proteins. Phosphorylated GTSE1 proteins were confirmed by ProQ staining. (B) 
In vitro phosphorylation of TACC3 by Aurora A kinase, and detected using coomassie staining or 
western using indicated antibodies. (C) The pulldown analysis examining the interaction 
between phosphorylated GST-GTSE1 and phosphorylated TACC3 proteins. Western blot was 
performed using anti-pS558 TACC3 antibodies. (D) In vivo IPs by anti-GFP antibodies from 
cell lines stably expressed GTSE1-WT-GFP or GTSE1- 5xLID-GFP in the presence or 
absence of aurora A kinase inhibitor (MLN8054). IPs were performed by Dr. Arnaud 
Rondelet. 
 
We next aimed to reconstitute the whole microtubule-stabilizing complex including CHC, 
TACC3, ch-TOG and GTSE1 in vitro. We thereby checked the pair interactions among these 
proteins first. The interaction between CHC and TACC3 has been described in detail from 
previous study (Lin et al., 2010) as well as the interaction between TACC3 and ch-TOG 
(Gutiérrez-Caballero et al., 2015; Hood et al., 2013; Thakur et al., 2014). We next tried to 
reproduce these interactions in our hands. Because phosphorylated TACC3 allows itself to 
bind CHC, we then phosphorylated TACC3 by Aurora A. As shown in Figure 3-23A, the full-
length phosphorylated TACC3 can be pulled down by both GST-CHC-FL and GST-CHC (1-
642). We could detect very weak interaction between non-phosphorylated TACC3 and CHC. 
However, it might be due to the high concentration of proteins that forces the interaction in 
our reactions. Next, we used a shorter fragment of TACC3 containing only the TACC domain 
(410-838).  As expected, the TACC domain following the Aurora A phosphorylation binds to 
CHC (1-642) as well (Figure 3-23B and C). We can also confirm that a short fragment of ch-
TOG (1806-2032) interacts with TACC3 (Figure 3-23D) as shown from the previous study 
(Hood et al., 2013).  
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Figure 3-23. TACC3 interacts with both CHC and ch-TOG 
CHC directly interacts with TACC3 in (A)(C). (A) GST-CHC-FL and GST-CHC (1-642) can pull 
down TACC3 following Aurora A phosphorylation. (B) A SDS-gel showing that the TACC domain 
(410-838) is phosphorylated by Aurora A and induces the molecular weight shift. (C) The 
phosphorylated TACC domain (410-838) interacts with CHC (1-642). (D) A shortest fragment of ch-
TOG (1806-2032) interacts with TACC3 independent of Aurora A phosphorylation. 
  
From previous pulldown experiments, we found that CHC (1-642) interacts with both GTSE1 
(639-739) and phosphorylated TACC3, and the phosphorylated TACC3 (410-838) can bind 
ch-TOG (1806-2032) as well (data not shown). Due to the identified interactions among these 
proteins as shown in Figure 3-23, we postulated that CHC, TACC3, ch-TOG and GTSE1 can 
form one integral complex at the one arm of CHC triskelion. Because CHC (1-642) lacks the 
trimerization domain, it would stay in a monomer in our assays. The idea is that GTSE1 (639-
739) can interact with a monomer CHC (1-642). Once TACC3 and ch-TOG were added into 
the reaction, this CHC-GTSE1 complex can indirectly pull down ch-TOG by the CHC-
TACC3 interaction. Therefore, each arm of CHC triskelion enables to recruit all these 
proteins together. We then tested this hypothesis. As shown in Figure 3-24, we first examined 
that GTSE1 (639-739) neither binds ch-TOG (1806-203) (line 7) nor the ch-TOG (1806-
2032)-pTACC3 (410-838) complex (lines 10 and 11). As expected, GTSE1 can interact with 
CHC (line 2). The CHC-GTSE1 complex could pull down very little pTACC3 (line 4). 
Noteworthy, this complex tended to pull down more pTACC3 in the presence of ch-TOG 
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(line 6) as compared to the line 4, suggesting that ch-TOG might increase the interaction 
between CHC and pTACC3. However, we do not know yet the mechanism of how ch-TOG 
enhances pTACC3 to bind CHC. Our results support the mesh hypothesis in which the CHC 
triskelion has to bridge at least two microtubules, meaning that each CHC of the triskelion 
must interact with TACC3 to generate a microtubule-binding surface. In conclusion, here we 
showed that CHC (1-642), as a monomer, can interact with GTSE1 and the pTACC3-ch-TOG 
complex as well, supporting the idea that each individual arm of the CHC triskelion contains 
all these proteins in order to bind/bridge microtubules. 
 
 
 
Figure 3-24. CHC interacts with GTSE1 and the TACC3-chTOG complex 
MBP-GTSE1 (639-739) was incubated with indicated proteins to perform the pulldown assays. 
Samples were analyzed by western blot using indicated antibodies. 
 
Even though the CHC triskelion could cross-link microtubules, the CHC TD has its unique 
roles to stabilize microtubules independent of the bridging functions in mitosis. Here we 
revealed that the CHC TD directly interacts with GTSE1 (Figure 3-2) and this interaction is 
required for GTSE1 to localize on mitotic spindles (Figure 3-16). The 5xLID mutant, which is 
unable to interact with the CHC TD, delocalizes from spindles and causes mitotic defects 
(Figure 3-16).  Our lab previously identified that GTSE1 is a novel microtubule stabilizer by 
inhibiting MCAK-depolymerizing activity. Thus, one mechanism by which CHC promotes 
microtubule stability in mitosis is by recruiting GTSE1 to inhibit MCAK. However, CHC 
itself is unable to bind microtubules. Thus, CHC has to interact with TACC3 to translocate 
onto spindles in order to regulate spindle integrity. Our model therefore hypothesized that 
these proteins including CHC, TACC3, ch-TOG, GTSE1 and MCAK should presumably 
form a large-interacting complex. To test that, we used an in vitro pulldown assay in which 
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we purified CHC FL, TACC3 FL, MACK FL, GST-GTSE1 FL and ch-TOG (1806-2032) 
proteins. To test the interactions among them, TACC3 and GST-GTSE1 proteins were first 
phosphorylated by Aurora A kinase. Phospho-GST-GTSE1 proteins were then immobilized 
on GSH beads as baits to perform the pulldown. As shown in Figure 3-25, GTSE1 could form 
an interacting complex with all these proteins, supporting the model in which the TACC3-
CHC complex recruits GTSE1 to spindles to stabilize microtubules through the inhibition of 
MCAK.   
   
 
Figure 3-25. The microtubule-stabilizing complex interacts with MCAK 
GST-GTSE1-FL can pull down a complex containing CHC-FL, TACC3-FL-, ch-TOG (1806-2032) 
and MCAK-FL. GST-GTSE1-FL and TACC3 proteins were phosphorylated by Aurora A kinase. 
GST-GTSE1-FL proteins were immobilized on GSH beads to perform the pull down assay.  
 
The N-terminal region of GTSE1 binds MCAK (Bendre et al., 2016) and its C-terminus 
interacts with CHC identified from our study, suggesting the CHC-GTSE1-MCAK axis exists 
in cells. GTSE1 is an intrinsically disordered protein, and some disordered proteins indeed 
need their interacting partners to stabilize their protein conformation. It raises a question if the 
CHC binding on GTSE1 could affect GTSE1’s interaction with MCAK and vice versa, 
meaning that there could be either a competition or a synergistic effect among these 
interactions. Because the GTSE1 5xLID mutant does not interact with CHC, we can compare 
the GTSE1-MCAK interaction between the GTSE1 WT and mutant in the presence of CHC. 
This experiment allowed us to address if CHC has any effects on the GTSE1-MCAK 
interaction. As expected, GTSE1-WT bound CHC (Figure 3-26A line 2) but not GTSE1-
5xLID (Figure 3-26A line 3). We next examined whether this mutant effects the interaction 
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with MCAK. MCAK binds to the N-terminal region of phosphorylated GTSE1; therefore, 
theoretically, the C-terminal 5xLID mutant should not affect its interaction with MCAK. As 
shown in line 4 and line 5, MCAK was sufficiently and equally pulled down by both GTSE1-
WT and 5xLID, suggesting that the 5xLID mutant has no detectable effect on the MCAK 
binding. As shown in line 6, GTSE1-WT can efficiently pull down both CHC and MCAK. 
Interestingly, GTSE1-5xLID remains the same binding capability to MCAK (line 7) in 
comparison with GTSE1-WT (line 6), indicating that the CHC-GTSE1 interaction does not 
affect GTSE1 to bind MCAK. To conclude the pulldown experiments, we showed that 
GTSE1 binds both CHC and MCAK and one pair of interactions has no effect on the other 
one. The GTSE1 5xLID mutant still binds MACK, which is consistent with the PLA assays 
where both GTSE1-WT and mutant could bind MCAK on kinetochores (Figure 3-19).    
 
 
 
Figure 3-26. GTSE1 interacts with both CHC and MCAK 
(A) Pulldown experiments showing the interaction among GTSE1, CHC and MCAK. (B) A-SDS-page 
showing the quality of GST, GST-GTSE1-WT and 5xLID proteins.
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4. Discussion 
4. Discussion 
 
CHC has been shown to bridge microtubules through forming the triskelion by its C-terminus, 
which stabilizes microtubules and maintains spindle integrity. However, a mutation on the 
CHC TD, abolishing the interaction with its adaptor proteins, does not affect its trimerization 
but causes mitotic defects. Thus, in addition to the bridging function, the CHC TD has its 
unique roles during mitosis. However, the function of the CHC TD has not been revealed yet. 
Here we identified GTSE1, a microtubule-stabilizing protein, and acts as a downstream 
effector of CHC. GTSE1 directly binds the CHC TD through an adaptor-like interaction that 
recruits GTSE1 to mitotic spindles. GTSE1 might be the first protein that is involved in the 
CHC TD-mediated microtubule stability in mitosis. As a consequence, the GTSE1 5xLID 
mutant, which can not bind to CHC and does not localize to spindles, leads to a global 
microtubule stability defects in spindle integrity, chromosome alignment and timely mitosis. 
We previously determined that GTSE1 inhibits MCAK activity that is required for the proper 
microtubule dynamics in mitosis (Bendre et al., 2016). Thus, one mechanism of how the CHC 
TD controls microtubule stability is through the GTSE1-MCAK axis. To gain insight these 
interacting networks, we could reconstitute a microtubule-stabilizing complex including 
CHC, TACC3, ch-TOG and GTSE1 in vitro, and this complex can further interact with 
MCAK. We previously revealed that GTSE1 might be involved in regulating microtubule-
kinetochore attachment. In our study, we further confirmed that both GTSE1-WT and 5xLID 
mutant could weakly interact with kinetochores dependent on Aurora B phosphorylation, and 
they could occasionally associate with MCAK on kinetochores independent of microtubules. 
It sheds a light on a novel mechanism in which GTSE1 colocalizes with MCAK and regulates 
its activity on kinetochores to control the proper microtubule-kinetochore attachment.        
 
4.1 The binding-stoichiometry and crystal structure of the CHC-GTSE1 complex. 
In our study, we identified the interacting surfaces in detail on CHC and GTSE1 (Figure 3-2D 
and 3-3C). It becomes clear that two pairs interactions between them can stabilize the CHC-
GTSE1 complex (Figure 3-8A). Therefore, GTSE1-C containing these two-binding domains 
has the stronger interaction than short fragments including C1 and C3 (Figure 3-3C). 
Consistent with the idea, some CHC adaptor proteins often use more than one motif to 
interact with the CHC TD; for instance, amphiphysin and β-arrestin2L (Kang et al., 2009; 
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Miele et al., 2004). Due to the fact that GTSE1 contains 5 almost identical LID motifs, it 
raises a question why GTSE1 specifically used two pairs of these motifs to bind CHC. Since 
GTSE1 can interact with CHC in both interphase and mitosis, does GTSE1 change its 
stoichiometry to bind CHC during the cell cycle? CHC and GTSE1 might behave differently 
in interphase and mitosis. The most well known function of CHC in interphase is to form a 
cage by its triskelion to mediate endocytosis. On the contrary, CHC prefers to maintain the 
triskelion and localizes on spindle in metaphase. Because high concentration of CHC triskelia 
can spontaneously pack into a cage, mechanisms may exist to avoid their polymerization to 
form a cage on the spindle. For example, protein interactors or post-translational 
modifications may prevent CHC from forming a cage in mitosis. Actually, some CHC 
adaptors are phosphorylated during mitosis, for instance; AP1 and AP2, which abolish their 
interactions with CHC (Wilde and Brodsky, 1996). Furthermore, most CHC adaptor proteins 
are not found to localize to spindles that might not help CHC polymerization (Royle, 2012; 
Royle, 2013). Additionally, another hypothesis is that free triskelia on spindles might be far 
away from each other which also prevents the cage formation. Nevertheless, the CHC cage is 
very different from the free triskelion in terms of the distance between two CHC TDs. CHC 
triskelia are highly packed in the cage, and therefore this distance between two N-terminal 
domains (~64 Å) might be shorter than the free triskelion. Additionally, we found a loop 
between these two CHC-binding domains on GTSE1 is long enough to fit this distance. Thus, 
due to the fact that CHC favors to polymerize and forms a cage in interphase, we postulated 
that GTSE1 might bridge two CHC TDs to stimulate the cage formation rather than binding 
two sites within a triskelion. To support the idea in which GTSE1 is able to bind CHC cages, 
a short peptide of GTSE1 containing the 5 LID motifs was artificially bound on membrane, 
which was shown to further recruit CHC onto the membrane and induce CHC-mediated 
vesicle formation (Wood 2017 JCB). Furthermore, GTSE1 has been shown to trap in the 
CHC cages following Auxilin depletion (Borner et al., 2012). Although GTSE1 is not known 
to be an endocytotic protein yet, it is still able to bind and even recruits CHC. To further 
confirm if GTSE1 is surely presented in the CHC cage in vitro, we could co-incubate the 
CHC cage with GTSE1 full-length protein together and visualize this complex by the electron 
microscopy, which would also answer the binding stoichiometry of this complex in the cage-
stage. Additionally, the CHC triskelion purified in vitro can spontaneously polymerize into 
cages only in the presence of magnesium or calcium ions at low pH (<6.5) (Crowther and 
Pearse, 1981; Ungewickell and Branton, 1981) and spontaneously disassemble at pH 8.5. 
However, the CHC cage formation can be enhanced at neutral pH by incubating with its 
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adaptor proteins; for instance AP1 and AP2 (Keen, 1990). It might be interesting to see if 
GTSE1 plays roles to enhance the cage formation at neutral pH or stabilize the cage at pH 8.5.   
In mitosis, GTSE1 is heavily phosphorylated by different kinases. Interestingly, there are 
several (S/T)P sites close to each LID motifs except the Box A, which are phosphorylated by 
Cdk1 confirmed in our lab (Divya Singh, unpublished data) and a database of mass 
spectrometry studies (https://www.phosphosite.org/). It raises a question if these 
phosphorylations change the way that GTSE1 binds CHC. Although we did not detect 
remarkable difference of the interaction before and after Cdk1 phosphorylation (Figure 3-9), 
this experiment did not tell us if the phosphorylation changes the binding stoichiometry, or 
even induces GTSE1 to bind CHC by using different pairs of LID motifs. An interesting 
experiment to examine that is to use short fragments including C1 (Box A and B), C2 (Box C) 
and C3 (Box D and E). Because the Box C (C2 fragment) does not contribute too much for 
the binding (Figure 3-3C), it will be interesting to see if the C2 fragment alters the interaction 
before and after the phosphorylation. Additionally, it would be also good to compare the 
interaction of C1 and C3 before and after the phosphorylation. These experiments might tell 
us if the phosphorylation of GTSE1 changes different way to bind CHC as compared to the 
unphosphorylated state. However, to gain insight into the stoichiometry, the best way is to use 
the AUC (analytic ultracentrifugation). By the measurement using AUC, we can roughly 
predict the molecular weight of the protein complex. Therefore, this molecular weight can be 
reflected to the binding ratio of the proteins, which indicates the stoichiometry of the CHC-
GTSE1 complex. Additionally, Auxilin, binding to the CHC TD, is known to uncoat the CHC 
cage by creating a global distortion of the CHC triskelion/cage (Fotin et al., 2004). However, 
the isoform of Auxilin in somatic cells, GAK, does not present on mitotic spindles, suggesting 
that it could not uncoat the CHC cage at spindles, and there must be some proteins to help 
CHC stay in a triskelion. Interestingly, in fact, a GTSE1 short peptide indeed enhances the 
CHC vesicles formation in cells during interphase (Wood et al., 2017). Since GTSE1 binds 
CHC in interphase and mitosis, why GTSE1 does not tend to maintain the CHC cage in 
mitosis? Does the phosphorylation on GTSE1 change the binding stoichiometry to CHC in 
mitosis, and therefore destabilize the cage? Further experiments have to plan to ask these 
interesting questions.  
In our crystal structure, we unexpectedly found that the Box E can bind to the CHC TD site 1 
(Figure 3-14C). This binding in our crystal differs from our biochemical experiments in 
which the Box E does not contribute the interaction too much (Figure 3-5A and 3-6D). 
Because we just had one packing form from all diffracted crystals, we could not confirm if 
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this binding is happened universally in different crystal packings. To examine this possibility, 
we could try different buffer conditions in the crystallization to get different packing forms. 
However, it is surprising that we do not see the Box A or B binds to the CHC TD site1. One 
possible reason is that the peptide that we used is too short from the N-terminus (from the 
residue 662). This short peptide only contains two amino acids before the Box A, and 
therefore it might reduce the binding to CHC. In order to compare the result from the 
pulldown (GTSE1-C1 fragment, N-terminus is from the residue 651, Figure 3-3C), we should 
use the same length from the N-terminus as we used for the pulldown. The short peptide in 
the crystal (only two residues before the Box A) might not be sufficient enough to bind the 
CHC site 1. 
 
4.2 The CHC-GTSE1 complex in interphase  
Here, we identify the CHC-GTSE1 interaction in not only mitosis but also interphase. It 
suggested that this interaction could be also important during interphase. More recently, CHC 
has been shown to control cell migration. One important stage in cell migration is the focal 
adhesion disassembly. A focal adhesion is a large protein complex that connects the cell to 
the extracellular environment. Integrin, a transmembrane protein that acts as a connector 
between cells and the substrate, is one of these components in focal adhesions (Parsons et al., 
2010). Thus, the internalization of integrin is thought to be an important step during focal 
adhesion disassembly. CHC is known to recycle different integrins by its endocytosis function 
through which CHC enhances focal adhesion turnover. Therefore, CHC depletion leads to 
accumulate focal adhesions in cells and reduces cell motility (Chao and Kunz, 2009; Ezratty 
et al., 2009). In order to recycle these integrins, CHC has to physiologically localize at focal 
adhesions. Actually, some of CHC’s adaptor proteins do localize at focal adhesions; for 
example Numb, which can further recruit CHC (Nishimura and Kaibuchi, 2007). However, 
this recruitment is hard to explain how CHC that is far away from focal adhesions can interact 
with Numb. Thus, CHC has to be transported next to focal adhesions and further be recruited. 
One possible mechanism to explain how CHC transportation works is by microtubules. 
Microtubule is shown to transport vesicles by using different cargo proteins. Interestingly, in 
fact, microtubules are known to target focal adhesions, suggesting that microtubules might 
bring some essential components to induce focal adhesion turnover while targeting (Ezratty 
2005). However, CHC does not bind microtubules by itself, but CHC occasionally colocalizes 
with microtubules in interphase. Arrestin, which binds both CHC and microtubules, can act as 
a linker between them; therefore, arrestin knockout leads to an increase of the number and 
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size of focal adhesions and reduces cell mobility. Notably, CHC also binds much less 
microtubules by a cosedimentation assay in arrestin knockout cells (Cleghorn et al., 2015). 
These results well explained how microtubules could bring CHC to specific subcellular 
localization by CHC-interacting proteins. It raises a question: what if CHC can interact with 
+TIPs? Because +TIPs are usually accumulated on the plus end of microtubules, it might 
concentrate CHC on the microtubule tips. In our study, we identify the direct interaction 
between a +TIP, GTSE1, and CHC. In fact, this interaction is also detected in interphase 
(Figure 3-21A), and GTSE1 indeed plays roles in regulating cell migration. First, GTSE1 is 
overly expressed in different cancers and highly invasive cell lines (Scolz et al., 2012). 
Additionally, increasing GTSE1 level in cells by transfecting cDNA enhances cell migration 
and reduces the amount of focal adhesions (Figure s5-1F and G), although focal adhesion 
dynamics in this status have not be checked yet. Similarly, down-regulating GTSE1 
expression following siRNA depletion significantly reduces cell mobility due to the 
accumulation of focal adhesions (Figure s5-1A and D) and a decrease of focal adhesion 
disassembly rate (Figure s5-1H and I).  
Remarkably, we found that GTSE1 targets towards focal adhesions through its EB1-binding 
during microtubule-mediated targeting (Figure s5-2A). Interestingly, the tip-tracking activity 
of GTSE1 is essential for its roles in cell migration. A SXXP mutation on GTSE1, which 
abolishes the interaction with EB1 and does not accumulate on microtubule tips but still binds 
microtubule lattices, induces neither cell migration nor focal adhesion turnover (Scolz, 2012). 
This observation suggests that the tip-tracking activity is required for GTSE1-induced cell 
migration. One explanation is that GTSE1 might bring its interacting proteins to the sites 
while microtubules/GTSE1 target towards focal adhesions. Since GTSE1 interacts with CHC 
in interphase, we hypothesize that GTSE1 could “concentrate” CHC on focal adhesions while 
the microtubule targeting which induces the CHC-mediated focal adhesion disassembly. This 
might explain why the EB1-binding mutant of GTSE1, which binds microtubules and should 
not perturb the interaction with CHC, could not mediate the GTSE1-incuded cell migration 
(Scolz et al., 2012). Because this mutant does not enrich at microtubule tips, it might not 
“concentrate” CHC while microtubules target towards focal adhesions. Thus, CHC on the 
microtubule tips seems to be more important than transporting CHC along microtubules in 
regulating cell migration. The more CHC triskelia are accumulated at focal adhesions by 
+TIP while microtubule targeting, the more focal adhesions are disassembled. Notably, we 
also saw that CHC shows the tip tracking while co-overexpressed both CHC and GTSE1 in 
cells (data not shown). Even though CHC does not show the tip tracking in the endogenous 
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level, we could not rule out the possibility that only a little endogenous CHC is presented on 
the tip of microtubules. To confirm this hypothesis, we could isolate the focal adhesion 
fractionation and compare the amount of CHC between the WT and the SXXP mutant. 
Additionally, the CHC-GTSE1 interaction is also important to regulate cell migration. We 
found that the 5xLID mutant could not mediate GTSE-induced cell migration (Figure s5-2B). 
The possible mechanism is that the CHC-GTSE1 interaction is required for transporting CHC 
towards focal adhesions and therefore induces focal adhesion disassembly. Thus, it will be 
interesting to check the amount of CHC at focal adhesions by an IF or by the fractionation, 
and also examines the focal adhesion dynamics in the 5xLID mutant.  
ACF7, another +TIP protein, has been shown in modulating cell migration (Wu et al., 2008; 
Wu et al., 2011). Interestingly, ACF7 is not only a microtubule-binder but also an actin-
interacting protein (Yue et al., 2016). A proposed model of ACF7 in regulating cell migration 
is that it can physiologically cross-link microtubule and actin, guiding microtubules along 
actin filaments towards focal adhesions, and induces focal adhesion disassembly. 
Interestingly, GTSE1 can also bind to F-actin by the pulldown assay, suggesting that it might 
potentially cross-link actins and microtubules (Figure s5-3). However, GTSE1 does not seem 
to co-localize with actin filaments in cells by IF, and we did not check yet the organization of 
the actin network following GTSE1 depletion. Thus, to examine if GTSE1 is a real actin-
binding protein, further experiments need to be performed; for example the flow cell assays. 
Based on observations in which GTSE1 shows accumulation on the tips and interacts with 
CHC and probably F-actin in interphase, a proposed mechanism is that GTSE1 might 
involved in guiding microtubules along F-actins to bring CHC to focal adhesions and induces 
CHC-mediated focal adhesion disassembly.   
 
Figure 4-1. A proposed model of how GTSE1 regulates focal adhesion disassembly 
GTSE1 guides microtubules to target towards focal adhesions along actin filaments. Additionally, 
GTSE1 interacts with CHC, which can bring CHC to focal adhesions. CHC can further recycle 
integrins and mediates focal adhesion disassembly.    
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4.3	How	does	the	CHC-TACC3	complex	specifically	bind/stabilize	K-fiber? 
Neither CHC nor TACC3 binds microtubules by itself. Nevertheless, both of them localize to 
spindles in mitosis. One hypothesis is that this interacting-complex creates an interacting-
surface to bind microtubules. However, it is an open question whether this complex is 
sufficient to bind microtubules. The two proteins plus Aurora A in the presence of ATP 
weakly bound to microtubules by a flow cell assay (Hood et al., 2013). On the contrary, this 
complex after phosphorylation by Aurora A does not seems to bind microtubules by the 
cosedimentation assay (Lin et al., 2010). Actually, the interaction between CHC and TACC3 
recombinant proteins is never too strong in our hands. We can only detect this interaction by 
western blot as opposed to coomassie staining in pull-down assays. If these two proteins must 
bind together first and then interact with microtubule, the low affinity of this complex could 
explain why the microtubule binding is hard to see in vitro. Consistent with the idea, an 
artificial fusion of Clathrin and TACC3 (CLACC) should overcome the problem of their 
weak interaction (Hood et al., 2013). In fact, this fusion protein indeed localizes on spindle in 
cells. However, it is hard to distinguish whether this fusion binds microtubules directly or is 
recruited to spindles by other proteins in cells. Nevertheless, this fusion does not seem to bind 
microtubules in interphase. Actually, due to the fact that CHC only presents on K-fibers, the 
CHC-TACC3 might only bind to specific microtubules. Microtubules within K-fibers are 
undergone several modifications including polyglutamination, acetylation and detyrosination 
(Janke and Bulinski, 2011). These modifications indeed change the property of microtubules 
in terms of the binding affinity. For example, Kinesin-1 prefers to bind detyrosinated 
microtubules rather than tyrosinated microtubules (Reed et al., 2006). Thus, it would not be 
surprising if CHC only binds K-fibers because of these specific posttranslational 
modifications. This could be the reason why it is hard to detect the CHC-TACC3 complex 
binding microtubules in vitro. Recently, TACC3 has been shown to recruit a new player, 
PI3K-C2α, to spindles. Interestingly, this protein can bind both TACC3 and CHC and is 
required for CHC to localize to spindles. Thus, PI3K-C2α is important to stabilize or bridge 
the CHC-TACC3 complex together (Gulluni et al., 2017), and therefore further increases the 
microtubule binding affinity of the CHC-TACC3 complex. In our study, we showed that 
GTSE1 delocalizes from mitotic spindles following Hec1 depletion (Figure 3-17B). 
Additionally, GTSE1 is recruited by CHC to spindles (Figure 3-16A). These results strongly 
suggest that GTSE1 mainly presents on the K-fiber, and the CHC-TACC3 complex is 
required for this localization. It will be also interesting to see if the CHC-TACC3 complex or 
the CLACC fusion is able to recruit GTSE1 onto microtubules by the flow cell assay in vitro. 
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However, to choose right modifications of microtubules to bind the CHC-TACC3 complex 
might be a challenge.  
GTSE1 itself is a microtubule binding protein and indeed binds microtubule lattices during 
interphase. Interestingly, it is highly phosphorylated during mitosis and almost completely 
loses its microtubule binding (Scolz et al., 2012), and we also comfirmed this results in our 
hands (Figure S5-4). Therefore, its spindle localization in mitosis is highly dependent on the 
CHC-TACC3 complex. However, it is still a debate if GTSE1 can not bind microtubule in 
metaphase due to the phosphorylation. In fact, we did see very little signal of the GTSE1-
5xLID-GFP mutant on spindles (Figure 2-16A(iii)), and weak GTSE-WT-GFP staining on 
microtubules following Hec1 depletion (Figure 2-17B(v)). These data suggested that GTSE1 
might not completely lose its entire microtubule binding in mitosis due to the 
phosphorylation. Actually, the transition between phosphorylation and dephosphorylation 
might be very dynamic and fast in cells although the major population of GTSE1 in 
metaphase is highly phosphorylated. Since we do not know yet which phosphorylation sites 
are corresponding to the microtubule binding, we can not rule out that once GTSE1 is slightly 
dephosphorylated in mitosis, it could bind microtubules again. This might well explain why 
GTSE1 is mainly localized on K-fibers and very weakly present on non-k-fiber microtubules 
in metaphase. However, this weak microtubule binding from the partially phospho-GTSE is 
not sufficient enough to stabilize spindle integrity by inhibiting MCAK. Thus, the 5xLID 
mutant, which almost delocalizes from entire spindles, leads to severe mitotic defects 
including abnormal bipolar spindles and misaligned chromosomes (Figure 3-16A(iii)).  
It is interesting why cells use so much energy to phosphorylate GTSE1 and make it not bind 
microtubules directly in mitosis; however, the CHC-TACC3 complex later brings it back onto 
spindle microtubules again. It is indeed a matter if GTSE1 binds microtubule directly or 
indirectly. In fact, unphosphorylated purified-GTSE1 (1-460) proteins can bundle 
microtubules in vitro (Figure S5-5), suggesting that it is not only an intrinsic microtubule 
binder but also a microtubule stabilizer. Additionally, GTSE1 is more expressed during 
mitosis than interphase. Therefore, if large amounts of GTSE1 directly bind to microtubules 
and cause bundles of spindle microtubules, that perhaps affects the formation of normal 
bipolar spindle during mitosis. Therefore, GTSE1 has to indirectly bind to microtubules by 
the TACC3-CHC complex and stabilizes microtubules by inhibiting MCAK in mitosis.    
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4.4 The mitotic defects caused by 5xLID might be distinct from GTSE1 depletion. 
In general, GTSE1 is mainly localized at centrosomes, spindle poles, K-fibers and little on 
kinetochores during mitosis. After GTSE1 depletion, MCAK becomes highly active at these 
places and destabilizes microtubules. Therefore, GTSE1 depletion leads to defects in astral 
microtubules, inner spindle intensity and microtubule-kinetochore attachment (Bendre et al., 
2016). The GTSE1-5xLID is delocalized from spindles, but appears to retain some 
localization capacity from GTSE1-WT. It does not localize on K-fibers but it still interacts 
with kinetochores (Figure 3-18B) and probably localizes at poles. Due to that 5xLID does not 
present on K-fiber/spindles, this mutant is unable to inhibit MCAK activity and stabilizes 
spindle microtubules. Thus, we often saw abnormal bipolar spindles and misaligned 
chromosomes (Figure 3-16A(iii)). To confirm if these defects are due to the less microtubules 
density in the mutant, we can measure the microtubule intensity in the inner spindle by IF. 
Furthermore, if these defects are due to the problems of less stable microtubules, we should 
rescue these defects by adding low dose Taxol to stabilize microtubules. Additionally, we 
could not clearly detect the pole localization of the mutant because of the high cytosolic 
background by IF (Figure 3-16A(iii)). Conversely, GTSE1 can be clearly detected at poles 
following CHC depletion in live cells (Hubner et al., 2010). It suggested that the pole 
localization of GTSE1 is not dependent on CHC; therefore, the 5xLID mutant is unlikely to 
totally lose its pole localization. However, we can not rule out that the mutant presents much 
less at poles than the WT. Interestingly, we did see that astral microtubules are significantly 
shorter in the 5xLID mutant, indicating that the amount of 5xLID mutant at poles is 
insufficiently to inhibit MCAK activity (unpublished data). Another possibility is that GTSE1 
has to interact with CHC in order to inhibit MCAK. It seems unlikely because GTSE1 alone 
is enough to do this job (Bendre et al., 2016). However, it will be interesting to see in the help 
of CHC if GTSE1 could increase the MCAK inhibition in vitro.  
In fact, the 5xLID mutant still interacts with MCAK in vitro, and we could not see any 
remarkable changes of the interaction as comparing to the WT (Figure 3-26A). This result 
suggested that the 5xLID mutant might be able to inhibit the MCAK activity as well. 
Contrary to the in vitro result, this mutant binds much weaker in vivo confirmed by IPs 
(unpublished data). Is it simply because it does not present on spindle? Due to the absence of 
this mutant on spindles, the portion of the GTSE1-MCAK interaction on spindle is gone and 
therefore the total interactions are less in the mutant by IP. Another hypothesis is that the 
interaction between GTSE1 and MCAK is mediated by Aurora kinase A. Since the 5xLID 
mutant is unable to localize on spindles, it might get less phosphorylations by Aurora A that 
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reduces its interaction with MCAK. However, we did not have any evidences to support that 
the phosphorylation states are much less on this mutant. Since this mutant still interacts with 
MCAK and localizes on kinetochores after Aurora B phosphorylation (Figure 3-18 and 19), it 
should also inhibit MCAK activity on kinetochores. Therefore, this mutant should not have 
the microtubule-kinetochore attachment problem. To test that, we can deplete endogenous 
GTSE1 in U2OS-WT and U2OS-5xLID cells. Cells following GTSE1 depletion are then 
treated with Cdk1 inhibitor and synchronized in metaphase by MG132 for 2 hour. Within 
these 2 hour, cells should have enough time to align and congress chromosomes on the 
metaphase plates. If there is a microtubule kinetochore attachment problem, we should see 
misaligned chromosomes in cells under this setup. We will assume to see the defect in U2OS-
WT but not in U2OS-5xLID cells following GTSE1 depletion. Additionally, our lab 
previously found that up-regulation of MCAK activity following GTSE1 depletion reduces 
hyper-stable microtubule-kinetochore attachments, which reduces lagging chromosomes in 
U2OS (Bendre et al., 2016). Since the GTSE1-5xLID mutant still localizes at kinetochores 
and interacts with MCAK, it should not reduce the hyper-stable microtubule-kinetochore 
attachments. Thus, it will be interesting to check the lagging chromosomes in U2OS 
expressing 5xLID mutant.        
 
4.5 How does Aurora A kinase increase microtubule stability? 
It has been shown that Aurora A overexpression leads to an increase in microtubule 
polymerization rates that induces hyper-stabilized microtubules and causes CIN (Ertych et al., 
2014). Notably, hyper-stabilized microtubules and CIN can be rescued by partially depleting 
either TACC3 or ch-TOG, suggesting that this TACC3-ch-TOG complex might be the 
downstream effector of Aurora A (Ertych et al., 2014). ch-TOG is a microtubule polymerase 
and enhances microtubule stability by simply polymerizing microtubules. Additionally, the 
recruitment of ch-TOG onto spindle is dependent on TACC3 (Cheeseman et al., 2013; 
Gutierrez-Caballero et al., 2015); however, their interaction does not depend on Aurora A. 
Therefore, overexpression of Aurora A might not directly enhance their interaction. 
Remarkably, TACC3 is identified as a substrate of Aurora A (Kinoshita et al., 2005). As 
expected, while Aurora A is overexpressed, an increase in TACC3 phosphorylation is 
observed in different cell lines (Ertych et al., 2014). TACC3 interacts with CHC in an Aurora 
A dependent manner, which permits this complex to localize at spindles. Therefore, it highly 
suggests that more TACC3-CHC complexes are on spindles while increasing Aurora A 
expression. Even through Aurora A does not directly enhance the interaction between TACC3 
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and ch-TOG, forming more TACC3-CHC complexes by Aurora A can indirectly recruits 
more ch-TOG to spindles.  
Furthermore, the TACC3-CHC complex can bring GTSE1, another microtubule stabilizer, to 
spindles. GTSE1 is an intrinsic microtubule binding protein in interphase. Surprisingly, once 
GTSE1 is phosphorylated by Aurora A, it significantly reduces the microtubule binding 
(Figure S5-4). Interestingly, the interaction between GTSE1 and MCAK is also mediated by 
Aurora A. Thus, once GTSE1 is phosphorylated by Aurora A, GTSE1 reduces its microtubule 
binding and bundling activity. In the meantime, Aurora A permits the TACC3-CHC complex 
on spindles, which further brings GTSE1 on spindles. The phospho-GTSE1 by Aurora A and 
then interacts and inhibits the MCAK-depolymerizing activity, by which GTSE1 indirectly 
stabilizes microtubules on spindles. In conclusion, one mechanism of how Aurora A stabilizes 
microtubules is to enhance the TACC3-CHC complex onto spindles as a central interacting 
hub. On one hand, TACC3 can recruit ch-TOG and the TACC3-ch-TOG complex could 
antagonize the MCAK-depolymerizing activity (Kinoshita et al., 2005). On the other hand, 
CHC can bring GTSE1 in which GTSE1 can further inhibit the MCAK activity in the Aurora 
A-dependent manner. Importantly, these interacting-networks are highly dependent on Aurora 
A kinase. 
 
4.6 Can GTSE1 be a microtubule polymerase? 
Proteins interacting with both tubulin dimer and microtubules can stabilize microtubules by 
different mechanisms. First, they can sit close to microtubule ends by the microtubule-binding 
activity and add new tubulin dimers, which increase microtubule growth rate; for example, 
ch-TOG. Additionally, some proteins do not add tubulin dimmers on tips but act as caps on 
microtubule ends due to the tubulin binding to inhibit catastrophes, which also promotes 
microtubule growth such as CPAP and CLASP (Al-Bassam et al., 2010; Sharma et al., 2016).        
GTSE1 is a microtubule-binding protein (Scolz et al., 2012) and bundles microtubules under 
the non-phosphorylated state (Figure S5-4). Interestingly, we found that GTSE1 also binds 
tubulin dimers (Figure S5-6 left), but this activity is inhibited by phosphorylation (Figure S5-
6 right). It supports the idea that GTSE1 might not directly increase microtubule stability by 
binding both tubulin dimers and microtubules during mitosis. Since GTSE1 could bind both 
microtubules and tubulin dimers in interphase, can GTSE1 be a microtubule polymerase or 
how can GTSE1 stabilize microtubules?  To test if GTSE1 could act as a polymerase, we can 
incubate tubulin dimers with GTSE1 and see if GTSE1 can induce the microtubule 
polymerization by the microtubule turbidity assay. Additionally, we can immobilize 
4.	Discussion	 	 75		
microtubule seeds on the flow cells and add tubulin dimers and GTSE1 proteins in solution. 
By tracing the dynamics of microtubules using the TIRF microscopy, we can quantify the 
dynamic events of microtubules. Although GTSE1 does not have any TOG domain, a HEAT 
loop (X-Trp-X-X-Arg-X) is presented on its N-terminal region (Ser-Ser-Trp-Gln-Ala-Lys-
Arg-Val). The HEAT loop is well known to bind tubulin dimers, and mutations of Trp and 
Arg on this loop can totally abolish the binding with tubulin dimers (Slep, 2009). It will be 
interesting to mutate these two amino acids on GTSE1 and examines the tubulin binding. If 
this mutant prevents GTSE1 to bind tubulin dimers but not the microtubules, we can further 
compare the microtubule dynamics between WT and this mutant.       
 
4.7 How does the microtubule-stabilizing complex stabilize/bridge microtubules in 
mitosis? 
Here, we defined that the CHC-TACC3-ch-TOG-GTSE1 complex as a microtubule-
stabilizing complex. Actually, both ch-TOG and GTSE1 are microtubule-binding proteins. 
Even through phospho-GTSE1 significant reduces its microtubule-binding, we can not rule 
out the partial microtubule binding activity that could slightly bundle and stabilize 
microtubules. Thus, it will be good to remove the microtubule-binding domain from GTSE1 
and ch-TOG as well. In our work, we identified the minimal domain of GTSE1 (639-739) that 
binds CHC but not microtubules. The ch-TOG fragment (1806-2032) that we used for the 
pulldown assays does not bind microtubules either. We can also confirm that these short 
fragments can form a mini-complex by the pulldown (Figure 3-24). Thus, if this mini-
complex of TACC3-CHC-GTSE1(fragment)-ch-TOG(fragment) can bind microtubules, this 
binding is mediated by the TACC3-CHC complex. Recently, this complex has been proposed 
to bundle microtubules after Aurora A phosphorylation (Nixon et al., 2015). However, it 
might be simply due to the partially microtubule-bundling activity from GTSE1. It will be 
interesting to use this mini-complex and see how it stabilizes microtubules in vitro. 
Additionally, we can also visualize this complex with microtubules under the electron 
microscopy, which could also gain insight the structure of this microtubule-stabilizing 
complex.     
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5. Supplementary Figures  
5.1 GTSE-mediated cell migration in interphase 
 
Figure s5-1. GTSE1 is required for focal adhesion disassembly 
Microtubule-induced focal adhesion disassembly assay (A)(B)(D). (A) immunofluorescence of 
pY397- FAK (a marker of focal adhesions) in control siRNA (siControl) and GTSE1-depleted 
(siGTSE1) HT1080 cells. Imagines were taken at 0 and 30 minute after nocodazole washed out and 
microtubule regrowth. (B) A protocol shows the method of GTSE1 depletion and microtubule 
regrowth. (C) Two siRNAs (NO 2 and NO 3) are used against GTSE1. Western blot showed GTSE1 
protein level after the depletion in HT1080 cells. (D) Quantitative analysis of focal adhesions in either 
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siControl or siGTSE1 cells. Cells were scored positive if they retained more than 10 pY397-FAK 
staining after nocodazole release (n=100 in triplicate). GTSE1 protein level is inversely correlated 
with focal adhesion amount (E)(F)(G). (E) Depletion of GTSE1 increases the amount of focal 
adhesions in asynchronized HT1080 cells. Overexpression of GTSE1 reduced the amount of focal 
adhesions in HT1080 cells shown in (F) and (G). (F) immunofluorescence of pY397-FAK in EGFP-
GTSE1 transient transfected HT1080 cells. Yellow arrow showed the dynamics of focal adhesions. (G) 
Western blot showed pY397 FAK protein levels in either EGFP- or EGFP-GTSE1 transient transfected 
cells. GTSE1 regulates focal adhesion dynamics (H)(I). (H) Representative time-lapse images of 
mcherry-paxillin following Control or GTSE1 depletion in HT1080 cells, Yellow arrow shows 
individual focal adhesion undergoing disassembly. (I) Quantitative analysis of the disassembly rate of 
focal adhesions. Each dot represents individual focal adhesion. The disassembly rate of focal 
adhesions is reduced in GTSE1 depleted HT1080 cells (two independent experiments). 
 
5.2 GTSE targets towards focal adhesions, and the CHC-binding is required for GTSE1-
induced cell migration.  
 
 
Figure s5-2. GTSE1 targets towards focal adhesions and regulates cell migration through a 
cooperation with CHC 
(A) Time-lapse images of EGFP-GTSE1 showing that GTSE1 targets focal adhesions. mcherry-
paxillin was used as a marker for focal adhesions (B) Transwell migration assay in U2OS cells, and 
U2OS cells stably expressing RNAi-resistant GTSE1-WT-GFP, or RNAi-resistant GTSE1-5xLID-
GFP. Cells were treated with or without GTSE1 siRNA for 48 h and seeded on transwell membranes 
for 16 h. Error bars represent the standard error of the mean from two independent experiments. (C) 
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Western blots were performed on cells after the same treatment, and blotted with anti-GTSE1 and 
anti-tubulin. 
 
5.3 GTSE1 binds F-actin 
 
 
Figure s5-3. GTSE1 binds F-actin 
Two µM GST-GTSE1-FL or GST proteins were immobilized on the GSH beads and incubated with 2 
µM F-actin in 50 µl F-actin binding-buffer at 4°C for 2 hour. 5 % of each reaction was taken as input. 
Beads were washed 3 times with F-actin binding buffer and indicated as output. Samples were 
analyzed by a SDS-page and western blot. GST-GTSE1 could pull down F-actin shown by the SDS-
page and western blot against anti-actin antibodies.  
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5.4 GTSE1 reduces the microtubule-binding after Aurora A phosphorylation 
 
Figure s5-4. GTSE1 reduces its microtubules-binding after Aurora A phosphorylation 
GTSE1-GFP-FL proteins were phosphorylated with or without Aurora A kinase and performed the 
flow cells assay. Upper panel; 500 nM of un-phosphorylated proteins were add into the flow cell and 
imagined after 10 min. GTSE1-GFP-FL strongly bound to microtubules. However, phospho-GTSE1 
significantly reduced its microtubule binding after Aurora A phosphorylation shown in the lower 
panel.       
 
5.5 GTSE1 (1-460) bundles microtubules 
 
 
Figure s5-5. GTSE1 (1-460) bundles microtubules 
Two nM of Rhodamine-labelled microtubules were incubated with GTSE1 (1-460) or (463-739) at 
room temperature for 10 min. Reactions were terminated by adding 0.2 % glutaraldehyde and fixed on 
slides. GTSE1 (1-460) could induce microtubule bundling in different concentrations; however, 
GTSE1 (463-739) has no effect on microtubule bundling.   
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5.6 GTSE1 loses tubulin binding after phosphorylation. 
  
 
Figure s5-6. GTSE1 significantly reduces the tubulin binding after the phosphorylation 
Left; GTSE1 binds tubulin dimer. Two µM GST-GTSE1-FL or GST proteins were immobilized on the 
GSH beads and incubated with 2 µM tubulin in 50 µl BRB buffer at 4°C for 2 hour. 5 % of each 
reaction was taken as input. Beads were washed 3 times with BRB buffer and indicated as output. 
Samples were analyzed by a SDS-page and western blot. GST-GTSE1 could pull down tubulin 
dimmer indicated by the SDS-page and western blot against anti-tubulin antibodies. Right; 
Phosphorylated GTSE1 by Aurora A and cdk1 strongly reduces the tubulin binding. 2 µM GST-
GTSE1-FL proteins were phosphorylated by either Aurora A (AurA), cdk1 or Aurora A plus cdk1 
(A+C). The phosphorylated or non-phosphorylated GTSE1 proteins were incubated with tubulin and 
performed pulldowns.  Pulldowns were analyzed by a SDS-page and western blot. 
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6. Materials and Methods 
6.1 Chemicals and Solutions 
Table 6-1. List of chemicals and solutions 
Chemical Name Ingredients Company 
Agarose  
Carl Roth GmbH, Karlsruhe, 
Germany 
Ammonium persulfate 
(APS) 
 
Max-Planck-Institute, Dortmund, 
Germany 
Ampicillin sodium salt  
GERBU Biotechnik GmbH; 
Heidelberg; Germany 
Blasticidine  Invitrogen, California, U.S.A 
Bradford Solution  
Bio-Rad Laboratories GmbH, 
Munich, Germany 
BRB80 Buffer 
80 mM Pipes-KOH pH 6.9 
 
1 mM EGTA 
 
1mM MgCl2 
 
150 mM KCl 
 
 
10 µM ATP 
 
1 mM TCEP 
 
Sigma-Aldrich GmbH, Steinheim, 
Germany 
Thermo Fisher Scientific, 
Waltham, U.S.A 
J.T Baker Chemicals, Center 
Valley, USA 
Avantor Performance Materials 
(J.T. Baker), Center Valley, 
U.S.A. 
Sigma-Aldrich GmbH, Steinheim, 
Germany 
Biosynth AG; Staad; Switzerland 
 
Buffer A 
50 mM HEPES pH 7.5 
 
300 mM NaCl 
 
5% Glycerol 
Sigma-Aldrich GmbH, Seelze, 
Germany 
VWR Chemicals, Darmstadt, 
Germany 
GERBU Biotechnik GmbH, 
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2 mM TCEP 
Heidelberg, Germany 
Biosynth AG; Staad; Switzerland 
Cdk1 inhibitor (RO-
3306) 
 Calibiochem 
Cell Lysis Buffer 
50 mM HEPES pH7.2  
 
50 mM Na2HPO4, 
 
 
150 mM NaCl 
 
10% glycerol 
 
1% Triton X-100 
 
1 mM EGTA 
 
1.5 mM MgCl2  
 
Sigma-Aldrich GmbH, Seelze, 
Germany 
Avantor Performance Materials 
(J.T. Baker), Center Valley, 
U.S.A 
VWR Chemicals, Darmstadt, 
Germany 
GERBU Biotechnik GmbH, 
Heidelberg, Germany 
Thermo Fisher Scientific, 
Waltham, U.S.A 
Thermo Fisher Scientific, 
Waltham, U.S.A 
J.T Baker Chemicals, Center 
Valley, USA 
CO2 Independent 
Medium 
 
Thermo Fisher Scientific (Gibco), 
Waltham, U.S.A. 
Coomassie Brilliant 
Blue staining solution 
10% Acetic acid 
 
2.5% Coomassie G250 
 
Sigma-Aldrich GmbH, Hamburg, 
Germany 
Serva GmbH, Heidelberg, 
Germany 
Destaining solution for 
ProQ Diamond staining  
20% Acetonitrile 
 
50 mM Sodium acetate 
 
Fisher Scientific, UK 
 
Sigma-Aldrich GmbH, Steinheim, 
Germany 
Dimethyl sulfoxide 
(DMSO) 
 
SERVA Electrophoresis GmbH, 
Heidelberg, Germany 
Disodium 
phosphate(Na2HPO4) 
 
Avantor Performance Materials 
(J.T. Baker), Center Valley, 
U.S.A. 
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Dithiothreitol (DTT)  
SERVA Electrophoresis GmbH, 
Heidelberg, Germany 
DNA Loading Buffer 
(6x) 
0.4% Orange G 
 
30% Glycerol 
 
10 mM Tris-HCl 
25 mM 
Ethylenediaminetetraacetic 
acid (EDTA) 
Sigma Aldrich, Hamburg, 
Germany 
GERBU Biotechnik GmbH, 
Heidelberg, Germany 
Carl Roth, Karlsruhe, Germany 
GERBU Biotechnik GmbH, 
Heidelberg, Germany 
Dulbecco's Modified 
Eagle's 
Medium (DMEM) 
 
PAN Biotech, Aidenbach, 
Germany 
Dynabeads Protein G 
magnetic beads 
 
Invitrogen GmbH, Karlsruhe, 
Germany 
ECL prime Western 
blotting detection 
reagent 
 
GE Healthcare, Freiburg, 
Germany 
Effectene transfection 
reagent 
 
QIAGEN GmbH, Hilden, 
Germany 
Ethanol  
Sigma-Aldrich GmbH, Seelze, 
Germany 
Fetal Bovine Serum   
Thermo Fisher Scientific (Gibco), 
Waltham U.S.A. 
Fixing solution for 
ProQ Diamond staining 
50% Methanol 
 
10% Acetic acid 
 
Sigma-Aldrich GmbH, Steinheim, 
Germany 
Sigma-Aldrich GmbH, Steinheim, 
Germany 
FuGENE® HD 
Transfection Reagent 
 
Promega GmbH, Mannheim, 
Germany 
GeneRuler 1 kb Plus 
DNA  
 
Fermentas, Hennigsdorf, 
Germany 
Gentamycin  
Sigma-Aldrich GmbH, Seelze, 
Germany 
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GSH Amintra 
Glutathione 
Resin 
 Amintra, Cambridge, UK 
GST-Binding buffer 
25 mM HEPES pH 7.5 
 
300 mM NaCl 
 
1 mM EDTA 
 
5% Glycerol  
 
1% Triton X-100 
 
DNase 
 
Sigma-Aldrich GmbH, Seelze, 
Germany 
VWR Chemicals, Darmstadt, 
Germany 
GERBU Biotechnik GmbH, 
Heidelberg, Germany 
GERBU Biotechnik GmbH, 
Heidelberg, Germany 
Thermo Fisher Scientific, 
Waltham, U.S.A 
Sigma-Aldrich GmbH, Seelze, 
Germany 
HEPES  
Sigma-Aldrich GmbH, Seelze, 
Germany 
Isopropyl β-D-1-
thiogalactopyranosid 
(IPTG) 
 Carl Roth, Karlsruhe, Germany 
Imidazole  
Merck Millipore, Darmstadt, 
Germany 
Kanamycin  
GERBU Biotechnik GmbH; 
Heidelberg; Germany 
L-Glutamine  
Thermo Fisher Scientific, 
Waltham, U.S.A. 
L-Glutathion reduced  Biochemica, Darmstadt, Germany 
Laemmli SDS Sample 
loading buffer (5X) 
4% Sodium dodecyl sulfate 
(SDS) 
10% Glycerol 
 
1% 2-Beta mercaptoethanol 
 
0.02% Bromophenol Blue 
Sigma-Aldrich GmbH, Steinheim, 
Germany 
GERBU Biotechnik GmbH, 
Heidelberg, Germany 
Thermo Fisher Scientific, 
Waltham, U.S.A 
Sigma Aldrich, Hamburg, 
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50 mM Tris-HCl 
 
Germany 
Carl Roth GmbH, Karlsruhe, 
Germany 
Lipofectamine 2000 
Reagent 
 
Invitrogen GmbH, Karlsruhe, 
Germany 
Luria-Bertani medium 
(LB medium) 
1% Peptone 
 
0.5% Yeast extract 
 
0.5% NaCl 
 
Sigma Aldrich, Hamburg, 
Germany 
GERBU Biotechnik GmbH, 
Heidelberg, Germany 
VWR Chemicals, Darmstadt, 
Germany 
Methanol  
Sigma-Aldrich GmbH, Steinheim, 
Germany 
Midori Green DNA 
Stain 
 
Nippon Genetics Europe GmbH, 
Düren, Germany 
Milk powder  Carl Roth, Karlsruhe, Germany 
MLN8054  
Sigma-Aldrich GmbH, Seelze, 
Germany 
Nickel-NTA-Superose 
Beads 
 
GE Healthcare, Freiburg, 
Germany 
BioTrace Nitrocellulose 
Membrane 
 
Pall Life Sciences, Pensacola, 
Florida, USA 
Nocodazole  
Sigma-Aldrich GmbH, Steinheim, 
Germany 
OptiMEM  
Invitrogen GmbH, Karlsruhe, 
Germany 
Oligofectamine  
Invitrogen GmbH, Karlsruhe, 
Germany 
Paraformaldehyde 
(PFA, 16%) 
 
Thermo Scientific, Rockford, 
USA 
Penicillin Streptomycin  
PAN-Biotech GmbH, Aidenbach, 
Germany 
Phenylmethylsulfonyl- 
fluorid (PMSF) 
 
Serva Electrophoresis GmbH, 
Heidelberg, Germany 
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Phosphate buffered 
saline (PBS) 
 
137 mM Sodium chloride  
 
2.7 mM Potassium chloride  
10 mM Di-Sodium 
hydrogen phosphate 
dihydrate 
2 mM Potassium 
dihydrogen-phophate (0.2 
g/l) 
VWR Chemicals, Darmstadt, 
Germany  
J.T.Baker Chemicals, Center 
Valley, USA 
Merck Millipore, Darmstadt, 
Germany 
 
AppliChem GmbH, Darmstadt, 
Germany 
Poly-L-Lysin 
 
 
Sigma Aldrich, Hamburg, 
Germany 
Potassium chloride 
(KCl) 
 
Avantor Performance Materials 
(J.T. Baker), Center Valley, 
U.S.A. 
Precision Plus Protein 
unstained standards 
 
Bio-Rad, Munich, Germany 
 
Precision Plus Protein 
prestained standards 
 
Bio-Rad, Munich, Germany 
 
ProLong® Gold 
antifade mounting 
solution with DAPI 
 
Molecular Probes, Life 
technology 
ProQ Diamond 
Phosphoproetin gel 
stain 
 
Invitrogen, Molecular probes, 
Eugene, Oregon, USA 
Protease Inhibitor mix 
(500X) 
 
Serva GmbH, Heidelberg, 
Germany 
Pull-down buffer 
20 mM HEPES pH 6.9 
 
150 mM NaCl 
 
1 mM ATP 
 
Sigma-Aldrich GmbH, Seelze, 
Germany 
VWR Chemicals, Darmstadt, 
Germany 
Sigma-Aldrich GmbH, Steinheim, 
Germany 
Sf-900 III medium  
Thermo Fisher Scientific Gibco, 
Waltham, U.S.A. 
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SDS PAGE 
electrophoresis buffer 
25 mM Tris-HCl 
 
200 mM Glycin 
 
3.5 mM SDS 
Carl Roth, Karlsruhe, Germany 
 
Sigma Aldrich, Hamburg, 
Germany 
Carl Roth, Karlsruhe, Germany 
Size Exclusion 
Chromatography (SEC) 
buffer  
20 mM HEPES pH 6.9 
 
150 mM NaCl 
 
5% Glycerol 
 
1mM TCEP 
 
10 µM ATP 
 
Sigma-Aldrich GmbH, Seelze, 
Germany 
VWR Chemicals, Darmstadt, 
Germany 
GERBU Biotechnik GmbH, 
Heidelberg, Germany 
Biosynth AG; Staad; Switzerland 
 
Sigma-Aldrich GmbH, Steinheim, 
Germany 
Taxol  
Sigma-Aldrich GmbH, Steinheim, 
Germany 
TCEP (tris(2-
carboxyethyl)phosphine
) 
 Biosynth AG; Staad; Switzerland 
Tris-Acetate-EDTA 
(TAE) 
buffer (50X) 
 
50 mM Tris-Base 
57.1 ml Glacial acetic acid 
 
0.5 M EDTA (pH 8) 
 
Carl Roth, Karlsruhe, Germany 
Sigma-Aldrich GmbH, 
Hamburg,Germany 
GERBU Biotechnik GmbH, 
Heidelberg, Germany 
Tetramethylethylenedia
mine (TEMED) 
 
SERVA Electrophoresis GmbH, 
Heidelberg, Germany 
Tertracycline  
Sigma-Aldrich GmbH, Steinheim, 
Germany 
Thymidine  
Sigma-Aldrich GmbH, Steinheim, 
Germany 
Triton X-100  
Thermo Fisher Scientific, 
Waltham, U.S.A. 
Trypan blue solution  Thermo Fisher Scientific, 
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(0.4 %) Waltham, U.S.A. 
Trypsin-EDTA  
PAN-Biotech GmbH, Aidenbach, 
Germany 
Tween-20  
SERVA Electrophoresis GmbH, 
Heidelberg, Germany 
Wash buffer for pull-
downs 
 
20 mM HEPES 
 
500 mM NaCl 
 
5% Glycerol 
 
0.1% Triton X-100 
 
1mM TCEP 
Sigma-Aldrich GmbH, Seelze, 
Germany 
VWR Chemicals, Darmstadt, 
Germany 
GERBU Biotechnik GmbH, 
Heidelberg, Germany 
Thermo Fisher Scientific, 
Waltham, U.S.A 
Biosynth AG; Staad; Switzerland 
Western transfer buffer 
 
25 mM Tris 
 
190 mM Glycin 
 
10 % Methanol 
 
Carl Roth, Karlsruhe, Germany 
 
Carl Roth, Karlsruhe, Germany 
 
Sigma Aldrich, Hamburg, 
Germany 
X-Galactoside  
Sigma-Aldrich GmbH, Steinheim, 
Germany 
β-Mercaptoethanol 
 
 
Serva Electrophoresis GmbH, 
Heidelberg, Germany 
6.2 Instruments and devices 
Table 6-2. List of instrument and devices 
Device Model Company 
-80° freezer MDF-U5386S 
SANYO Electric Co., Ltd.; Moriguchi, 
Japan  
Cell Counter  Countess  Invitrogen GmbH, Karlsruhe, Germany 
Cell Counter  
Scepter Handheld 
Automated Cell counter 
2.0 
Merck Chemicals GmbH; Darmstadt; 
Germany 
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Centrifuge Mini Spin plus 
Eppendorf GmbH; Wesseling-Berzdorf; 
Germany 
Centrifuge 5418 Eppendorf GmbH; Hamburg Germany 
Centrifuge 5417 R 
Eppendorf GmbH; Wesseling-Berzdorf; 
Germany 
Centrifuge 5804 R 
Eppendorf GmbH; Wesseling-Berzdorf; 
Germany 
Centrifuge Avanti J-20 XP 
Beckman and Coulter GmbH; Krefeld, 
Germany  
Centrifuge Allegra J-30 I New  
Beckmann and Coulter GmbH; 
Engelsdorf, Germany 
Centrifuge (high 
speed) 
Avanti J-30 I Old 
Beckman and Coulter GmbH; Krefeld, 
Germany 
Cryogenic Freezer 
MDF-1156-PE Ultra 
Low Temperature 
Freezer 
Panasonic Biomedical Sales Europe B.V  
DNA 
Electrophoresis Unit 
CRHU10, Min-Plus 
Horizontal 
Carl Roth, Karlsruhe, Germany 
Electrophoresis 
power supply  
Power SourceTM 300V 
VWR International GmbH; Langenfeld; 
Germany  
Flake ice machine  AF 100 Scotsman Ice Systems; Milan; Italy 
Fluorescence 
Microscopy  
EVOS® FL Imaging 
System 
Life Technologies; Thermo Fisher 
Scientific, Waltham, U.S.A. 
Freezer -20 °C LGex 3410 MediLine 
Liebherr-Elektronik GmbH; Lindau; 
Deutschland 
Freezer -20 °C LGUex 1500 MediLine 
Liebherr-Elektronik GmbH; Lindau; 
Deutschland 
Fridge 4 °C LKexv 1800 
Liebherr-Elektronik GmbH; Lindau; 
Deutschland 
Fridge 4 °C  
LKUexv 1610 
MediLine 
Liebherr-Elektronik GmbH; Lindau; 
Deutschland 
Imaging System  ChemiDoc MP 
Bio-Rad Laboratories GmbH, Munich, 
Germany  
Incubator  Heraeus B6030 Thermo Electron LED GmbH; 
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Langenselbold Germany 
Incubator CO2-DH 
Autoflow 
NU-5500 NuAir 
ibidi Imaging 
chamber 
15 µ-Slide 8 well iBidi, Martinsried, Germany 
ibidi Imaging 
chamber 
µ-Dish 35 mm dish iBidi, Martinsried, Germany 
Incubator shaker  Multitron Standard  Infors HAT AG; Bottmingen; Switzerland 
Incubator shaker  Minitron Infors HAT AG; Bottmingen; Switzerland 
Mini Rocker Shaker MR1 BioSan 
PCR cycler T3000 Thermocylcer Biometra GmbH; Göttingen; Germany 
Photometer NanoDrop 2000 
Thermo Electron LED GmbH; 
Langenselbold Germany 
Photometer  Biophotometer 6131 
Eppendorf GmbH; Wesseling-Berzdorf; 
Germany 
SDS Page 
Electrophoresis Unit 
Mini Protean Tetra Cell Biorad, China 
Scale BL150 S Sartorius 
Scale PE 3600 Mettler 
See-saw rocker SSL4 
Bibby Scientific Limited; Staffordshire; 
UK 
Sonicator  Sonifier 450 
Branson Ultraschall- Emerson 
Technologies GmbH; Dietzenbach; 
Germany  
Sterile bench Herasafe™ KS 
Thermo Electron LED GmbH; 
Langenselbold Germany 
Sterile Bench  NU-437 (Nuaire) 
Ibs tecnomara GmbH; Fernwald; 
Germany  
Thermostat-Metal 
Techne Dri-Block 
D13.3 
Germany 
Thermostat BT 100 Kleinfeld Labortechnik, Germany 
Thermostat MBT 250 ETG-Ilmenau; Illmenau; Germany  
Thermomixer  Thermomixer comfort  Eppendorf GmbH; Wesseling-Berzdorf; 
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Germany  
Thermomixer Thermomixer 5436 
Eppendorf GmbH; Wesseling-Berzdorf; 
Germany 
Ultracentrifuge 
Optimal TL 
TL361547 Beckman Coulter 
Vortex Vortex-Genie 2 
Scientific Industries, Inc; New York; 
U.S.A. 
Water bath  WNB7 
Memmert (Shanghai) Trading Co. Ltd; 
Shanghai City; China 
Waterbath  TW8 Julabo 
Western Blot 
electrophoresis 
chamber 
Mini Protean II TM Biorad, Italy 
6.3 Cloning using restriction enzyme digestion and ligation. 
Primers are attached with restriction enzyme sequence corresponding to the targeted vectors. 
Genes of interest were amplified by PCR using Q5 2X Master Mix.  To clean DNA after 
PCR, DNA was purified using PCR clean up kit after and digested by restriction enzymes for 
few hour or overnight at 37 °C. DNA was purified again by PCR clean up kit before ligation. 
Table 6-3. Standard program for PCR amplification 
Step Temperature Time 
Denaturation  98 °C 2 min 
98 °C 30 s  
30-35x Annealing  52 °C – 65 °C 30 s 
Elongation 72 °C 1 -3 min 
(10 min for 
site-direct 
mutagenesis) 
72 °C 5 min 
Pause 4 °C ~ 
 
Table 6-4. Standard scheme for ligation 
Component Volume for 10 µL ligation reaction 
Vector:Insert  1:3  (molar ratio) 
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T4 DNA Ligase 1 µL 
5X T4 Ligase Buffer 2 µL 
ddH2O X µL 
6.4 Transformation 
The competent cells were placed on ice to thaw. The plasmid DNA was incubated with 
competent cells for 5 min on ice and then perfromed heat shock at 42 °C for 45 sec. 1ml fresh 
LB medium was added into bacterial cells following heat shock, and incubated at 37 °C with 
shaking for 1 hour before plating on LB agar plates containing antibiotics. 
Table 6-5. List of competent cells for transformation 
Bacteria Strain Company 
E. coli  Rosetta 2(DE3) Max-Planck Institute, DPF, 
Dortmund, Germany.  
E. coli OmniMax (chemically 
competent cells)  
Max-Planck Institute, DPF, 
Dortmund, Germany. 
E. coli Top10 (chemically 
competent cells) 
Thermo Fisher Scientific 
(Gibco), Waltham, USA 
E. coli Max Efficiency 
DH10BacTM Chemically 
competent cells 
(EMBACY) 
Thermo Fisher Scientific 
(Gibco), Waltham, USA 
Table 6-6. List of DNA constructs, vectors and primers 
Construct 
name 
Vector & 
company  
Primers (5’-3’) 
pGEX-6p-1 
CHC 
1-330  
pGEX-6p-1 
GE 
healthcare 
 
Fwd-  
aaaGGATCCATGGCCCAGATTCTGCCAATTCGT 
Rev-   
aaaGTCGACTTCCACACACACTGACAGAACTTG 
pGEX-6p-1 
CHC 
1-364  
pGEX-6p-1 
GE 
healthcare 
 
Fwd-  
aaaGGATCCATGGCCCAGATTCTGCCAATTCGT 
Rev-   
aaaGTCGACTTAAAAGAGTTCTTCAGCACCGG (STOP) 
pGEX-6p-1 
CHC 
pGEX-6p-1 
GE 
Fwd-  
aaaGGATCCATGGCCCAGATTCTGCCAATTCGT 
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1-642  
 
healthcare 
 
Rev-   
aaaGTCGACGTGAACCACTGCACGTTTTAT 
pET28a-
GTSE1 
 (1-460) 
 
pET28a (+) 
Novagen 
Fwd-  
aaaGGATCCATGGAAGGAGGCGGCGGCCG 
Rev- 
aaaGTCGACTGTCTTGGAATTTAGACAGGAA 
pET28a-
GTSE1 
 (463-739) 
 
pET28a (+) 
Novagen 
Fwd-  
aaaGGATCCATGCCTACTCCTACAAATCA 
Rev-  
aaaGTCGACGAACTTGAGGAGTGGGGAAT 
pET28a-
GTSE1 
 (639-739) 
 
pET28a (+) 
Novagen  
Fwd-  
aaaGGATCCATGGCCCCTAGTGAGGCTCTTCT 
Rev-   
aaaGTCGACGAACTTGAGGAGTGGGGAAT 
pGEX-6P-
1-GTSE1-C 
(639-739) 
 
pGEX-6p-1 
GE 
healthcare 
 
Fwd-  
aaaGGATCCATGGCCCCTAGTGAGGCTCTTCT 
Rev-   
aaaGTCGACTTAGAACTTGAGGAGTGGGGA (stop) 
pGEX-6P-
1-GTSE1-
C1 (652-
687)  
pGEX-6p-1 
GE 
healthcare 
 
Fwd-  
aaaGGATCCCCACTCGCGGTCACTCCAGAT 
Rev-  
aaaGTCGACCTACCTGCTTTCAGATCCTACA (stop ) 
pGEX-6P-
1-GTSE1-
C2 (672-
708) 
pGEX-6p-1 
GE 
healthcare 
 
Fwd-  
aaaGGATCCTTCTGCGATACCCCAGAAG 
Rev-  
aaaGTCGACTTACGGTGAAGGTTTGGCCACATTTT 
(stop) 
pGEX-6P-
1-GTSE1-
C3 (693-
739)  
pGEX-6p-1 
GE 
healthcare 
 
Fwd-  
aaaGGATCCATGGAAGGAGGCGGCGGCCGCGAT 
Rev-  
aaaGTCGACTTAGAACTTGAGTGGGGAATCCAC 
(STOP) 
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6.5 Site-direct mutagenesis 
Mutations were generated by site-direct mutagenesis using Q5 2X Master Mix. Wild-type 
plasmids were used as templates for DNA amplification. The PCR products were digested by 
DpnI for 2 hour and then performed transformation. 
Table 6-7. List of mutants and primers 
Construct 
name 
Original 
template  
Primers (5’-3’) 
pGEX-6p-1 
CHC 
1-330 
(S1M)  
pGEX-6p-1 
CHC 
1-330 
T87A_Q89A_Fwd 
AAGCTCTTGCGATTTTTAACATTGAAA 
T87A_Q89A_Rev 
AAATCGCAAGAGCTTTCCCAGCTTTCAGT 
K96E_K98E_Fwd 
AAATGGAAAGTGAAATGAAGGCTCATA 
K96E_K98E_Rev 
TTCATTTCACTTTCCATTTCAATGTTAAAAA 
pGEX-6p-1 
CHC 
1-330 
(S2M) 
pGEX-6p-1 
CHC 
1-330 
Q152L_I154Q_Fwd 
TGCCTGATTCAAAATTACCGTACAGATGCA 
Q152L_I154Q_Rev 
GTAATTTTGAATCAGGCACCCTGCAAGGCTAGAA 
pGEX-6p-1 
CHC 
1-330 
(S3M) 
pGEX-6p-1 
CHC 
1-330 
R188A_Q192A_Fwd 
TGCGAAAGTGTCTGCGCCCATTGAAGGACATGC 
R188A_Q192A_Rev  
GGGCGCAGACACTTTCGCATCTACAGAATATAGCTGC
AT 
pGEX-6P-
1-GTSE1-
C1 (652-
687)  
A  
pGEX-6P1-
GTSE1-C1 
(652-687 
Fwd-  
AAGCCAGCCCGCCGCTGCCCTTCCTCTCATCGACTTCT
GCG 
Rev-  
GAAGGGCAGCGGCGGGCTGGCTTGCAGCATCTGGAG 
pGEX-6P-
1-GTSE1-
C1 (652-
687)  
B 
pGEX-6P-
1-GTSE1-
C1 (652-
687 
Fwd- 
CCTGCCGCCGCCTTCTGCGATACCCCAGAAGCA 
Rev- 
AGAAGGCGGCGGCAGGAAGGTCAATGAGGGGCTGGC
T 
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pGEX-6P-
1-GTSE1-
C1 (652-
687) AB 
  
pGEX-6P-
1-GTSE1-
C1 (652-
687 
Fwd- 
CCCGCCGCTGCCCTTCCTGCCGCCGCCTTCTGCGATAC
CCCAGA 
Rev- 
AAGGCGGCGGCAGGAAGGGCAGCGGCGGGCTGGCTT
GCAGCATCT 
pGEX-6P-
1-GTSE1-
C3 (693-
739)  
D-LID 
 
pGEX-6P-
1-GTSE1-
C3 (693-
739) 
Fwd- 
CCGCAGCCCTGAGCTCCCCTCTGATCCAGCTGA 
Rev- 
GGAGCTCAGGGCTGCGGCCTGTCCCACCACCGGT 
pGEX-6P-
1-GTSE1-
C3 (693-
739)  
D-IDL 
 
pGEX-6P-
1-GTSE1-
C3 (693-
739) 
Fwd- 
GGACAGCTCGCAGCCGCGAGCTCCCCTCTGATCC 
Rev- 
GGGGAGCTCGCGGCTGCGAGCTGTCCCACCACCGGT 
pGEX-6P-
1-GTSE1-
C3 (693-
739)  
D-LIDxL 
 
pGEX-6P-
1-GTSE1-
C3 (693-
739) 
Fwd- 
GGGACAGGCCGCAGACGCGAGCTCCCCTCTG 
Rev- 
AGCTCGCGTCTGCGGCCTGTCCCACCACCGGT 
pGEX-6P-
1-GTSE1-
C3 (693-
739)  
E 
pGEX-6P-
1-GTSE1-
C3 (693-
739) 
Fwd- 
CTCCCCTGCGGCCGCGCTGAGCCCTGAGGCTGA 
Rev- 
AGGGCTCAGCGCGGCCGCAGGGGAGCTCAGG 
6.6 Cloning using Gibson Assembly  
Gibson Master mix which contains dNTPs, T5 exonuclease, Phusion polymerase, Taq ligase 
was made in house (Ingrid Hoffmann). DNA fragments were amplified by PCR. Fragments 
that join together need to overlap at least 15 nucleotides. 5 µl mixture of DNA was mixed 
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with 15 µl of Gibson Master mix and incubated at 50 °C for 1 hour. 5-10 µL of this Gibson 
assembly reaction mix was transformed into competent cells. 
6.7 Plasmid extraction and DNA purification 
Plasmids and DNA were extracted using the following kits according to manufacturer’s 
protocol. 
 
Table 6-8. List of kits for plasmid/BAC DNA extraction 
Kit Name Company 
NucleoSpin Plasmid (NoLid) Macherey-Nagel GmbH; Düren, Germany  
Roti-Prep Plasmid MINI  Carl Roth GmbH, Karlsruhe, Germany 
Zymoclean Gel DNA Recovery Kit  Zymo Research Corporation, Irvine, U.S.A. 
GeneJET Plasmid Miniprep Kit Thermo Scientific, Baltics, U.S.A 
QiaQuick PCR Purification Kit Qiagen, Hilden, Germany 
Wizard SV Gel and PCR Clean-up 
system 
Qiagen, Hilden, Germany 
6.8 Proteins purification from bacteria 
Genes of interest were cloned into pGEX-6p-1 or pET28(A)+ vectors and expressed in 
Rosetta. Bacteria were grown in TB medium until they reached an O.D600 of 0.8 and added 1 
mM IPTG overnight at 20 °C for protein expression. The bacterial cells were pelleted by 
centrifugation at 6000 rpm for 10 min at room temperature. Cells were resuspended in GST 
binding buffer (25 mM HEPES pH 7.5, 300 mM NaCl, 1 mM EDTA, 5% glycerol, 1% Triton 
X-100, DNase) with 1 mM PMSF, lysed by sonication and cleared by centrifugation at 30,000 
rpm for 30 min at 4 °C. The supernatant after the centrifugation was incubated with 
Glutathione resin (Amintra) for 4~8 hour at 4 °C. The beads were washed with GST binding 
buffer and the purified protein was used for experiments. 
6.9 GST pull-down experiments 
In vitro GST pull-downs were performed in GST binding buffer by incubating proteins of 
interest with GST alone or GST-tagged proteins (immobilized on Glutathione resin) for 1~3 
hour at 4 °C. The reactions were washed with 1 ml GST binding buffer for three times, and 
samples were analyzed by SDS-page or Western blotting.  
6.10 Protein expression in insect cells (Shweta Bendre’s protocol) 
The gene of interest was cloned into pFG vector and confirmed by sequencing. The 
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recombinant DNA was transformed into EMBACY E.Coli competent cells using heat shock 
method, and incubated at 37 °C for 6 hour. Bacterial cells were plated onto LB agar plates 
supplemented with 10 g/mL Gentamycin, 7 g/mL Tetracycline, 50 g/mL Kanamycin, 40 g/mL 
IPTG and 100 g/mL X-Gal. The EMBACY cells contain a BAC that harbors the Baculovirus 
genome along with a helper plasmid containing the Tn7 transposon enzyme complex under an 
IPTG inducible promoter. In the pFG vector, our gene of interest is flanked by Tn7R and 
Tn7L transposon sequences. In EMBACY cells after induction with IPTG, Tn7 transposon 
enzyme complex allows integration of our gene from the pFG vector to a site on the BAC, 
which disrupts the LacZα gene. Bacteria containing the recombinant BAC were identified 
using blue/white screening. One white colony was grown in liquid culture containing 10 g/mL 
Gentamycin, 7 g/mL Tetracycline, 50 g/mL Kanamycin overnight at 37 °C. The purified BAC 
was precipitated using isopropanol for 30 min on ice and further washed twice using 70% 
ethanol. The ethanol was removed under sterile conditions and the BAC was resuspended in 
Tris-EDTA buffer. Transfections were performed in 6 well dishes containing Sf9 cells (1*106 
cells/mL; immortalized cell line from Spodoptera frugiperda) using FuGENE transfection 
reagent. The cells after transfection were incubated for 3 days at 27 °C. After 72 h, cells were 
resuspended and added to a 10 cm dish containing 1*106 Sf9 cells/mL and incubated for 4 
days at 27 °C for amplification of the virus. After 96 h, the cells were harvested and 
centrifuged at 2500 rpm for 5 min at 27 °C. Thereafter, 5% FBS was added to the supernatant, 
which was then sterile filtered and stored at 4 °C as V0 (Virus0). The virus was further 
amplified by adding 1:50 of the V0 to 50 mL 1*106 Sf9 cells/mL and incubated for 4 days at 
27 °C. The 50 mL culture was harvested by centrifugation and the supernatant was stored at 4 
°C as V1. Similarly, the V1 was further amplified to produce V2, by adding 1:50 V1 in 50 mL 
Sf9 culture. This V2 was further used for large-scale expression of proteins in Tnao38 
(Trichoplusia ni) cells. 
6.11 In vitro proteins phosphorylation  
Proteins of interest were phosphorylated by Aurora A, Aurora or Cdk1 using a molar ratio 
1:100 (kinase: protein) overnight on ice in the buffer further supplemented with 10 mM 
MgCl2, 1 mM sodium orthovanadate and 2 mM ATP. The phosphorylation reaction was 
stopped by adding 5 µM RO-3306 (Cdk1 inhibitor) or 500 nM MLN8054 (Aurora A 
inhibitor) for 10 min on ice. The proteins were then either used for GST pulldown. 
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 6.12 ProQ Diamond staining  
Phosphorylation of GTSE1 was confirmed using ProQ diamond staining. Equimolar 
concentrations (2 µM) of all proteins phosphorylated and unphosphorylated were resolved on 
a SDS PAGE gel. The gels were incubated with fixing solution overnight following which 
they were washed three times with water to remove all traces of fixing solution. Next the gels 
were incubated with ProQ Diamond phospho-specific stain for 90 min with shaking in dark. 
Gels were destained thrice for 30 min each with destaining solution followed by washing with 
water for 10 min thrice. All the steps were performed at room temperature. The signal for 
ProQ was detected using the BioRad developer. The gel was then stained with Coomassie 
blue (CB) to confirm equal protein loading. 
6.13 Cell culture and cell expressing BAC lines 
U2OS and U2OS BAC-transgene lines were grown in DMEM media containing 10% fetal 
bovine serum, 2 mM L-Glutamine, 100U/mL Penicillin and 0.1mg/mL streptomycin at 37 °C 
in 5% CO2. U2OS cells expressing GTSE1-WT-GFP or GTSE1-5xLID-GFP were generated 
by transfecting the respective BACs using Effectene transfection reagent according to 
manufacturers protocol, and selecting for stable lines. 
6.14 Gene silencing using RNA interference (RNAi) 
Cells were seeded into 3,5 cm dishes one day before siRNA treatment. 3,0 µl lipofectamine 
RNAiMax and 25-50 nM siRNA were pre-incubated with 200 µl Opti-MEM for 5 min. These 
two mixtures were mixed and further incubated for 25 min. Cells were wished with PBS for 2 
times, and added 1,6 ml Opti-MEM into the dishes. The siRNA/lipofectamine RNAiMax 
mixtures were further added into dishes. These reagents were replaced with culture medium 
following incubating for 6-8 hour. Cells were analyzed 48 to 60 hour after siRNA treatment. 
Sequences of siRNAs were shown below. GTSE1: 5ʹ-GAUUCAUACAGGAGUCAAA-3ʹ 
(Ambion), CHC: 5ʹ-GGUUGCUCUUGUUACGGAUtt-3ʹ, Hec1-No.1: 5ʹ-
AACCCUGGGUCGUCAGGAA-3ʹ, Hec1-No.2: 5ʹ-AAGAGUAGAACUAGAAUGUGAA-
3ʹ. 
6.15 Antibodies 
Table 6-9. List of primary and secondary antibodies 
Primary 
antibody 
Directed 
to 
Made in 
Dilution Clone number and 
Company WB IF 
 DM1α  Human Mouse 1:10,000 1:400 Sigma Aldrich 
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Anti-GTSE1 
3753 
Human Rabbit  1:30,000 1:1000 
MPI CBG, Dresden 
(Scolz et al., 2012) 
Anti-CREST  Human Human - 1:500 
CS1058; Europa 
Bioproducts Ltd. 
Anti-GFP  Rabit 1:10,000 1:500 Abcam (ab6556) 
Anti-His  Mouse  1:5000  Qiagen 
Anti-MCAK Human Mouse 1:100 1:200 
Clone 1G2; Abnova 
Corporation 
Anti-CHC Human Mouse 1:1000 1:500 Abcam (X22) 
Anti-GST  Mouse 1:10,000  Novagen #71097-3 
Anti-TACC3 Human Rabbit 1:5000 1:500 
Santa Cruz 
Biotechnlogy, H-300 
Anti-pTACC3 Human Rabbit 1:1000 1:2000 
Kind gift from Kazu 
Kinoshita 
Anti-MBP  Mouse 1:10000  NEB #E8032S 
Anti-Aurora A Human Rabbit 1:2000  Abcam #12875 
Texas Red (594) 
dye-conjugated 
AffinityPure  
Mouse Donkey - 1:500 
Jackson 
ImmunoResearch 
Europe Ltd., UK 
Texas Red (594) 
dye-conjugated 
AffinityPure 
Rabbit Donkey  1:500 
Bethyl Laboratories, 
Inc. Montgomery, 
USA 
Texas Red (594) 
dye-conjugated 
AffinityPure 
Human Donkey  1:500 
Jackson 
ImmunoResearch 
Laboratories 
Alexa 488-
conjugated 
AffinityPure 
Mouse Donkey  1:500 
Bethyl Laboratories, 
Inc. Montgomery, 
USA 
Alexa 488-
conjugated 
AffinityPure 
Rabbit  Donkey - 1:500 
Bethyl Laboratories, 
Inc. Montgomery, 
USA 
Cy5-conjugated 
AffinityPure 
Mouse Donkey  1:300 
Bethyl Laboratories, 
Inc. Montgomery, 
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6.16 Immunofluorescence 
Cells on coverslips were fixed using −20 °C methanol or 4% PFA/PIPES. For methanol 
fixation, cells were fixed using −20 °C methanol for 10 min and wished with PBS for 3 times 
to remove methanol. To prepare PFA/PIPES, 4% PFA dissolved in Pipes (50 mM Pipes, pH 
7.2, 10 mM EGTA, 1 mM MgCl2, and 0.2% Triton X-100). For fixation, cells were incubated 
with 4% PFA/PIPES at room temperature for 10 min and then further incubated with 0.25% 
Triton X-100 for 5 min. Cells were then wished with PBS to remove the reagents. For 
immunofluorescence, cells were incubated with primary antibodies in 0.5% BSA in PBST for 
overnight at 4 °C in a humidified chamber. They were then washed for 30 min with PBST, 
and the same process was repeated with secondary antibodies. Coverslips were mounted with 
ProLong gold containing DAPI. 
6.17 Immunoprecipitation 
To prepare mitotic cells, 80% confluence of cells was arrested by adding 3.3 µM nocodazole 
for 18 hour and then harvested by shake-off. Cells were lysed using cell lysis buffer with 
protease inhibitor followed by centrifugation at 13,000 rpm for 10 min at 4 °C. Final 
concentration of the cell lysate was around 1mg/ml. 1-2 µg of the indicated antibody was 
added to ~900 µL of the cell lysate and incubated for 2 hour at 4 °C with rotation. 25 µL of 
Dynabeads coupled to protein G was washed with cell lysis buffer for 3 times and then added 
to the extracts to incubate for 4 hour at 4 °C. The beads were washed three times with 1 mL of 
cell lysis buffer and once with 1X PBS and then resuspended in hot Laemmli buffer to be 
analyzed by Western blotting. 
USA 
Cy5-conjugated 
AffinityPure 
Rabbit Donkey  1:300 
Bethyl Laboratories, 
Inc. Montgomery, 
USA 
Cy5-conjugated 
AffinityPure 
Human Donkey  1:500 
Jackson 
ImmunoResearch 
Laboratories 
HRP-conjugated Mouse Goat 1:5000 - GE/Amersham 
HRP-conjugated Rabbit Donkey 1:5000 - GE/Amersham 
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6.18 Sodium dodecyl sulfate (SDS) electrophoresis  
Proteins are denatured using Laemmli buffer, which contains a negatively charged detergent 
SDS that coats the polypeptide chains. Due to this the proteins obtain a net negative charge. 
These negatively charged proteins move with different speeds towards the anode. The speed 
at which they move depends on the molecular weight of proteins and the percentage of 
acrylamide in the gel. Smaller proteins move faster through the pores towards the anode, 
whereas, the motion of larger proteins is retarded due to the small pore size of the acrylamide 
gel. SDS PAGE gels were run using SDS-PAGE running buffer at 120-180 V for 1-1.5 hour.  
6.19 Western blot 
Proteins from SDS-PAGE gels were transferred onto nitrocellulose membrane using Western 
transfer buffer at 300 mA for 2 hour at 4 °C. The membrane was blocked with 5 % skimmed 
milk in 1X PBS containing 0.1% Tween20 (PBS-T) and incubated with primary antibodies 
overnight at 4 °C. The membrane was then washed three times for 10 min each using PBS-T 
followed by incubation with appropriate secondary antibodies for 1 h at room temperature. 
The membrane was washed three times for 15 min each with PBS-T. Protein signals were 
detected using enhanced chemiluminescence. 
6.20 Proximity ligation assay (PLA) 
Experiments were performed using the PLA kits (Sigma) according to manufacturer’s 
protocol. In Brief, Cells on coverslips were fixed by 4% PFA/PIPES and wished with PBS. 
Fixed cells were performed blocking by the blocking reagent from the kit at 37 °C for 1 hour. 
Diluted MCAK and GFP antibodies for 100 times in the antibody dilution buffer from the kit, 
and coverslips were incubated with primary antibodies at 4 °C overnight. Coverslips were 
washed with 1xBuffer A from kit for 2 times (5 min for each time). Anti-mouse and anti-
rabbit PLA probes were diluted for 5 times in the dilution buffer, and coverslips were 
incubated with the PLA probes at 37 °C for 1 hour. After the incubation, samples were 
wished with 1xBuffer A from kit for 2 times (5 min for each time). Samples with PLA probes 
were further preformed the ligation by ligase (1:40 dilution) from the kit at 37 °C for 30 min 
and then wished with 1xBuffer A from kit for 2 times (5 min for each time). To amplify the 
PLA signal, coverslips were incubated with amplification enzyme (1:80 dilution) from the kit 
at 37 °C for 100 min. Coverslips were washed with 1X Buffer B from the kit for 2 times (10 
min for each time) and coverslips were mounted with mounting medium following washed 
with 0.01X Buffer B for 2 mim.       
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6.21 Fluorescence microtubule binding assay 
Rhodamine-labeled tubulin, biotin-labeled tubulin and unlabeled tubulin were mixed (the 
final concentration of tubulin is 10 µm) and polymerized in the presence of 1 mM GTP in 
BRB buffer at 34 °C for 15 min. The microtubules were then stabilized by adding 20 µm and 
incubated for 5 more min. Microtubules were diluted 10 times in BRB buffer with 10 mM 2-
mercaptoethanol. Coverslips for flow cells were incubated with 2% biotinylated poly-L-
Lysine-PEG at room temperature for half hour, and try with N2 gas. Coated coverslips were 
assembled as flow cells. The surface of the flow cell was passivated with 1% pluronic F-127 
at room temperature in a humility chamber for 1 hour. 0.1mg/ml avidin in BRB80 with 10uM 
taxol was added into the flow cell and incubated at room temperature for 10 min, and 
subsequently washed with at least 5 chamber volumes of BRB80 containing 10 uM taxol. 
Microtubules were added into the flow cell for 10 min. Protein of interest was then added into 
the flow cell. The flow cell was then imagined under microscopy. 
6.22 Microscopy  
Images were acquired using a Marianas (3i) spinning disk confocal system based on an Axio 
Observer Z1 microscopy (Zeiss) equipped with a Hamamatsu ORCA-Flash 4.0 Camera. 
Images were taken using 63x 1.4 NA Apochromat objective (Zeiss) and Slidebook software 
6.0. All other images were acquired using a DeltaVision imaging system (GE Healthcare) 
equipped with an sCMOS camera (PCO edge 5.5). Images were taken using a 60x 1.42 NA 
PlanApo-N objective (Olympus) at room temperature. Serial Z-stacks of 0.2 µm thickness 
were obtained and deconvolved using SoftWoRx 6.1.1 software. 
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